US20040185484A1 - Method for preparing single-stranded DNA libraries - Google Patents
Method for preparing single-stranded DNA libraries Download PDFInfo
- Publication number
- US20040185484A1 US20040185484A1 US10/767,894 US76789404A US2004185484A1 US 20040185484 A1 US20040185484 A1 US 20040185484A1 US 76789404 A US76789404 A US 76789404A US 2004185484 A1 US2004185484 A1 US 2004185484A1
- Authority
- US
- United States
- Prior art keywords
- dna
- adaptor
- universal
- single stranded
- dna molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108020004414 DNA Proteins 0.000 title claims abstract description 487
- 238000000034 method Methods 0.000 title claims abstract description 168
- 102000053602 DNA Human genes 0.000 title claims abstract description 144
- 108020004682 Single-Stranded DNA Proteins 0.000 title claims abstract description 89
- 239000012634 fragment Substances 0.000 claims abstract description 91
- 239000007787 solid Substances 0.000 claims abstract description 60
- 238000012163 sequencing technique Methods 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- 239000011324 bead Substances 0.000 claims description 128
- 150000007523 nucleic acids Chemical class 0.000 claims description 67
- 102000039446 nucleic acids Human genes 0.000 claims description 61
- 108020004707 nucleic acids Proteins 0.000 claims description 61
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 40
- 125000003729 nucleotide group Chemical group 0.000 claims description 36
- 239000002773 nucleotide Substances 0.000 claims description 35
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 32
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 32
- 230000029087 digestion Effects 0.000 claims description 28
- 230000037452 priming Effects 0.000 claims description 28
- 230000000295 complement effect Effects 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 25
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 23
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 23
- 229960002685 biotin Drugs 0.000 claims description 22
- 239000011616 biotin Substances 0.000 claims description 22
- 239000002299 complementary DNA Substances 0.000 claims description 22
- 235000020958 biotin Nutrition 0.000 claims description 20
- 238000009396 hybridization Methods 0.000 claims description 19
- 239000000839 emulsion Substances 0.000 claims description 17
- 238000002663 nebulization Methods 0.000 claims description 17
- 239000006199 nebulizer Substances 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 11
- 102000003960 Ligases Human genes 0.000 claims description 10
- 108090000364 Ligases Proteins 0.000 claims description 10
- 230000002255 enzymatic effect Effects 0.000 claims description 9
- 102000012410 DNA Ligases Human genes 0.000 claims description 8
- 108010061982 DNA Ligases Proteins 0.000 claims description 8
- 108010002747 Pfu DNA polymerase Proteins 0.000 claims description 8
- 210000004507 artificial chromosome Anatomy 0.000 claims description 7
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 claims description 6
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 claims description 6
- 239000007762 w/o emulsion Substances 0.000 claims description 6
- 108090001008 Avidin Proteins 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 230000002441 reversible effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 102000006306 Antigen Receptors Human genes 0.000 claims description 4
- 108010083359 Antigen Receptors Proteins 0.000 claims description 4
- 108091000080 Phosphotransferase Proteins 0.000 claims description 4
- 238000001502 gel electrophoresis Methods 0.000 claims description 4
- 102000020233 phosphotransferase Human genes 0.000 claims description 4
- 230000033616 DNA repair Effects 0.000 claims description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 230000005298 paramagnetic effect Effects 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 102000001253 Protein Kinase Human genes 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000003508 chemical denaturation Methods 0.000 claims description 2
- 108060006633 protein kinase Proteins 0.000 claims description 2
- 239000003352 sequestering agent Substances 0.000 claims description 2
- 230000003321 amplification Effects 0.000 abstract description 42
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 42
- 238000005498 polishing Methods 0.000 abstract description 22
- 238000006073 displacement reaction Methods 0.000 abstract description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 68
- 108091034117 Oligonucleotide Proteins 0.000 description 56
- 239000000243 solution Substances 0.000 description 53
- 239000000523 sample Substances 0.000 description 44
- 239000000872 buffer Substances 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000000499 gel Substances 0.000 description 33
- 108010090804 Streptavidin Proteins 0.000 description 23
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 23
- 239000003153 chemical reaction reagent Substances 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 22
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 21
- 241000894007 species Species 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- 238000000137 annealing Methods 0.000 description 19
- 238000002955 isolation Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 238000013467 fragmentation Methods 0.000 description 14
- 238000006062 fragmentation reaction Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 13
- 239000000539 dimer Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 239000007983 Tris buffer Substances 0.000 description 11
- 239000011543 agarose gel Substances 0.000 description 11
- 230000000692 anti-sense effect Effects 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 11
- 101710163270 Nuclease Proteins 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 102000040430 polynucleotide Human genes 0.000 description 9
- 108091033319 polynucleotide Proteins 0.000 description 9
- 239000002157 polynucleotide Substances 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000000527 sonication Methods 0.000 description 8
- 108010017826 DNA Polymerase I Proteins 0.000 description 7
- 102000004594 DNA Polymerase I Human genes 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 239000012149 elution buffer Substances 0.000 description 7
- 230000005291 magnetic effect Effects 0.000 description 7
- 229920002223 polystyrene Polymers 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000005755 formation reaction Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 229920000936 Agarose Polymers 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 5
- 239000011654 magnesium acetate Substances 0.000 description 5
- 235000011285 magnesium acetate Nutrition 0.000 description 5
- 229940069446 magnesium acetate Drugs 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- 108091028664 Ribonucleotide Proteins 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 239000005547 deoxyribonucleotide Substances 0.000 description 4
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000011535 reaction buffer Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000002336 ribonucleotide Substances 0.000 description 4
- 125000002652 ribonucleotide group Chemical group 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- FMKJUUQOYOHLTF-OWOJBTEDSA-N (e)-4-azaniumylbut-2-enoate Chemical compound NC\C=C\C(O)=O FMKJUUQOYOHLTF-OWOJBTEDSA-N 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- 108091092584 GDNA Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108010010677 Phosphodiesterase I Proteins 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 239000012082 adaptor molecule Substances 0.000 description 3
- -1 but not limited to Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 108091092742 A-DNA Proteins 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091081021 Sense strand Proteins 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 108010064978 Type II Site-Specific Deoxyribonucleases Proteins 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000007169 ligase reaction Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000005257 nucleotidylation Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000004713 phosphodiesters Chemical class 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 241000701844 Bacillus virus phi29 Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 101000856513 Homo sapiens Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Proteins 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 1
- 101000666730 Homo sapiens T-complex protein 1 subunit alpha Proteins 0.000 description 1
- 102100025509 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Human genes 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 1
- 101100248028 Mus musculus Rev3l gene Proteins 0.000 description 1
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100029812 Protein S100-A12 Human genes 0.000 description 1
- 101710110949 Protein S100-A12 Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 206010042602 Supraventricular extrasystoles Diseases 0.000 description 1
- 102100038410 T-complex protein 1 subunit alpha Human genes 0.000 description 1
- 241000193447 Thermoanaerobacter thermohydrosulfuricus Species 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 108700021042 biotin binding protein Proteins 0.000 description 1
- 102000043871 biotin binding protein Human genes 0.000 description 1
- 238000001818 capillary gel electrophoresis Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012938 design process Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- XXQCMVYBAALAJK-UHFFFAOYSA-N ethyl n-[4-[benzyl(2-phenylethyl)amino]-2-(2-phenylethyl)-1h-imidazo[4,5-c]pyridin-6-yl]carbamate Chemical compound N=1C=2C(N(CCC=3C=CC=CC=3)CC=3C=CC=CC=3)=NC(NC(=O)OCC)=CC=2NC=1CCC1=CC=CC=C1 XXQCMVYBAALAJK-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000012409 standard PCR amplification Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6867—Replicase-based amplification, e.g. using Q-beta replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/251—Colorimeters; Construction thereof
- G01N21/253—Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
- G01R33/1269—Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0819—Microarrays; Biochips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0877—Flow chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6484—Optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Definitions
- the invention relates to protein chemistry, molecular biology, and methods of preparing single-stranded libraries for sequence analysis. More specifically, this invention includes methods of processing DNA for use in amplification and sequencing reactions.
- PCR polymerase chain reaction
- two primers are designed to hybridize to the template DNA at positions complementary to respective primers that are separated on the DNA template molecule by some number of nucleotides.
- the base sequence of the template DNA between and including the primers is amplified by repetitive complementary strand extension reactions whereby the number of copies of the target DNA fragments is increased by several orders of magnitude.
- Amplification is exponential as 2 n , where n equals the number of amplification cycles.
- the amplified DNA may be sequenced through conventional sequencing methods (see, U.S. Pat. No. 6,274,320).
- Samples comprising large template DNA or whole DNA genomes comprising long nucleotide sequences are not conducive to efficient amplification by PCR. These long molecules do not naturally possess sequences useful for primer hybridization. In addition, if primer hybridization sequences are added to double stranded DNA molecules, it is difficult to ascertain the directionality of the amplified DNA molecules and this frustrates sequencing efforts.
- U.S. Pat. No. 5,508,169 describes that subsets of nucleic acid fragments may be indexed (i.e., selected or targeted) based upon the information contained in non-identical 5′-protruding or 3′-protruding cohesive ends. This includes fragments having 3, 4 or 5 base cohesive ends, such as those revealed by cleavage of DNA by Type II restriction endonucleases and interrupted palindrome recognizing type II restriction endonucleases.
- indexing linkers nucleic acid molecules similar to adaptors (called indexing linkers) which contain protruding single strands complementary to the cohesive ends of cleavage sites of restriction endonucleases (rather than the recognition sequences).
- Various functional groups or specific nucleic acid sequences designed for particular applications may be selectively attached to the aforementioned subsets of fragments. Selective attachment of indexing linkers having known base sequences in their cohesive ends to a subset of fragments bearing the complementary cohesive ends can be used for the detection, identification, isolation, amplification, and manipulation of the subset of fragments.
- U.S. Pat. No. 6,468,748 describes a method of sorting genes and/or gene fragments comprising several steps.
- ds cDNA molecules are prepared from mRNA molecules by reverse transcription, using a poly-T primer optionally having a general primer-template sequence upstream from the poly-T sequence, yielding ds cDNA molecules having the poly-T sequence, optionally having the general primer-template sequence.
- the ds cDNA molecules are digested with a restriction enzyme that produces digested cDNA molecules with cohesive ends having overhanging ssDNA sequences of a constant number of arbitrary nucleotides.
- the digested cDNA molecules are ligated to a set of dsDNA oligonucleotide adaptors, each of which adaptors has at one of its ends a cohesive-end ssDNA adaptor sequence complementary to one of the possible overhanging ssDNA sequences of the digested cDNA, at the opposite end a specific primer-template sequence specific for the ssDNA adaptor complementary sequence, and in between the ends a constant sequence that is the same for all of the different adaptors of the set.
- the ligated cDNA molecules are amplified by separate polymerase chain reactions, utilizing for each separate polymerase chain reaction a primer that anneals to the cDNA poly-T sequence optionally having the cDNA general primer-template, and a primer from a set of different specific primers that anneal to the cDNA specific primer-template sequences.
- the amplified cDNA molecules are sorted into nonoverlapping groups by collecting the amplification products after each separate polymerase chain reaction, each group of amplified cDNA molecules determined by the specific primer that annealed to the specific primer-template sequence and primed the polymerase chain reaction.
- U.S. Pat. No. 5,863,722 describes a method and materials for sorting polynucleotides with oligonucleotide tags.
- the oligonucleotide tags are capable of hybridizing to complementary oligomeric compounds consisting of subunits having enhanced binding strength and specificity as compared to natural oligonucleotides.
- tag complements Such complementary oligomeric compounds are referred to as “tag complements.”
- Subunits of tag complements may consist of monomers of non-natural nucleotide analogs, referred to as “antisense monomers” or they may comprise oligomers having lengths in the range of 3 to 6 nucleotides or analogs thereof, including antisense monomers, the oligomers being selected from a minimally cross-hybridizing set. In such a set, a duplex made up of an oligomer of the set and the complement of any other oligomer of the set contains at least two mismatches.
- an oligomer of a minimally cross-hybridizing set at best forms a duplex having at least two mismatches with the complement of any other oligomer of the same set.
- Tag complements attached to a solid phase support are used to sort polynucleotides from a mixture of polynucleotides each containing a tag. The surface of each support is derivatized by only one type of tag complement which has a particular sequence.
- the polynucleotides to be sorted each comprise an oligonucleotide tag in the repertoire, such that identical polynucleotides have the same tag and different polynucleotides have different tags.
- subpopulations of identical polynucleotides are sorted onto particular beads or regions.
- the subpopulations of polynucleotides can then be manipulated on the solid phase support by micro-biochemical techniques.
- U.S. Pat. No. 5,728,524 describes a process for the categorization of nucleic acid sequences in which these sequences are linked to a population of adaptor molecules, each exhibiting specificity for linking to a sequence including a predetermined nucleotide base. The resulting linked sequences are then categorized based upon selection for the particular base.
- the art does not describe methods for generating libraries of unknown fragment sequences additionally comprising two known sequences, each different than the other, one being adjoined at each end.
- This invention describes a novel method for preparing a library of multiple nucleic acid sequences from a sample where the library is suited to further quantitative and comparative analysis, particularly where the multiple nucleic acid sequences are unknown and derived from large template DNA or whole (or partial) genome DNA.
- sequences of single stranded DNA are prepared from a sample of large template DNA or whole or partial DNA genomes through fragmentation, polishing, adaptor ligation, nick repair, and isolation of ssDNA.
- the present invention provides a method for clonally isolating a library comprising a plurality of ssDNAs, wherein each ssDNA comprises a first single stranded universal adaptor and a second single stranded universal adaptor, the method comprising:
- the single stranded DNA molecules are delivered into droplets in a water-in-oil emulsion (i.e., microreactors), or onto multiwell surfaces (e.g., PicoTiter plates).
- a water-in-oil emulsion i.e., microreactors
- multiwell surfaces e.g., PicoTiter plates
- the single stranded DNA molecules may be delivered via attachment to a solid support (e.g., beads).
- a solid support e.g., beads
- the adaptor ligated DNA molecules comprising a first double stranded universal adaptor and second double stranded universal adaptor is attached to a solid support via one strand of the double stranded universal adaptor (via the first or second universal adaptor).
- the adaptor ligated DNA molecules which have not attached to a solid support are washed away, and one strand of the adaptor ligated DNA molecules is released. This generates a mixture comprising a plurality of ssDNAs comprising a population of single stranded molecules with a first and second universal adaptor pair, thereby generating a library.
- sequence of the fragmented DNA may be known or unknown.
- sequence of the fragmented DNA, particularly the sequence of the ends of the fragmented DNA is unknown.
- the present invention includes a method for generating a ssDNA library linked to solid supports comprising: (a) generating a library of ssDNA templates; (b) attaching the ssDNA templates to solid supports; and (c) isolating the solid supports on which one ssDNA template is attached.
- the present invention includes a library of mobile solid supports made by the method disclosed herein.
- FIG. 1 is a schematic representation of the entire process of library preparation including the steps of template DNA fragmentation (FIG. 1A), end polishing (FIG. 1B), adaptor ligation (FIG. 1C), nick repair, strand extension and gel isolation (FIG. 1D).
- FIG. 1 also depicts a representative agarose gel containing a sample preparation of a 180-350 base pair adenovirus DNA library according to the methods of this invention.
- FIG. 2A is a schematic representation of the universal adaptor design according one embodiment of the present invention.
- Each universal adaptor is generated from two complementary ssDNA oligonucleotides that are designed to contain a 20 bp nucleotide sequence for PCR priming, a 20 bp nucleotide sequence for sequence priming and a unique 4 bp discriminating sequence comprised of a non-repeating nucleotide sequence (i.e., ACGT, CAGT, etc.).
- a non-repeating nucleotide sequence i.e., ACGT, CAGT, etc.
- FIG. 2B depicts a representative universal adaptor sequence pair for use with the invention.
- Adaptor A sense strand SEQ ID NO:1;
- Adaptor A antisense strand SEQ ID NO:2;
- Adaptor B sense strand SEQ ID NO:3;
- Adaptor B antisense strand SEQ ID NO:4.
- FIG. 2C is a schematic representation of universal adaptor design for use with the invention.
- FIG. 3 represents the strand displacement and extension of nicked double-stranded DNA fragments according to the present invention.
- double-stranded DNA fragments will be generated that contain two nicked regions following T4 DNA ligase treatment (FIG. 3A).
- a strand displacing enzyme i.e., Bst DNA polymerase I
- FIG. 3B strand displace the nicked strand and complete nucleotide extension of the strand
- FIG. 3D non-nicked double-stranded DNA fragments
- FIG. 4 represents the isolation of directionally-ligated single-stranded DNA according to the present invention using streptavidin-coated magnetic beads.
- double-stranded DNA will contain adaptors in four possible combinations: AA, BB, AB, and BA.
- universal adaptor B contains a 5′-biotin
- magnetic streptavidin-coated solid supports are used to capture and isolate the AB, BA, and BB populations (population AA is washed away).
- the BB population is retained on the beads as each end of the double-stranded DNA is attached to a bead and is not released.
- FIG. 5 represents an insert flanked by PCR primers and sequencing primers.
- FIG. 6 represents truncated product produced by PCR primer mismatch at cross-hybridization region (CHR).
- FIGS. 7A-7D depict the assembly for the nebulizer used for the methods of the invention.
- a tube cap was placed over the top of the nebulizer (FIG. 7A) and the cap was secured with a nebulizer clamp assembly (FIG. 7B).
- the bottom of the nebulizer was attached to the nitrogen supply (FIG. 7C) and the entire device was wrapped in parafilm (FIG. 7D).
- FIG. 8 depicts representative BioAnalyzer output from analysis of a single stranded DNA library.
- FIG. 9A depicts representative results for LabChip analysis of a single stranded DNA library following nebulization and polishing.
- FIG. 9B depicts representative size distribution results for an adaptor-ligated single stranded DNA library following nebulization, polishing, and gel purification.
- FIG. 10 depicts the calculation for primer candidates based on melting temperature.
- This invention relates to the preparation of sample DNA for amplification and sequencing reactions.
- the invention includes a method for preparing the sample DNA comprised of the following steps: (a) fragmenting large template DNA or whole genomic DNA samples to generate a plurality of digested DNA fragments; (b) creating compatible ends on the plurality of digested DNA samples; (c) ligating a set of universal adaptor sequences onto the ends of fragmented DNA molecules to make a plurality of adaptor-ligated DNA molecules, wherein each universal adaptor sequence comprises a PCR primer sequence, a sequencing primer sequence and a discriminating key sequence and wherein one adaptor is attached to biotin; (d) separating and isolating the plurality of ligated DNA fragments; (e) removing any portion of the plurality of ligated DNA fragments; (f) nick repair and strand extension of the plurality of ligated DNA fragments; (g) attaching each of the ligated DNA fragments to a solid support; and (h) isolating populations
- the term “universal adaptor” refers to two complementary and annealed oligonucleotides that are designed to contain a nucleotide sequence for PCR priming and a nucleotide sequence for sequence priming.
- the universal adaptor may further include a unique discriminating key sequence comprised of a non-repeating nucleotide sequence (i.e., ACGT, CAGT, etc.).
- a set of universal adaptors comprises two unique and distinct double-stranded sequences that can be ligated to the ends of double-stranded DNA. Therefore, the same universal adaptor or different universal adaptors can be ligated to either end of the DNA molecule.
- the universal adaptor may be referred to as a single stranded universal adaptor.
- discriminating key sequence refers to a sequence including a combination of the four deoxyribonucleotides (i.e., A, C, G, T). The same discriminating sequence can be used for an entire library of DNA fragments. Alternatively, different discriminating key sequences can be used to track libraries of DNA fragments derived from different organisms. Longer discriminating key sequences can be used for a mixture of more than one library.
- the term “plurality of molecules” refers to DNA isolated from the same source, whereby different organisms may be prepared separately by the same method.
- the plurality of DNA samples is derived from large segments of DNA, e.g., genomic DNA, cDNA, viral DNA, plasmid DNA, cosmid DNA, artificial chromosome DNA (e.g., BACs, YACs, MACs, PACs), synthetic DNA, phagemid DNA, phasemid DNA, or from reverse transcripts of viral RNA.
- This DNA may be derived from any source, including any mammal (i.e., human, nonhuman primate, rodent, or canine), plant, bird, reptile, fish, fungus, bacteria, or virus.
- library refers to a subset of smaller sized DNA species generated from a larger DNA template, e.g., a segmented or whole genome.
- unique refers to a sequence that does not exist or exists at an extremely low copy level within the DNA molecules to be amplified or sequenced.
- compatible refers to an end of double stranded DNA to which an adaptor molecule may be attached (i.e., blunt end or cohesive end).
- fragmenting refers to a process by which a larger molecule of DNA is converted into smaller pieces of DNA.
- large template DNA would be DNA of more than 5 kb, 10 kb, or 25 kb, preferably more than 500 kb, more preferably more than 1 MB, and most preferably 5 MB or larger.
- stringent hybridization conditions refers to those conditions under which only fully complimentary sequences will hybridize to each other.
- the fragmentation of the DNA sample can be done by any means known to those of ordinary skill in the art.
- the fragmenting is performed by enzymatic, chemical, or mechanical means.
- the mechanical means may include sonication, French press, HPLC, HydroShear (GeneMachines, San Carlos, Calif.), and nebulization.
- the enzymatic means may be performed by digestion with Deoxyribonuclease I (DNase I), nonspecific nucleases, or single or multiple restriction endonucleases.
- DNase I Deoxyribonuclease I
- the fragmentation results in ends for which the sequence adjacent to the end is not known.
- the sequence adjacent to the end may be at least 5 bases, 10 bases, 20 bases, 30 bases, or 50 bases.
- the enzymatic means is DNase I.
- DNase I is a versatile enzyme that nonspecifically cleaves double-stranded DNA (dsDNA) to release 5′-phosphorylated oligonucleotide products.
- DNase I has optimal activity in buffers containing Mn 2+ , Mg 2+ and Ca 2+ .
- the purpose of the DNase I digestion step is to fragment a large DNA genome into smaller species comprising a library.
- the cleavage characteristics of DNase I will result in random digestion of template DNA (i.e., minimal sequence bias) and in the predominance of blunt-ended dsDNA fragments when used in the presence of manganese-based buffers (Melgar, E. and D. A.
- DNase I is used to digest large template DNA or whole genome DNA for 1-2 minutes to generate a population of oligonucleotides that range from 50 to 500 bp, or 50 to 700 bp.
- the DNase I digestion is performed at a temperature of 10° C.-37° C.
- the digested DNA fragments are 50 bp to 700 bp in length.
- nucleic acid fragmentation Another preferred method for nucleic acid fragmentation is mechanical fragmentation.
- Mechanical fragmentation methods include sonication and nebulization, and use of HydroShear, HPLC, and French Press devices.
- Sonication may be performed by a tube containing DNA in a suitable buffer (i.e., 10 mM Tris, 0.1 mM EDTA) and sonicating for a varying number of 10 second bursts using maximum output and continuous power Sonicators are commercially available from, e.g., Misonix Inc. (Farmingdale, N.Y.), and can be used essentially as described by Bankier and Barrell (Bankier, A. T., Weston, K. M., and Barrell, B.
- sonication it is preferred to maintain the nucleic acid at a uniform temperature by keeping the sample on ice. Constant temperature conditions, at 0° C. for example, are preferred to maintain an even fragment distribution.
- the optimal conditions for sonication may be determined empirically for a given DNA sample before preparative sonication is performed. For example, aliquots of DNA can be treated for different times under sonication and the size and quality of DNA can be analyzed by PAGE. Once optimal sonication conditions are determined, the remaining DNA can be sonicated according to those pre-determined conditions.
- nucleic acid fragmentation is treatment by nebulizers (e.g., protocols, and hardware available from GeneMachines, San Carlos, Calif. Also see U.S. Pat. Nos. 5,506,100 and 5,610,010).
- nebulizers e.g., protocols, and hardware available from GeneMachines, San Carlos, Calif. Also see U.S. Pat. Nos. 5,506,100 and 5,610,010).
- hydrodynamic shearing forces are used to fragment DNA strands.
- DNA in a aqueous solution can be passed through a tube with an abrupt contraction. As the solution approaches the contraction, the fluid accelerates to maintain the volumetric flow rate through the smaller area of the contraction. During this acceleration, drag forces stretch the DNA until it snaps.
- the DNA solution can be passed several times (e.g., 15 to 20 cycles) through the contraction until the fragments are too short for further shearing.
- DNA may be suspended in various solutions including, but not limited to, water, Tris buffer, Tris-EDTA buffer, and Tris-EDTA with up to 0.5 M NaCl.
- Polishing digestion of genomic DNA (gDNA) templates with DNase I in the presence of Mn 2+ produces fragments of DNA that are either blunt-ended or have protruding termini with one or two nucleotides in length.
- fragmentation of DNA by mechanical means provides a combination of fragments with blunt-ends or overhanging ends.
- Polishing also called end repair refers to the conversion of non-blunt ended DNA into blunt ended DNA.
- polishing may be performed by treatment with a single strand-specific exonuclease, such as BAL32 nuclease or Mung Bean nuclease. Generally, the nuclease should be calibrated prior to use.
- blunt ends are created with Pfu DNA polymerase.
- blunt ends are created with other DNA polymerases such as T4 DNA polymerase or Klenow DNA polymerase.
- Pfu “polishing” or blunt ending can be used to increase the amount of blunt-ended species generated following genomic template digestion with DNase I.
- Pfu DNA polymerase fills in 5′ overhangs.
- Pfu DNA polymerase exhibits 3′ ⁇ 5′ exonuclease activity.
- the enzyme can be used to remove single and double nucleotide extensions to further increase the amount of blunt-ended DNA fragments available for adaptor ligation (see, e.g., Costa, G. L. and M. P. Weiner. 1994a.
- the universal adaptors can be added to each DNA fragment.
- the universal adaptors are designed to include: 1) a set of unique PCR priming regions that are typically 10-20 bp in length (any suitable size may be used) located adjacent to; 2) a set of unique sequencing priming regions that are typically 10-20 bp in length (any suitable size may be used) optionally followed by; 3) a unique discriminating key sequence (e.g., 1-12 bp in length) including a combination of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
- the discriminating key sequence is 4 bases in length.
- the discriminating key sequence may be combinations of 1-4 bases.
- the key sequence includes one of each of the four nucleotides.
- the key sequence includes one or more ribonucleotides, e.g., U.
- each unique universal adaptor is forty-four bp (44 bp) in length, although any suitable size may be used.
- the universal adaptors are ligated, using T4 DNA ligase, onto each end of the DNA fragment to generate a total nucleotide addition of 88 bp to each DNA fragment, although any suitable size may be used.
- Different universal adaptors can be specifically designed for each DNA library preparation and therefore provide a unique identifier for each organism. For example, different library preparations can employ different key sequences. It is understood that the size and sequence of the universal adaptors may be modified as would be apparent to one of skill in the art. Thus, the adaptors for use with the invention are not limited to the size and sequence described herein.
- first and second single-stranded oligonucleotides may be ordered from a commercial vendor (e.g., Integrated DNA Technologies, IA or Operon Technologies, CA).
- a commercial vendor e.g., Integrated DNA Technologies, IA or Operon Technologies, CA.
- all of the first adaptors for a library share one nucleotide sequence, including a PCR priming sequence, sequencing primer sequence, and discriminating key sequence, while all of the second adaptors share another nucleotide sequence.
- the universal adaptor oligonucleotide sequences are modified during synthesis with one or more phosphorothioate linkages in place of phosphodiester linkages.
- adaptor oligonucleotides can include two or three phosphorothioate linkages at both the 5′ and 3′ ends, or at one end.
- Unmodified oligonucleotides are typically subject to rapid degradation by contaminating nucleases that catalyze the hydrolytic cleavage of the phosphodiester linkage between nucleotide bases.
- nuclease-resistant chemistry available for use in oligonucleotide applications is the phosphorothioate modification. In phosphorothioates, a sulfur atom replaces a non-bridging oxygen in the oligonucleotide backbone making it resistant to all forms of nuclease digestion (i.e.
- Each oligonucleotide is HPLC-purified to ensure there are no contaminating or spurious oligonucleotide sequences in the synthetic oligonucleotide preparation.
- the universal adaptors are designed to allow directional ligation to the fragmented DNA.
- Each set of double-stranded universal adaptors is designed with a PCR priming region that includes non-complementary 5′ four-base overhangs which are unable to ligate to each other or to the blunt-ended DNA fragment.
- binding occurs between the 3′ end of the adaptor and the 5′ end of the DNA fragment or between the 3′ end of the DNA fragment and the 5′ end of the adaptor.
- Double-stranded universal adaptor sequences are generated using single-stranded oligonucleotides that are designed with sequences that allow primarily complimentary oligonucleotides to anneal, and to prevent cross-hybridization between two non-complimentary oligonucleotides.
- 95% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
- 97% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
- 99% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
- 100% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
- an overhanging nucleotide e.g., T
- a polymerase is used to add an overhanging nucleotide (e.g., A) to the blunt 5′ ends of the template DNA.
- the overhanging nucleotides of the adaptors and template are complementary to allow more efficient adaptor ligation.
- a plasmid capture system is used in accordance with the disclosed methods.
- the double stranded universal adaptors can be inserted into a plasmid.
- the adaptor region can include the following sequences, in order: Restriction Site(s), PCR Primer Sequence 1, Sequencing Primer Sequence 1, Key Sequence 1, Restriction Site(s), Key Sequence 2, Sequencing Primer Sequence 2, PCR Priming Sequence 2, and Restriction Site(s).
- the plasmid is digested with one or more restriction enzymes that cut between Key Sequence 1 and Key Sequence 2.
- the fragmented template DNA is ligated between Key Sequence 1 and Key Sequence 2.
- the ligated construct is then digested to cut after PCR Priming Sequence 2.
- the digested end next to PCR Priming Sequence 2 is filled in with biotinylated nucleotides.
- the biotinylated construct is digested to cut prior to PCR Primer Sequence 1.
- the Adaptor-DNA fragment-Adaptor-biotin segment is excised and isolated, e.g., by binding to a streptavidin magnetic bead.
- Other embodiments of the plasmid capture system are also possible through application of known cloning techniques. These embodiments are also encompassed by the invention.
- One of the two adaptors can be linked to a support binding moiety.
- a 5′ biotin is added to the first universal adaptor to allow subsequent isolation of ssDNA template and noncovalent coupling of the universal adaptor to the surface of a solid support that is saturated with a biotin-binding protein (e.g., streptavidin, NeutrAvidinTM or avidin).
- Suitable supports include but are not limited to magnetic beads, affinity columns, membranes (e.g., PDVF membrane, nitrocellulose, etc.), which can be coated with streptavidin or another member of a binding pair.
- Other linkages are well known in the art and may be used in place of biotin-streptavidin.
- the solid support is a bead, preferably a polystyrene bead.
- the bead has a diameter of about 2.8 ⁇ m, although any suitable size may be used.
- the bead is a paramagnetic bead (e.g., Dynal Biotech, Inc., Lake Success, N.Y.). As used herein, this bead is referred to as a “sample prep bead”.
- Each universal adaptor may be prepared by combining and annealing two ssDNA oligonucleotides, one containing the sense sequence and the second containing the antisense (complementary) sequence. Schematic representation of the universal adaptor design is depicted in FIG. 2.
- the universal adaptor ligation results in the formation of fragmented DNAs with adaptors on each end, unbound single adaptors, and adaptor dimers.
- agarose gel electrophoresis is used as a method to separate and isolate the adapted DNA library population from the unligated single adaptors and adaptor dimer populations.
- the fragments may be separated by size exclusion chromatography, filtration, sucrose sedimentation, or other nucleic acid separation techniques known to those skilled in the art.
- the procedure of DNase I digestion of DNA typically yields a library population that ranges from 50-700 bp.
- the addition of the 88 bp universal adaptor set will shift the DNA library population to a larger size and will result in a migration profile in the size range of approximately 130-800 bp; adaptor dimers will migrate at 88 bp; and adaptors not ligated will migrate at 44 bp. Therefore, numerous double-stranded DNA libraries in sizes ranging from 200-800 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. In one embodiment, gel isolation of the adapted ligated DNA library will result in the recovery of a library population ranging in size from 200-500 bp. Other methods of distinguishing adaptor-ligated fragments are known to one of skill in the art.
- gaps will be present at the 3′ junctions of the fragmented DNAs following ligase treatment (see FIG. 3A). These “gaps” or “nicks” can be filled in by using a DNA polymerase enzyme that can bind to, strand displace, and extend the nicked DNA fragments.
- DNA polymerases that lack 3′ ⁇ 5′ exonuclease activity but exhibit 5′ ⁇ 3′ exonuclease activity have the ability to recognize nicks, displace the nicked strands, and extend the strand in a manner that results in the repair of the nicks and in the formation of non-nicked double-stranded DNA (see FIG. 3B and 3C) (Hamilton, S. C., J. W. Farchaus and M. C. Davis. 2001. DNA polymerases as engines for biotechnology. BioTechniques 31:370).
- DNA polymerases that can be used in the methods of the invention include, for example, E. coli DNA polymerase I, Thermoanaerobacter thermohydrosulfuricus polymerase I, and bacteriophage phi 29.
- the strand displacing enzyme Bacillus stearothermophilus polymerase I Bacillus stearothermophilus polymerase I ( Bst DNA polymerase I) is used to repair the nicked dsDNA and results in non-nicked dsDNA (see FIG. 3D).
- the ligase is T4 DNA ligase and the kinase is T4 polynucleotide kinase.
- ssDNAs comprising both the first and second adaptor molecules may be isolated.
- Double-stranded DNA libraries will have adaptors bound in the following configurations:
- a and B correspond to the first and second adaptors.
- the desired populations are designated with asterisks.
- the universal adaptors are designed such that only one universal adaptor has a 5′ biotin moiety.
- universal adaptor B has a 5′ biotin moiety
- streptavidin-coated sample prep beads can be used to bind all double-stranded DNA library species with universal adaptor B.
- Genomic library populations that contain two universal adaptor A species will not contain a 5′ biotin moiety and will not bind to streptavidin-containing sample prep beads and thus can be washed away.
- the only species that will remain attached to beads are those with universal adaptors A and B and those with two universal adaptor B sequences.
- DNA species with two universal adaptor B sequences will be bound to streptavidin-coated sample prep beads at each end, as each strand comprised in the double strand will be bound.
- Double-stranded DNA species with a universal adaptor A and a universal adaptor B will contain a single 5′ biotin moiety and thus will be bound to streptavidin-coated beads at only one end. Where the sample prep beads are magnetic, the beads will remain coupled to a solid support when magnetized.
- ssDNA libraries that are created according to the methods of the invention are quantitated to calculate the number of molecules per unit volume.
- the molecules can be annealed to a solid support that includes oligonucleotide capture primers that are complementary to the PCR priming regions of the universal adaptor ends of the ssDNA species.
- beads comprising capture primers annealed to ssDNA library molecules can be transferred to a thermocycler to allow PCR amplification. Clonal populations of single species of single stranded DNA captured on DNA beads may then sequenced.
- the solid support is a bead, preferably a sepharose bead. As used herein, this bead is referred to as a “DNA capture bead”.
- the beads used herein may be of any convenient size and fabricated from any number of known materials.
- Example of such materials include: inorganics, natural polymers, and synthetic polymers. Specific examples of these materials include: cellulose, cellulose derivatives, acrylic resins, glass; silica gels, polystyrene, gelatin, polyvinyl pyrrolidone, co-polymers of vinyl and acrylamide, polystyrene cross-linked with divinylbenzene or the like (see, Merrifield Biochemistry 1964, 3, 1385-1390), polyacrylamides, latex gels, polystyrene, dextran, rubber, silicon, plastics, nitrocellulose, celluloses, natural sponges, silica gels, glass, metals plastic, cellulose, cross-linked dextrans (e.g., SephadexTM) and agarose gel (SepharoseTM) and solid phase supports known to those of skill in the art.
- cross-linked dextrans e.g., SephadexTM
- the diameter of the DNA capture bead is 20-70 ⁇ m. In a preferred embodiment, the diameter of the DNA capture bead is 20-50 ⁇ m. In a more preferred embodiment, the diameter of the DNA capture bead is about 30 ⁇ m.
- the invention includes a method for generating a library of solid supports comprising: (a) preparing a population of ssDNA templates according to the methods disclosed herein; (b) attaching each DNA template to a solid support such that there is one molecule of DNA per solid support; (c) amplifying the population of single-stranded templates such that the amplification generates a clonal population of each DNA fragment on each solid support; (d) sequencing clonal populations of the ssDNA templates.
- the solid support is a DNA capture bead.
- the DNA is genomic DNA, cDNA, or reverse transcripts of RNA (e.g., viral RNA).
- the DNA may be attached to the solid support, for example, via a biotin-streptavidin linkage, a covalent linkage, or by complementary oligonucleotide hybridization.
- each DNA template is ligated to a set of universal adaptors.
- the universal adaptor pair comprises a PCR primer sequence, a sequencing primer sequence, and a discriminating key sequence. Single-stranded DNAs with unique ends are isolated and then attached to a solid support and exposed to amplification techniques for clonal amplification.
- the DNA may be amplified by PCR.
- the invention provides a library attached to solid supports made by the methods described herein.
- the DNA prepared by this method may be used for many molecular biological procedures, such as linear extension, rolling circle amplification, PCR, and sequencing.
- the linkage reaction can be driven, for example, by using a high molar ratio of bead to DNA.
- the capture of single-stranded DNA molecules follows a Poisson distribution and results in subsets of beads having no DNA attached, one molecule of DNA attached, or more than one molecule of DNA attached.
- a single stranded nucleic acid template to be amplified is attached to a capture bead.
- the nucleic acid template may be attached to the solid support capture bead in any manner known in the art. Numerous methods exist in the art for attaching DNA to a solid support such as the preferred microscopic bead. According to the present invention, covalent chemical attachment of the DNA to the bead can be accomplished by using standard coupling agents, such as water-soluble carbodiimide, to link the 5′-phosphate on the DNA to amine-coated capture beads through a phosphoamidate bond.
- Another alternative is to first couple specific oligonucleotide linkers to the bead using similar chemistry, and to then use DNA ligase to link the DNA to the linker on the bead.
- Other linkage chemistries to join the oligonucleotide to the beads include the use of N-hydroxysuccinamide (NHS) and its derivatives.
- one end of the oligonucleotide may contain a reactive group (such as an amide group) which forms a covalent bond with the solid support, while the other end of the linker contains a second reactive group that can bond with the oligonucleotide to be immobilized.
- the oligonucleotide is bound to the DNA capture bead by covalent linkage.
- non-covalent linkages such as chelation or antigen-antibody complexes, may also be used to join the oligonucleotide to the bead.
- Oligonucleotide linkers can be employed which specifically hybridize to unique sequences at the end of the DNA fragment, such as the overlapping end from a restriction enzyme site or the “sticky ends” of bacteriophage lambda based cloning vectors, but blunt-end ligations can also be used beneficially. These methods are described in detail in U.S. Pat. No. 5,674,743. It is preferred that any method used to immobilize the beads will continue to bind the immobilized oligonucleotide throughout the steps in the methods of the invention.
- each capture bead is designed to have a plurality of nucleic acid primers that recognize (i.e., are complementary to) a portion of the nucleic template, and the nucleic acid template is thus hybridized to the capture bead.
- nucleic acid primers that recognize (i.e., are complementary to) a portion of the nucleic template, and the nucleic acid template is thus hybridized to the capture bead.
- clonal amplification of the template species is desired, so it is preferred that only one unique nucleic acid template is attached to any one capture bead.
- the beads used herein may be of any convenient size and fabricated from any number of known materials.
- Example of such materials include: inorganics, natural polymers, and synthetic polymers. Specific examples of these materials include: cellulose, cellulose derivatives, acrylic resins, glass, silica gels, polystyrene, gelatin, polyvinyl pyrrolidone, co-polymers of vinyl and acrylamide, polystyrene cross-linked with divinylbenzene or the like (as described, e.g., in Merrifield, Biochemistry 1964, 3, 1385-1390), polyacrylamides, latex gels, polystyrene, dextran, rubber, silicon, plastics, nitrocellulose, natural sponges, silica gels, control pore glass, metals, cross-linked dextrans (e.g., SephadexTM) agarose gel (SepharoseTM), and solid phase supports known to those of skill in the art.
- the capture beads are Sepharose beads approximately
- capture beads with or without attached nucleic acid template may be suspended in a heat stable water-in-oil emulsion. It is contemplated that a plurality of the microreactors include only one template and one bead. There may be many droplets that do not contain a template or which do not contain a bead. Likewise there may be droplets that contain more than one copy of a template.
- the emulsion may be formed according to any suitable method known in the art. One method of creating emulsion is described below but any method for making an emulsion may be used. These methods are known in the art and include adjuvant methods, counter-flow methods, cross-current methods, rotating drum methods, and membrane methods.
- the size of the microcapsules may be adjusted by varying the flow rate and speed of the components. For example, in dropwise addition, the size of the drops and the total time of delivery may be varied.
- the emulsion contains a density of about 3,000 beads encapsulated per microliter.
- This method involves compartmentalizing a gene, expressing the gene, and sorting the compartmentalized gene based on the expressed product.
- the microencapsulated sorting method of Griffith is not suitable for parallel analysis of multiple microcapsules because their nucleic acid product is not anchored and cannot be anchored. Since the nucleic acids of Griffiths are not anchored, they would be mixed together during demulsification.
- the emulsion is preferably generated by adding beads to an amplification solution.
- amplification solution means the sufficient mixture of reagents that is necessary to perform amplification of template DNA.
- a PCR amplification solution is provided in the Examples below. It will be appreciated that various modifications may be made to the amplification solution based on the type of amplification being performed and whether the template DNA is attached to the beads or provided in solution.
- the mixture of beads and amplification solution is added dropwise into a spinning mixture of biocompatible oil (e.g., light mineral oil, Sigma) and allowed to emulsify.
- biocompatible oil e.g., light mineral oil, Sigma
- the beads and amplification solution are added dropwise into a cross-flow of biocompatible oil.
- the oil used may be supplemented with one or more biocompatible emulsion stabilizers.
- emulsion stabilizers may include Atlox 4912, Span 80, and other recognized and commercially available suitable stabilizers.
- the emulsion is heat stable to allow thermal cycling, e.g., to at least 94° C., at least 95° C., or at least 96° C.
- the droplets formed range in size from about 5 microns to about 500 microns, more preferably from about 10 microns to about 350 microns, even more preferably from about 50 to 250 microns, and most preferably from about 100 microns to about 200 microns.
- cross-flow fluid mixing allows for control of the droplet formation, and uniformity of droplet size.
- smaller water droplets not containing beads may be present in the emulsion.
- the microreactors should be sufficiently large to encompass sufficient amplification reagents for the degree of amplification required. However, the microreactors should be sufficiently small so that a population of microreactors, each containing a member of a DNA library, can be amplified by conventional laboratory equipment, e.g., PCR thermocycling equipment, test tubes, incubators and the like.
- microreactors allows amplification of complex mixtures of templates (e.g., genomic DNA samples or whole cell RNA) without intermixing of sequences, or domination by one or more templates (e.g., PCR selection bias; see, Wagner et al., 1994, Suzuki and Giovannoni, 1996; Chandler et al., 1997, Polz and Cavanaugh, 1998).
- templates e.g., genomic DNA samples or whole cell RNA
- the optimal size of a microreactor may be on average 100 to 200 microns in diameter. Microreactors of this size would allow amplification of a DNA library comprising about 600,000 members in a suspension of microreactors of less than 10 ml in volume. For example, if PCR is the chosen amplification method, 10 ml of microreactors would fit into 96 tubes of a regular thermocycler with 96 tube capacity. In a preferred embodiment, the suspension of 600,000 microreactors would have a volume of less than 1 ml. A suspension of less than 1 ml may be amplified in about 10 tubes of a conventional PCR thermocycler. In a most preferred embodiment, the suspension of 600,000 microreactors would have a volume of less than 0.5 ml.
- Another embodiment of the invention is directed to a method of performing nucleic acid amplification with a template and a bead, but without attachment of the template to the bead.
- the bead may comprise a linker molecule that can bind the amplified nucleic acid after amplification.
- the linker may be a linker that can be activated.
- Such linkers are well known and include temperature sensitive or salt sensitive binding pairs such as streptavidin/biotin and antibodies/antigen.
- the template nucleic acid may be encapsulated with a bead and amplified. Following amplification, the amplified nucleic acid may be linked to the beads, e.g., by adjustments in temperature or salt concentration.
- the template nucleic acid may be amplified, while attached or unattached to beads, by any suitable method of amplification including transcription-based amplification systems (Kwoh D. et al., Proc. Natl. Acad Sci. (U.S.A.) 86:1173 (1989); Gingeras T. R. et al., WO 88/10315; Davey, C. et al., EP Publication No. 329,822; Miller, H. I. et al., WO 89/06700), “RACE” (Frohman, M.
- a nucleic acid template is amplified after encapsulation with a bead in a microreactor.
- a nucleic acid template is amplified after distribution onto a multiwell surface, e.g., a PicoTiter plate.
- DNA amplification is performed by PCR.
- PCR according to the present invention may be performed by encapsulating the target nucleic acid with a PCR solution comprising all the necessary reagents for PCR. Then, PCR may be accomplished by exposing the emulsion to any suitable thermocycling regimen known in the art. In a preferred embodiment, 30 to 50 cycles, preferably about 40 cycles, of amplification are performed. It is desirable, but not necessary, that following the amplification procedure there be one or more hybridization and extension cycles following the cycles of amplification. In a preferred embodiment, 10 to 30 cycles, preferably about 25 cycles, of hybridization and extension are performed (e.g., as described in the examples).
- the template DNA is amplified until typically at least 10,000 to 50,000,000 copies are immobilized on each bead. It is recognized that for nucleic acid detection applications, fewer copies of template are required. For nucleic acid sequencing applications we prefer that at least two million to fifty million copies, preferably about ten million to thirty million copies of the template DNA are immobilized on each bead. The skilled artisan will recognize that the size of bead (and capture site thereon) determines how many captive primers can be bound (and thus how many amplified templates may be captured onto each bead).
- the invention encompasses a method for clonally isolating a library comprising a plurality of single stranded DNA molecules comprising: a) fragmenting large template DNA molecules to generate a plurality of fragmented DNA molecules; b) attaching a first or second universal double stranded adaptor to a first end of each fragmented DNA molecule and a first or second universal adaptor to a second end of each fragmented DNA molecule to form a mixture of adaptor ligated DNA molecules; c) isolating a plurality of single stranded DNA molecules each comprising a first single stranded universal adaptor and a second single stranded universal adaptor to obtain a library; and d) delivering the single stranded DNA molecules into reactors such that a plurality of the reactors include one DNA molecule, thereby clonally isolating the library.
- the invention encompasses a method for generating a library comprising a plurality of single stranded DNA molecules, comprising: a) fragmenting large or whole genomic template DNA molecules to generate a plurality of fragmented DNA molecules; b) ligating a first universal double stranded adaptor or a second universal adaptor to a first end of each fragmented DNA molecule and a first universal adaptor or second universal adaptor to a second end of each fragmented DNA molecule to produce a mixture of adaptor ligated DNA molecules, wherein the first universal adaptor contains a moiety that binds to a solid support; c) attaching to a solid support those DNA molecules comprising a first double stranded universal adaptor; d) washing away adaptor ligated DNA molecules which have not attached to the solid support; e) strand separating those adaptor ligated DNA molecules that are attached to the solid support to release a plurality of single stranded DNA molecules comprising a first single strand
- (f) can be accomplished by: i) delivering the single stranded DNA molecules onto a location on a reactor array; or ii) delivering the single stranded DNA molecules into droplets in a water-in-oil emulsion.
- the first universal double stranded adaptor or the second universal adaptor can be attached to the fragmented DNA molecules by ligation.
- DNA ligase may be used.
- These methods can further include a step of repairing single stranded nicks in the mixture of adaptor ligated DNA molecules using DNA repair and modifying enzymes, such as a polymerase, ligase, kinase, or combinations thereof.
- the enzymes can include Bacillus stearothermophilus polymerase I, T4 ligase, and T4 polynucleotide kinase.
- the template DNA for these methods can comprise genomic DNA, cDNA, plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, phagemid DNA, or reverse transcripts. Fragmenting may be performed by enzymatic, chemical, or mechanical means.
- DNase I enzyme can be used in a digestion performed at a temperature of 10-37° C. for 1-2 minutes. Alternatively, a restriction enzyme may be used.
- the mechanical means can be a nebulizer, French Press, sonicator, or a HydroShear.
- the fragmented DNA molecules can be 50 bp to 700 bp in length.
- the compatible ends can be blunt ends, or the compatible ends can include an A or T overhang. Blunt ends can be created with an enzyme such as Pfu polymerase, T4 DNA polymerase, and Klenow fragments.
- the first or second double stranded universal adaptor may comprise one or more phosphorothioate linkages, and may be attached to a biotin moiety.
- the first double stranded universal adaptors or the second double stranded universal adaptors or both double stranded universal adaptors may comprise a discriminating key sequence.
- the discriminating key sequence is 3-12 nucleotides in length and comprise at least one nucleotide selected from the group consisting of A, G, C, U, and T.
- the first and second double stranded universal adaptor may comprise a PCR priming sequence and a sequencing primer sequence.
- the PCR priming sequence is 10-20 base pairs in length
- the sequencing primer sequence is 10-20 base pairs in length.
- the PCR priming sequence and the sequencing primer sequence may overlap.
- the mixture of adaptor ligated DNA molecules is separated by a method selected from the group consisting of gel electrophoresis, filtration, size exclusion chromatography, and sucrose sedimentation.
- the plurality of single stranded DNA molecules may be obtained by a treatment selected from the group consisting of low salt treatment, high pH treatment, and chemical denaturation treatment.
- the plurality of single stranded DNA molecules may be attached to a DNA capture bead.
- the DNA capture bead may comprise a component of a binding pair, such as avidin/biotin, ligand/receptor, antigen/antibody or complementary nucleotides.
- the DNA capture bead is a paramagnetic bead.
- the invention also encompasses a method for generating a single stranded DNA library attached to solid supports comprising: a) generating a plurality of single stranded DNA templates; b) attaching each of the plurality of ssDNA templates to a solid support; and c) isolating the solid supports on which the single stranded DNA templates are attached.
- the invention further encompasses a method for generating a single stranded DNA library attached to solid supports comprising: a) fragmenting large template DNA molecules to generate a plurality of fragmented DNA molecules; b) attaching a first or second universal double stranded adaptor to a first end of each fragmented DNA molecule and a first or second universal adaptor to a second end of each fragmented DNA molecule to make a mixture of adaptor ligated DNA molecules; c) isolating those single stranded DNA molecules which comprise a first single stranded universal adaptor and a second single stranded universal adaptor; and d) attaching the isolated single stranded molecules from (c) to a solid support.
- the solid support may be a DNA capture bead, and the DNA may be genomic DNA, cDNA, plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, or phagemid DNA.
- the DNA is attached to the solid support via a binding pair such as avidin/biotin, ligand/receptor, antigen/antibody and complementary nucleotides.
- a binding pair such as avidin/biotin, ligand/receptor, antigen/antibody and complementary nucleotides.
- a library of mobile solid supports made by this method.
- the invention comprises a nucleic acid molecule comprising a first adaptor, a fragment of template DNA, and a second adaptor, wherein the first adaptor and second adaptor each comprise a sequencing primer, a PCR primer, and a discriminating key sequence, and wherein the first adaptor and second adaptor, when dissociated, do not cross-hybridize to each other under stringent hybridization conditions.
- the PCR primer may be 10-20 base pairs in length
- the sequencing primer may be 10-20 base pairs in length
- the discriminating key sequence may be 3 to 12 base pairs in length.
- the template DNA can be genomic DNA, cDNA plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, or phagemid DNA.
- the nucleic acid molecule when dissociated, has minimal cross-hybridization to dissociated template DNA.
- Also encompassed by the invention is a method for preparing single stranded DNA molecules, comprising: a) fragmenting large or whole genomic template DNA molecules to generate a plurality of fragmented DNA molecules; b) ligating a first universal double stranded adaptor or a second universal adaptor to a first end of each fragmented DNA molecule and a first universal adaptor or second universal adaptor to a second end of each fragmented DNA molecule to produce a mixture of adaptor ligated DNA molecules; c) attaching adaptor ligated DNA molecules comprising a first double stranded universal adaptor and a second double stranded adaptor to a solid support via one strand of the first double stranded universal adaptor; d) washing away adaptor ligated DNA molecules which have not attached to the solid support; e) strand separating those adaptor ligated DNA molecules that are attached to the solid support to release a plurality of single stranded DNA molecules comprising a first single stranded universal
- the isolating step may comprise attaching the nucleic acid templates to a bead, or encapsulating the nucleic acid template in an emulsion of a water-in-oil emulsion.
- the nucleic acid template may be encapsulated with a bead that can bind the nucleic acid.
- the delivering step may comprise delivering the sequestered nucleic acid to a plurality of reaction centers, wherein each reaction center is a well on a picotiter plate.
- the method can further comprising the step of attaching the isolated single stranded molecules each individually to a solid support.
- the DNA should be of high quality and free from contaminants such as proteins, nucleases, lipids, and other chemicals (such as residual EDTA from preparation) and salts. It is preferred that genomic DNA should have a 260/280 ratio of 1.8 or higher. If it is desired to sequence the genome of only one organism, then the DNA should be quality checked to ensure that there is no contaminating DNA. For example: a preparation of human DNA may be checked by PCR to ensure that it is not contaminated by bacterial DNA molecules. Another method of checking for contamination is by restriction digestion patterns and especially restriction digestion followed by Southern Blot using suitable probes known to be specific for an organism (e.g., human or mouse) and a second probe known to be specific for a possible contaminating organism (e.g., E. coli ). If it is desired, the DNA should originate from a single clone of the organism (e.g., a colony if from bacteria).
- DNase I The purpose of the DNase I digestion step is to fragment a large stretch of DNA such as a whole genome or a large portion of a genome into smaller species. This population of smaller-sized DNA species generated from a single DNA template is referred to as a “library”.
- DNase I is an endonuclease which cleaves double-stranded template DNA. The cleavage characteristics of DNase I allow random digestion of template DNA (i.e., minimal sequence bias) and will result in the predominance of blunt-ended, double-stranded DNA fragments when used in the presence of manganese-based buffers (Melgar and Goldthwait 1968).
- the digestion of genomic templates by DNase I is dependent on three factors: i) quantity of enzyme used (units); ii) temperature of digestion (° C.); and iii) incubation time (minutes).
- the DNase I digestion conditions outlined below were optimized to yield DNA libraries in a size range from 50-700 base pairs (bp).
- DNA was obtained and prepared to a concentration of 0.3 mg/ml in Tris-HCl (10 mM, pH 7-8). A total of 134 ⁇ l of DNA (15 ⁇ g) was needed for this preparation. It is recommended to not use DNA preparations diluted with buffers containing EDTA (i.e., TE, Tris/EDTA). The presence of EDTA is inhibitory to enzyme digestion with DNase I. If the DNA preparation contains EDTA, it is important that the DNA be “salted” out of solution and reconstituted with the appropriate Tris-HCl buffer (10 mM, pH 7-8) or nanopure H 2 O (pH 7-8).
- Tris-HCl buffer 10 mM, pH 7-8
- nanopure H 2 O pH 7-8
- DNase I Buffer comprising 50 ⁇ l Tris pH 7.5 (1M), 10 ⁇ l MnCl 2 (1M), 1 ⁇ l BSA (100 mg/ml), and 39 ⁇ l water was prepared.
- the digested DNA was purified by using the QiaQuick PCR purification kit. The digestion reaction was then split into four aliquots, and four spin columns were used to purify each aliquot (37.5 ⁇ l per spin column). Each column was eluted with 30 ⁇ l elution buffer (EB) according to the manufacturer's protocol. The eluates were then combined to generate a final reaction volume of 120 ⁇ l.
- EB elution buffer
- Pfu polishing is used to increase the amount of blunt-ended species by fill-in (i.e., “blunting”) of 5′ overhangs. Additionally, Pfu DNA polymerase has 3′ ⁇ 5′ exonuclease activity that will result in the removal of single and double nucleotide extensions. Pfu polishing increases the amount of blunt-ended DNA fragments available for adaptor ligation (Costa 1994a, 1994b, 1994c). The following Pfu polishing protocol was used.
- polishing reaction components were mixed well and incubated at 72° C. for 30 minutes.
- polishing reaction mixture was then split into four aliquots and purified using QiaQuick PCR purification columns (37.5 ⁇ L on each column). Each column was eluted with 30 ⁇ l buffer EB according to the manufacturer's protocol. The eluates were then combined to generate a final reaction volume of 120 ⁇ L.
- Step 3 Ligation of Universal Adaptors to Fragmented DNA Library
- Universal Adaptors are comprised of double-stranded oligonucleotides that contain specific priming regions that afford both PCR amplification and nucleotide sequencing.
- the Universal Adaptors are designed to include a set of unique PCR priming regions that are 20 base pairs in length located adjacent to a set of unique sequencing priming regions that are 20 base pairs in length, followed by a unique 4-base “key” consisting of one of each deoxyribonucleotide (i.e., A, C, G, T).
- Each unique Universal Adaptor (termed “Universal Adaptor A” and “Universal Adaptor B”) is forty-four base pairs (44 bp) in length. Universal Adaptors are ligated, using T4 DNA ligase, onto each end of the DNA fragment to generate a total nucleotide addition of 88 bp to each DNA fragment. Different Universal Adaptors are designed specifically for each genomic DNA library preparation and will therefore provide a unique identifier for each organism.
- Universal Adaptor DNA oligonucleotides are designed with two phosphorothioate linkages at each oligonucleotide end that serve to protect against nuclease activity (Samini, T. D., B. Jolles, and A. Laigle. 2001. Best minimally modified antisense oligonucleotides according to cell nuclease activity. Antisense Nucleic Acid Drug Dev . 11(3):129., the disclosure of which is incorporated in toto herein by reference.). Each oligonucleotide is HPLC-purified to ensure there are no contaminating or spurious DNA oligonucleotide sequences in the final prep.
- the Universal Adaptors are designed to allow directional ligation to the blunt-ended, fragmented genomic DNA.
- the PCR priming region contains a 5′ four-base overhang and a blunt-ended 3′ Key region.
- Directionality is achieved as the blunt-end side of the Universal Adaptor ligates to the blunt-ended DNA fragment while the 5′ overhang of the adaptor cannot ligate to the blunt-ended DNA fragment.
- a 5′ biotin is added to the Universal Adaptor B to allow subsequent isolation of ssDNA template (Step 8).
- Each Universal Adaptor is prepared by annealing, in a single tube, the two single-stranded complementary DNA oligonucleotides (i.e., one oligo containing the sense sequence and the second oligo containing the antisense sequence). The following ligation protocol was used.
- Step 3a Microcon Filtration and Adaptor Construction. Total Preparation Time was Approximately 25 min.
- the Universal Adaptor ligation reaction requires a 100-fold excess of adaptors.
- the double-stranded gDNA library is filtered through a Microcon YM-100 filter device.
- Microcon YM-100 membranes can be used to remove double stranded DNA smaller than 125 bp. Therefore, unbound adaptors (44 bp), as well as adaptor dimers (88 bp) can be removed from the ligated gDNA library population. The following filtration protocol was used:
- Adaptors were HPLC-purified and modified with phosphorothioate linkages prior to use.
- Adaptor “A” (10 ⁇ M)
- the primers were annealed using the ANNEAL program on the Sample Prep Labthermal cycler (see below).
- Adaptor “B” (10 ⁇ M)
- 10 ⁇ l of 100 ⁇ M Adaptor B 40 bp, sense
- 10 ⁇ l of 100 ⁇ M Adaptor B 44 bp, antisense
- the primers were annealed using the ANNEAL program on the Sample Prep Lab thermal cycler.
- Adaptor sets could be stored at ⁇ 20° C. until use.
- Step 4 Gel Electrophoresis and Extraction of Adapted DNA Library
- the Universal Adaptor ligation protocol produces the following: 1) fragmented DNAs with adaptors on either end; 2) unbound single adaptors; or 3) the formation of adaptor dimers.
- Agarose gel electrophoresis is used as a method to separate and isolate the adapted DNA library population from the unligated, single adaptors and adaptor dimer populations.
- the procedure of DNase I digestion of genomic DNA yields a library population that ranges from 50-700 bp (Step 1).
- the addition of the 88-bp Universal Adaptor set will shift the population to a larger size and will result in a migration profile in the size range of approximately 130-800 bp.
- Adaptor dimers will migrate at 88 bp and adaptors unligated will migrate at 44 bp. Therefore, genomic DNA libraries in size ranges >200 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. Gel isolation of the adapted DNA library will result in the recovery of a library population in a size range that is ⁇ 200 bp (size range of library can be varied depending on application). The following electrophoresis and extraction protocol was used.
- Step 5 Strand Displacement and Extension of Nicked Double Stranded DNA Library
- DNA oligonucleotides used for the Universal Adaptors are not phosphorylated, gaps are present at the 3′ junctions of the fragmented gDNAs. These two “gaps” or “nicks” can be filled in by using a strand displacing DNA polymerase.
- the polymerase recognizes nicks, displaces the nicked strands, and extends the strand in a manner that results in repair of nicks and in the formation of non-nicked double-stranded DNA.
- the strand displacing enzyme used is the large fragment of Bst DNA polymerase.
- Step 7 Isolation of Single-Stranded DNA Library using Streptavidin Beads
- Double-stranded genomic DNA fragment pools will have adaptors bound in the following possible configurations:
- Genomic DNA species with two Universal Adaptor B sequences with two biotin molecules can bind to the streptavidin-containing beads at both ends.
- Species with A and B adaptors having only a single biotin molecule can bind to the beads only at the “B” end.
- the bead-bound double-stranded DNA is treated with a sodium hydroxide solution that serves to disrupt the hydrogen bonding between the complementary DNA strands. If the DNA fragment has biotin on each end (Universal Adaptor B ends), both resulting single strands remain bound to the beads. If the fragment has only a single biotin (Universal Adaptors A and B), then the complementary strand separates from the DNA-bead complex.
- the resulting single-stranded genomic DNA library is collected from the solution phase and is quantitated, e.g., using pyrophosphate sequencing (PyroSequence) or by using a RNA Pico 6000 LabChip (Agilent, Palo Alto, Calif.).
- Single-stranded genomic DNA libraries are quantitated by calculating the number of molecules per unit volume.
- Single-stranded gDNA molecules are then annealed (at a half copy per bead to obtain one effective copy per bead) to 25-30 ⁇ m sepharose beads containing DNA capture primers (PCR primer B).
- the templates are then amplified using emulsion polymerase chain reaction protocols. Subsequent sequencing may be conducted using known techniques. For isolation of the single stranded library, the following protocol was used.
- Step 8a Single-Stranded gDNA Quantitation using Pyrophosphate Sequencing. Total Preparation Time was Approximately 1 hr.
- Step 8b Single-Stranded gDNA Quantitation using RNA Pico 6000 LabChip. Total Preparation Time was Approximately 30 minutes.
- RNA Pico 6000 LabChip was prepared on the BioAnalyzer according to the manufacturers' guidelines.
- RNA LabChip ladder (RNA 6000 ladder) was prepared according to manufacturer's (Ambion) directions. Briefly, the RNA LabChip ladder, in solution, was heated to 70° C. for 2 minutes. The solution was chilled on ice for 5 minutes to snap cool the ladder. The solution was briefly centrifuged to clear any condensate from tube walls. The RNA LabChip Ladder was stored on ice and used within one day.
- the BioAnalyzer software was used to calculate the concentration of each ssDNA library lane (see the Table below and FIG. 8. The average of all three lanes was used to calculate the DNA concentration of the library using the procedure outlined below.
- the concentration of Library 1 was calculated as 1639 pg/ ⁇ l (Column 5) and the average fragment size was 434 nucleotides (Column 9). These values were obtained from the Agilent 2100 software as described in Steps (a)-(d), above.
- the average molecular weight (MW) of a ribonucleotide is 328.2 g/mole (Column 10).
- the MW of the average library fragment (1.42 ⁇ 10 5 g/mole, Column 11) was calculated by multiplying the average fragment length (434) by the average ribonucleotide (328.2).
- the quantitated library (1639 pg/ ⁇ l) was converted to grams per microliter (1.64 ⁇ 10 ⁇ 9 g/ ⁇ l, Column 12).
- the number of moles per microliter (1.15 ⁇ 10 ⁇ 14 moles/ ⁇ l, Column 14) was calculated by dividing the grams per microliter (1.64 ⁇ 10 ⁇ 9 g/ ⁇ l, Column 12) by the average molecular weight of the library fragments (1.42 ⁇ 10 5 , Column 11). Finally, the number of molecules per microliter (6.93 ⁇ 10 9 molecules/ ⁇ l, Column 15) was derived by multiplying the number of moles per microliter (1.15 ⁇ 10 ⁇ 14 moles/ ⁇ l, Column 14) by Avogadro's number (6.02 ⁇ 10 23 molecules/mole).
- the final library concentration was expected to be greater than 1 ⁇ 10 8 molecules/ ⁇ l.
- a more important factor for library quality was adaptor dimer concentration.
- the height of the library peak was determined approximately 10 fold greater than the adaptor dimer peak (the first peak after the marker).
- a library of good quality is expected to have a peak height at least 2 fold greater than the dimer peak.
- the RNA Pico 6000 LabChip provided estimates within 500% accuracy of the single-stranded gDNA concentration.
- the recommended input DNA is 2.5 cpb, 1 cpb, 0.5 cpb, and 0.1 cpb. This titration was easily checked using the 4slot bead loading chamber on a 14 ⁇ 43 PTP.
- Step 9 Dilution and Storage of Single-Stranded gDNA Library
- the single-stranded gDNA library was eluted and quantitated in Buffer EB. To prevent degradation, the single-stranded gDNA library was stored frozen at ⁇ 20° C. in the presence of EDTA. After quantitation, an equal volume of 10 mM TE was added to the library stock. All subsequent dilutions was in TE. The yield was as follows:
- single-stranded gDNA library was diluted to 100 million molecules/ ⁇ l in 1 ⁇ Library-Grade Elution Buffer. Aliquots of single-stranded gDNA library were prepared for common use. For this, 200,000 molecules/ ⁇ l were diluted in 1 ⁇ Library-Grade Elution Buffer and 20 ⁇ l aliquots were measured. Single-use library aliquots were stored at ⁇ 20° C.
- Step 10 Emulsion Polymerase Chain Reaction.
- the Stop Solution (50 mM EDTA) included 100 ⁇ l of 0.5 M EDTA mixed with 900 ⁇ l of nH 2 O to obtain 1.0 ml of 50 mM EDTA solution.
- 10 mM dNTPs (10 ⁇ l dCTP (100 mM), 10 ⁇ l DATP (100 mM), 10 ⁇ l dGTP (100 mM), and 10 ⁇ l dTTP (100 mM) were mixed with 60 ⁇ l molecular biology grade water. All four 100 mM nucleotide stocks were thawed on ice.
- each nucleotide was combined with 60 ⁇ l of nH 2 O to a final volume of 100 ⁇ l, and mixed thoroughly. Next, 1 ml aliquots were dispensed into 1.5 ml microcentrifuge tubes. The stock solutions could be stored at ⁇ 20° C. for one year.
- the 10 ⁇ Annealing buffer included 200 mM Tris (pH 7.5) and 50 mM magnesium acetate. For this solution, 24.23 g Tris was added to 800 ml nH 2 O and the mixture was adjusted to pH 7.5. To this solution, 10.72 g of magnesium acetate was added and dissolved completely. The solution was brought up to a final volume of 1000 ml and could be stored at 4° C. for 1 month.
- the 10 ⁇ TE included 100 mM Tris-HCl (pH 7.5) and 50 mM EDTA. These reagents were added together and mixed thoroughly. The solution could be stored at room temperature for 6 months.
- the universal adaptors are designed to include: 1) a set of unique PCR priming regions that are typically 20 bp in length (located adjacent to (2)); 2) a set of unique sequencing priming regions that are typically 20 bp in length; and 3) optionally followed by a unique discriminating key sequence consisting of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
- a unique discriminating key sequence consisting of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
- the single-stranded DNA library is utilized for PCR amplification and subsequent sequencing.
- Sequencing methodology requires random digestion of a given genome into 150 to 500 base pair fragments, after which two unique bipartite primers (composed of both a PCR and sequencing region) are ligated onto the 5′ and 3′ ends of the fragments (FIG. 5).
- T m melting temperature
- the disclosed process utilizes synthetic priming sites that necessitates careful de novo primer design.
- PCR/LDR work was particularly relevant and focused on designing oligonucleotide “zipcodes”, 24 base primers comprised of six specifically designed tetramers with a similar final T m . (see, Gerry, N. P., et al., Universal DNA microarray method for multiplex detection of low abundance point mutations. Journal of Molecular Biology, 1999. 292: p. 251-262; U.S. Pat. No. 6,506,594).
- Tetrameric components were chosen based on the following criteria: each tetramer differed from the others by at least two bases, tetramers that induced self-pairing or hairpin formations were excluded, and palindromic (AGCT) or repetitive tetramers (TATA) were omitted as well. Thirty-six of the 256 (4 4 ) possible permutations met the necessary requirements and were then subjected to further restrictions required for acceptable PCR primer design (Table 1).
- Table 1 shows a matrix demonstrating tetrameric primer component selection based on criteria outlined by Gerry et al. 1999 . J. Mol. Bio . 292: 251-262. Each tetramer was required to differ from all others by at least two bases. The tetramers could not be palindromic or complimentary with any other tetramer. Thirty-six tetramers were selected (bold, underlined); italicized sequences signal palindromic tetramers that were excluded from consideration.
- PCR primers were designed to meet specifications common to general primer design (see, Rubin, E. and A. A. Levy, A mathematical model and a computerized simulation of PCR using complex templates. Nucleic Acids Res, 1996. 24(18): p. 3538-45; Buck, G. A., et al., Design strategies and performance of custom DNA sequencing primers. Biotechniques, 1999. 27(3): p. 528-36), and the actual selection was conducted by a computer program, MMP. Primers were limited to a length of 20 bases (5 tetramers) for efficient synthesis of the total bipartite PCR/sequencing primer.
- Each primer contained a two base GC clamp on the 5′ end, and a single GC clamp on the 3′ end (Table 2), and all primers shared similar T m (+/ ⁇ 2° C.) (FIG. 10).
- No hairpinning within the primer (internal hairpin stem ⁇ G> ⁇ 1.9 kcal/mol) was permitted.
- Dimerization was also controlled; a 3 base maximum acceptable dimer was allowed, but it could occur in final six 3′ bases, and the maximum allowable ⁇ G for a 3′ dimer was ⁇ 2.0 kcal/mol. Additionally, a penalty was applied to primers in which the 3′ ends were too similar to others in the group, thus preventing cross-hybridization between one primer and the reverse complement of another.
- Table 2 shows possible permutations of the 36 selected tetrads providing two 5′ and a single 3′ G/C clamp. The internal positions are composed of remaining tetrads. This results in 8 ⁇ 19 ⁇ 19 ⁇ 19 ⁇ 9 permutations, or 493,848 possible combinations.
- FIG. 10 shows first pass, T m based selection of acceptable primers, reducing field of 493,848 primers to 56,246 candidates with T m of 64 to 66° C.
- TABLE 3 The probability of perfect sequence matches for primers increases with decreasing match length requirements and increasing size of the genome of interest.
- the probability of finding a 16 base perfect match is 97% for the sequences in the NCBI database (approximately 100 times larger than the Adenovirus genome).
- the probability of finding a 17 base perfect match to a 20 base primer is 99% for the sequences in the human genome (3 billion bases).
- the immobilized product would lack a sequencing primer binding site, and would result in an empty PicoTiter plate (PTP) well. If the CHR out-competed the bead-bound primer, the sequencing primer would still be present, and the only effect would be a shorter insert. Neither result would unduly compromise the sequencing quality. Given the large amount of genomic material used in the sample preparation process (currently 25 ⁇ g, containing 5.29 ⁇ 10 16 copies of the 35 Kb Adenovirus genome), oversampling can be used to provide fragments that lack the complete CHR, and allow standard PCR amplification of the region in question.
- the purpose of the Nebulization step is to fragment a large stretch of DNA such as a whole genome or a large portion of a genome into smaller molecular species that are amenable to DNA sequencing.
- This population of smaller-sized DNA species generated from a single DNA template is referred to as a library.
- Nebulization shears double-stranded template DNA into fragments ranging from 50 to 900 base pairs.
- the sheared library contains single-stranded ends that are end-repaired by a combination of T4 DNA polymerase, E. coli DNA polymerase I (Klenow fragment), and T4 polynucleotide kinase.
- Both T4 and Klenow DNA polymerases are used to “fill-in” 3′ recessed ends (5′ overhangs) of DNA via their 5′-3′ polymerase activity.
- the single-stranded 3′-5′ exonuclease activity of T4 and Klenow polymerases will remove 3′ overhang ends and the kinase activity of T4 polynucleotide kinase will add phosphates to 5′ hydroxyl termini.
- gDNA genomic DNA
- 10 mM TE 10 mM Tris, 0.1 mM EDTA, pH 7.6; see reagent list at the end of section.
- the DNA was analyzed for contamination by measuring the O.D. 260/280 ratio, which was 1.8 or higher.
- the final gDNA concentration was expected to be approximately 300 ⁇ g/ml.
- reaction mixture was placed in an ice-cold nebulizer (CIS-US, Bedford, Mass.).
- the recovered sample was purified using a QIAquick column (Qiagen Inc., Valencia, Calif.) according to manufacturer's directions. The large volume required the column to be loaded several times.
- the sample was eluted with 30 ⁇ l of Buffer EB (10 mM Tris HCl, pH 8.5; supplied in Qiagen kit) which was pre-warmed at 55° C.
- Nebulization of DNA templates yields many fragments of DNA with frayed ends. These ends are made blunt and ready for ligation to adaptor fragments by using three enzymes, T4 DNA polymerase, E. coli DNA polymerase (Klenow fragment) and T4 polynucleotide kinase.
- step 2 The solution of step 1 was mixed well and incubated at 25° C. for 10 minutes in a MJ thermocycler (any accurate incubator may be used).
- the treated DNA was purified using a QiaQuick column and eluted with 30 ⁇ l of Buffer EB (10 mM Tris HCl, pH 8.5) which was pre-warmed at 55° C.
- genomic DNA libraries isolated in size ranges ⁇ 250 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. Gel isolation of the adapted gDNA library will result in the recovery of a library population in a size range that is ⁇ 250 bp (size range of library can be varied depending on application).
- the library size range after ligation of adapters is 130 to 980 bp. It should be noted that the procedure may be adapted for isolation of any band size range, such as, for example, 130 to 200 bp, 200 to 400 bp, 250 to 500 bp, 300 to 600 bp, 500 to 700 bp and the like by cutting different regions of the gel. The procedure described below was used to isolated fragments of 250 bp to 500 bp.
- a 150 ml agarose gel was prepared to include 2% agarose, 1 ⁇ TBE, and 4.5 ⁇ l ethidium bromide (10 mg/ml stock).
- the ligated DNA was mixed with 10 ⁇ Ready Load Dye and loaded onto the gel.
- 10 ⁇ l of a 100-bp ladder (0.1 ⁇ g/ ⁇ l) was loaded on two lanes away from the ligation reaction flanking the sample.
- the gel was electrophoresed at 100 V for 3 hours. When the gel run was complete, the gel was removed from the gel box, transferred to a GelDoc, and covered with plastic wrap.
- the DNA bands were visualized using the Prep UV light.
- the gel slices were placed in a 15 ml falcon tube.
- the agarose-embedded gDNA library was isolated using a Qiagen MinElute Gel Extraction kit. Aliquots of each isolated gDNA library were analyzed using a BioAnalyzer DNA 1000 LabChip to assess the exact distribution of the gDNA library population.
- PB from the QiaQuick Purification kit
- 9 ⁇ l of 20% acetic acid were mixed.
- the beads in 250 ⁇ l Melt Solution were pelleted using a Dynal MPC and the supernatant was carefully removed and transferred to the freshly prepared PB/acetic acid solution.
- DNA from the 1500 ⁇ l solution was purified using a single MinElute purification spin column. This was performed by loading the sample through the same column twice at 750 ⁇ l per load.
- the single stranded gDNA library was eluted with 15 ⁇ l of Buffer EB which was pre-warmed at 55° C.
- Single-stranded gDNA was quantitated using RNA Pico 6000 LabChip as described in Example 1.
- the single stranded library was quantitated by a second assay to ensure the initial Agilent 2100 quantitation was performed accurately.
- RiboGreen quantitation was performed as described (ssDNA Quantitation by Fluorometry) to confirm the Agilent 2100 quantitation. If the two estimates differed by more than 3 fold, each analysis was repeated. If the quantitation showed greater than a 3 fold difference between the two procedures, a broader range of template to bead was used.
- FIG. 9A Typical results from Agilent 2100 DNA 1000 LabChip analysis of 1 ⁇ l of the material following Nebulization and polishing are shown in FIG. 9A. The size range distribution of the majority of the product was expected to fall around 50 to 900 base pairs. The mean size (top of peak) was expected to be approximately 450 bp. Typical results from gel purification of adaptor ligated library fragments are shown in FIG. 9B.
- reagents listed in the Examples represent standard reagents that are commercially available.
- Klenow, T4 DNA polymerase, T4 DNA polymerase buffer, T4 PNK, T4 PNK buffer, Quick T4 DNA Ligase, Quick Ligation Buffer, Bst DNA polymerase (Large Fragment) and ThermoPol reaction buffer are available from New England Biolabs (Beverly, Mass.).
- dNTP mix is available from Pierce (Rockford, Ill.).
- Agarose, UltraPure TBE, BlueJuice gel loading buffer and Ready-Load 100 bp DNA ladder may be purchased from Invitrogen (Carlsbad, Calif.).
- Ethidium Bromide and 2-Propanol may be purchased from Fisher (Hampton, N.H.).
- RNA Ladder may be purchased from Ambion (Austin, Tex.).
- Other reagents are either commonly known and/or are listed below:
- Melt Solution Ingredient Quantity Required Vendor Stock Number NaCl (5 M) 200 ⁇ l Invitrogen 24740-011 NaOH (10 N) 125 ⁇ l Fisher SS255-1 molecular biology 9.675 ml Eppendorf 0032-006-205 grade water
- the Melt Solution included 100 mM NaCl, and 125 mM NaOH. The listed reagents were combined and mixed thoroughly. The solution could be stored at RT for six months.
- the 2 ⁇ B&W buffer included final concentrations of 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 2 M NaCl.
- the listed reagents were combined by combined and mixed thoroughly. The solution could be stored at RT for 6 months.
- the 1 ⁇ B&W buffer was prepared by mixing 2 ⁇ B&W buffer with picopure H 2 O, 1:1. The final concentrations was half of that listed the above, i.e., 5 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, and 1 M NaCl.
- T4 DNA Polymerase Buffer 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl 2 , 1 mM dithiothreitol (pH 7.9 @ 25° C.).
- TE 10 mM Tris, 1 mM EDTA.
- Nebulization Buffer Ingredient Quantity Required Vendor Stock Number Glycerol 53.1 ml Sigma G5516 molecular biology 42.1 ml Eppendorf 0032-006-205 grade water UltraPure Tris-HCl 3.7 ml Invitrogen 15567-027 (pH 7.5, 1M) EDTA (0.5M) 1.1 ml Sigma M-10228
- ATP 10 mM: Ingredient Quantity Required Vendor Stock Number ATP (100 mM) 10 ⁇ l Roche 1140965 molecular biology 90 ⁇ l Eppendorf 0032-006-205 grade water
- the 10 ⁇ Annealing Buffer included 200 mM Tris (pH 7.5) and 50 mM magnesium acetate.
- 200 ml of Tris was added to 500 ml picopure H 2 O.
- 10.72 g of magnesium acetate was added to the solution and dissolved completely.
- the solution was adjusted to a final volume of 1000 ml.
- the solution could be stored at 4° C. for six months. To avoid the potential for contamination of libraries, the buffer was aliquotted for single or short-term usage.
- Adaptor “A” (400 ⁇ M): Quantity Ingredient Req. Vendor Stock No. Adaptor A (sense; HPLC- 10.0 ⁇ l IDT custom purified, phosphorothioate linkages, 44 bp, 1000 pmol/ ⁇ l) Adaptor A (antisense; HPLC- 10.0 ⁇ l IDT custom purified, Phosphorothioate linkages, 40 bp, 1000 pmol/ ⁇ l) Annealing buffer (10 ⁇ ) 2.5 ⁇ l 454 Corp. previous table molecular biology grade water 2.5 ⁇ l Eppendorf 0032-006-205
- Adaptor “B” (400 ⁇ M): Quantity Ingredient Req. Vendor Stock No. Adaptor B (sense; HPLC- 10 ⁇ l IDT Custom purified, phosphorothioate linkages, 40 bp, 1000 pmol/ ⁇ l)) Adaptor B (anti; HPLC-purified, 10 ⁇ l IDT Custom phosphorothioate linkages, 5′Biotinylated, 44 bp, 1000 pmol/ ⁇ l) Annealing buffer (10X) 2.5 ⁇ l 454 Corp. previous table molecular biology grade water 2.5 ⁇ l Eppendorf 0032-006-205
- Acetic Acid Quantity Ingredient Required Vendor Stock Number acetic acid, glacial 2 ml Fisher A35-500 molecular biology grade water 8 ml Eppendorf 0032-006-205
- MinElute kit hypertext transfer protocol://world wide web.qiagen.com/literature/handbooks/minelute/1016839_HBMinElute_Prot_Gel.pdf.
- BioAnalyzer DNA and RNA LabChip Usage (Agilent): hypertext transfer protocol://world wide web.agilent.com/chem/labonachip
- BioAnalyzer RNA 6000 Ladder (Ambion): hypertext transfer protocol://world wide web.ambion.com/techlib/spec/sp — 7152.pdf
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Photoreceptors In Electrophotography (AREA)
- Colloid Chemistry (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/767,894 US20040185484A1 (en) | 2003-01-29 | 2004-01-28 | Method for preparing single-stranded DNA libraries |
| US12/154,901 US20090011959A1 (en) | 2003-01-29 | 2008-05-27 | Method for preparing single-stranded DNA libraries |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44347103P | 2003-01-29 | 2003-01-29 | |
| US46507103P | 2003-04-23 | 2003-04-23 | |
| US47631303P | 2003-06-06 | 2003-06-06 | |
| US47659203P | 2003-06-06 | 2003-06-06 | |
| US47660203P | 2003-06-06 | 2003-06-06 | |
| US47650403P | 2003-06-06 | 2003-06-06 | |
| US49798503P | 2003-08-25 | 2003-08-25 | |
| US10/767,894 US20040185484A1 (en) | 2003-01-29 | 2004-01-28 | Method for preparing single-stranded DNA libraries |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/154,901 Division US20090011959A1 (en) | 2003-01-29 | 2008-05-27 | Method for preparing single-stranded DNA libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20040185484A1 true US20040185484A1 (en) | 2004-09-23 |
Family
ID=32854649
Family Applications (15)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/768,729 Expired - Fee Related US7244567B2 (en) | 2003-01-29 | 2004-01-28 | Double ended sequencing |
| US10/767,894 Abandoned US20040185484A1 (en) | 2003-01-29 | 2004-01-28 | Method for preparing single-stranded DNA libraries |
| US10/767,899 Expired - Lifetime US7842457B2 (en) | 2003-01-29 | 2004-01-28 | Bead emulsion nucleic acid amplification |
| US10/767,779 Expired - Lifetime US7323305B2 (en) | 2003-01-29 | 2004-01-28 | Methods of amplifying and sequencing nucleic acids |
| US11/788,838 Expired - Lifetime US8790876B2 (en) | 2003-01-29 | 2007-04-20 | Methods of amplifying and sequencing nucleic acids |
| US11/982,095 Expired - Lifetime US8012690B2 (en) | 2003-01-29 | 2007-10-31 | Bead emulsion nucleic acid amplification |
| US12/154,901 Abandoned US20090011959A1 (en) | 2003-01-29 | 2008-05-27 | Method for preparing single-stranded DNA libraries |
| US12/803,362 Expired - Lifetime US8158359B2 (en) | 2003-01-29 | 2010-06-24 | Methods of amplifying and sequencing nucleic acids |
| US13/033,240 Active 2026-01-22 US8748102B2 (en) | 2003-01-29 | 2011-02-23 | Bead emulsion nucleic acid amplification |
| US13/419,241 Abandoned US20120238475A1 (en) | 2003-01-29 | 2012-03-13 | Methods of Amplifying and Sequencing Nucleic Acids |
| US13/618,334 Expired - Lifetime US8765380B2 (en) | 2003-01-29 | 2012-09-14 | Bead emulsion nucleic acid amplification |
| US14/036,398 Abandoned US20140162885A1 (en) | 2003-01-29 | 2013-09-25 | Bead Emulsion Nucleic Acid Amplification |
| US14/518,700 Abandoned US20150099672A1 (en) | 2003-01-29 | 2014-10-20 | Bead emulsion nucleic acid amplification |
| US15/190,886 Expired - Lifetime US10240192B2 (en) | 2003-01-29 | 2016-06-23 | Bead emulsion nucleic acid amplification |
| US16/249,681 Expired - Fee Related US10982274B2 (en) | 2003-01-29 | 2019-01-16 | Bead emulsion nucleic acid amplification |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/768,729 Expired - Fee Related US7244567B2 (en) | 2003-01-29 | 2004-01-28 | Double ended sequencing |
Family Applications After (13)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/767,899 Expired - Lifetime US7842457B2 (en) | 2003-01-29 | 2004-01-28 | Bead emulsion nucleic acid amplification |
| US10/767,779 Expired - Lifetime US7323305B2 (en) | 2003-01-29 | 2004-01-28 | Methods of amplifying and sequencing nucleic acids |
| US11/788,838 Expired - Lifetime US8790876B2 (en) | 2003-01-29 | 2007-04-20 | Methods of amplifying and sequencing nucleic acids |
| US11/982,095 Expired - Lifetime US8012690B2 (en) | 2003-01-29 | 2007-10-31 | Bead emulsion nucleic acid amplification |
| US12/154,901 Abandoned US20090011959A1 (en) | 2003-01-29 | 2008-05-27 | Method for preparing single-stranded DNA libraries |
| US12/803,362 Expired - Lifetime US8158359B2 (en) | 2003-01-29 | 2010-06-24 | Methods of amplifying and sequencing nucleic acids |
| US13/033,240 Active 2026-01-22 US8748102B2 (en) | 2003-01-29 | 2011-02-23 | Bead emulsion nucleic acid amplification |
| US13/419,241 Abandoned US20120238475A1 (en) | 2003-01-29 | 2012-03-13 | Methods of Amplifying and Sequencing Nucleic Acids |
| US13/618,334 Expired - Lifetime US8765380B2 (en) | 2003-01-29 | 2012-09-14 | Bead emulsion nucleic acid amplification |
| US14/036,398 Abandoned US20140162885A1 (en) | 2003-01-29 | 2013-09-25 | Bead Emulsion Nucleic Acid Amplification |
| US14/518,700 Abandoned US20150099672A1 (en) | 2003-01-29 | 2014-10-20 | Bead emulsion nucleic acid amplification |
| US15/190,886 Expired - Lifetime US10240192B2 (en) | 2003-01-29 | 2016-06-23 | Bead emulsion nucleic acid amplification |
| US16/249,681 Expired - Fee Related US10982274B2 (en) | 2003-01-29 | 2019-01-16 | Bead emulsion nucleic acid amplification |
Country Status (10)
| Country | Link |
|---|---|
| US (15) | US7244567B2 (enExample) |
| EP (8) | EP1594950A4 (enExample) |
| JP (9) | JP4473878B2 (enExample) |
| CN (2) | CN101128601B (enExample) |
| AT (4) | ATE437945T1 (enExample) |
| AU (4) | AU2004254552B2 (enExample) |
| CA (6) | CA2513541A1 (enExample) |
| DE (4) | DE602004036672C5 (enExample) |
| ES (5) | ES2396245T3 (enExample) |
| WO (4) | WO2005003375A2 (enExample) |
Cited By (178)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030096268A1 (en) * | 2001-07-06 | 2003-05-22 | Michael Weiner | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US20040056018A1 (en) * | 2001-09-25 | 2004-03-25 | Beru Ag | Method for operating a multi-stage electrical heater comprised of several heating elements |
| WO2005010145A3 (en) * | 2003-07-05 | 2005-08-11 | Univ Johns Hopkins | Method and compositions for detection and enumeration of genetic variations |
| US20060110764A1 (en) * | 2004-10-25 | 2006-05-25 | Tom Tang | Large-scale parallelized DNA sequencing |
| US20060121470A1 (en) * | 2002-08-01 | 2006-06-08 | Henrik Pedersen | Multi-step synthesis of templated molecules |
| US20060269934A1 (en) * | 2005-03-16 | 2006-11-30 | Applera Corporation | Compositions and methods for clonal amplification and analysis of polynucleotides |
| US20060292603A1 (en) * | 2002-10-30 | 2006-12-28 | Gouliaev Alex H | Method for selecting a chemical entity from a tagged library |
| US20070031865A1 (en) * | 2005-07-07 | 2007-02-08 | David Willoughby | Novel Process for Construction of a DNA Library |
| US20070039866A1 (en) * | 2005-08-22 | 2007-02-22 | Schroeder Benjamin G | Device, system, and method for depositing processed immiscible-fluid-discrete-volumes |
| US20070117121A1 (en) * | 2005-09-16 | 2007-05-24 | Hutchison Stephen K | cDNA library preparation |
| US20070172839A1 (en) * | 2006-01-24 | 2007-07-26 | Smith Douglas R | Asymmetrical adapters and methods of use thereof |
| US20070231823A1 (en) * | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
| US20080132693A1 (en) * | 2003-01-29 | 2008-06-05 | Jan Berka | Bead emulsion nucleic acid amplification |
| US20080145898A1 (en) * | 2006-12-14 | 2008-06-19 | Applera Corporation | Sequencing methods |
| US20080193983A1 (en) * | 2002-12-19 | 2008-08-14 | Nuevolution A/S | Quasirandom Structure and Function Guided Synthesis Methods |
| US20080305957A1 (en) * | 2003-09-18 | 2008-12-11 | Thomas Thisted | Method for Obtaining Structural Information Concerning an Encoded Molecule and Method for Selecting Compounds |
| US20090053724A1 (en) * | 2007-06-28 | 2009-02-26 | 454 Life Sciences Corporation | System and method for adaptive reagent control in nucleic acid sequencing |
| US20090105959A1 (en) * | 2007-06-01 | 2009-04-23 | Braverman Michael S | System and method for identification of individual samples from a multiplex mixture |
| US20090203086A1 (en) * | 2008-02-06 | 2009-08-13 | 454 Life Sciences Corporation | System and method for improved signal detection in nucleic acid sequencing |
| US20090233291A1 (en) * | 2005-06-06 | 2009-09-17 | 454 Life Sciences Corporation | Paired end sequencing |
| US20090239211A1 (en) * | 2004-02-17 | 2009-09-24 | Nuevolution A/S | Method For Enrichment Involving Elimination By Mismatch Hybridisation |
| US7604940B1 (en) | 2005-03-16 | 2009-10-20 | Applied Biosystems, Llc | Compositions and methods for analyzing isolated polynucleotides |
| US20090318298A1 (en) * | 2006-09-28 | 2009-12-24 | President And Fellows Of Harvard College | Methods for Sequencing DNA |
| US20100016177A1 (en) * | 2001-06-20 | 2010-01-21 | Henrik Pedersen | Templated molecules and methods for using such molecules |
| US20100137143A1 (en) * | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
| US20100136557A1 (en) * | 2007-06-29 | 2010-06-03 | Sydney Brenner | Methods and Compositions for Isolating Nucleic Acid Sequence Variants |
| US20100143908A1 (en) * | 2006-11-15 | 2010-06-10 | Biospherex, Llc, A Limited Liability Company | Multitag sequencing ecogenomics analysis-us |
| USRE41780E1 (en) | 2003-03-14 | 2010-09-28 | Lawrence Livermore National Security, Llc | Chemical amplification based on fluid partitioning in an immiscible liquid |
| US20100261189A1 (en) * | 2008-10-03 | 2010-10-14 | Roche Molecular Systems, Inc. | System and method for detection of HLA Variants |
| US20100282617A1 (en) * | 2006-12-14 | 2010-11-11 | Ion Torrent Systems Incorporated | Methods and apparatus for detecting molecular interactions using fet arrays |
| US20100301398A1 (en) * | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
| US7888034B2 (en) | 2008-07-01 | 2011-02-15 | 454 Life Sciences Corporation | System and method for detection of HIV tropism variants |
| US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
| US20110087016A1 (en) * | 2009-10-09 | 2011-04-14 | 454 Life Sciences Corporation | System and Method for Emulsion Breaking and Recovery of Biological Elements |
| US7948015B2 (en) | 2006-12-14 | 2011-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US20110126911A1 (en) * | 2009-12-01 | 2011-06-02 | IntegenX Inc., a California Corporation | Composite Plastic Articles |
| US20110177587A1 (en) * | 2004-01-28 | 2011-07-21 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| US20110217738A1 (en) * | 2010-03-03 | 2011-09-08 | Gen9, Inc. | Methods and Devices for Nucleic Acid Synthesis |
| WO2011056872A3 (en) * | 2009-11-03 | 2011-11-03 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| WO2011106314A3 (en) * | 2010-02-25 | 2012-02-23 | Advanced Liquid Logic, Inc. | Method of making nucleic acid libraries |
| US20120135871A1 (en) * | 2006-04-04 | 2012-05-31 | Keygene N.V. | High throughput detection of molecular markers based on aflp and high through-put sequencing |
| US8217433B1 (en) | 2010-06-30 | 2012-07-10 | Life Technologies Corporation | One-transistor pixel array |
| US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| WO2012130681A1 (en) | 2011-03-25 | 2012-10-04 | Roche Diagnostics Gmbh | System and method for detection of hiv integrase variants |
| US8388908B2 (en) | 2009-06-02 | 2013-03-05 | Integenx Inc. | Fluidic devices with diaphragm valves |
| US8394642B2 (en) | 2009-06-05 | 2013-03-12 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
| US8431340B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Methods for processing and analyzing nucleic acid samples |
| US8470164B2 (en) | 2008-06-25 | 2013-06-25 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8476063B2 (en) | 2004-09-15 | 2013-07-02 | Integenx Inc. | Microfluidic devices |
| US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
| US8552771B1 (en) | 2012-05-29 | 2013-10-08 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US20130309668A1 (en) * | 2004-03-08 | 2013-11-21 | Rubicon Genomics, Inc. | Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| US8653567B2 (en) | 2010-07-03 | 2014-02-18 | Life Technologies Corporation | Chemically sensitive sensor with lightly doped drains |
| US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
| US8672532B2 (en) | 2008-12-31 | 2014-03-18 | Integenx Inc. | Microfluidic methods |
| WO2014043140A1 (en) * | 2012-09-12 | 2014-03-20 | The Regents Of The University Of California | Accurate genome sequencing of single cells by single-stranded amplification and sequencing |
| US8685324B2 (en) | 2010-09-24 | 2014-04-01 | Life Technologies Corporation | Matched pair transistor circuits |
| GB2497912B (en) * | 2010-10-08 | 2014-06-04 | Harvard College | High-throughput single cell barcoding |
| US8748165B2 (en) | 2008-01-22 | 2014-06-10 | Integenx Inc. | Methods for generating short tandem repeat (STR) profiles |
| US8747748B2 (en) | 2012-01-19 | 2014-06-10 | Life Technologies Corporation | Chemical sensor with conductive cup-shaped sensor surface |
| US8753812B2 (en) | 2004-11-12 | 2014-06-17 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection method for DNA and other molecules |
| WO2014068407A3 (en) * | 2012-10-26 | 2014-06-26 | Sysmex Corporation | Emulsion systems and emulsion-based amplification of nucleic acid |
| US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
| US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8808986B2 (en) | 2008-08-27 | 2014-08-19 | Gen9, Inc. | Methods and devices for high fidelity polynucleotide synthesis |
| US8808984B2 (en) | 2002-03-15 | 2014-08-19 | Neuvolution A/S | Method for synthesising templated molecules |
| US8815512B2 (en) | 2005-12-22 | 2014-08-26 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US8821798B2 (en) | 2012-01-19 | 2014-09-02 | Life Technologies Corporation | Titanium nitride as sensing layer for microwell structure |
| US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
| US8858782B2 (en) | 2010-06-30 | 2014-10-14 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
| US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
| US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
| EP2840148A1 (en) | 2013-08-23 | 2015-02-25 | F. Hoffmann-La Roche AG | System and method for nucleic acid amplification |
| EP2848698A1 (en) | 2013-08-26 | 2015-03-18 | F. Hoffmann-La Roche AG | System and method for automated nucleic acid amplification |
| US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
| US20150197789A1 (en) * | 2006-02-08 | 2015-07-16 | Illumina Cambridge Limited | End modification to prevent over-representation of fragments |
| US9096951B2 (en) | 2003-02-21 | 2015-08-04 | Nuevolution A/S | Method for producing second-generation library |
| US9109251B2 (en) | 2004-06-25 | 2015-08-18 | University Of Hawaii | Ultrasensitive biosensors |
| US9116117B2 (en) | 2013-03-15 | 2015-08-25 | Life Technologies Corporation | Chemical sensor with sidewall sensor surface |
| US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
| US9128044B2 (en) | 2013-03-15 | 2015-09-08 | Life Technologies Corporation | Chemical sensors with consistent sensor surface areas |
| US9217144B2 (en) | 2010-01-07 | 2015-12-22 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US9216414B2 (en) | 2009-11-25 | 2015-12-22 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| US9376716B2 (en) | 2005-06-23 | 2016-06-28 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9422600B2 (en) | 2009-11-25 | 2016-08-23 | Gen9, Inc. | Methods and apparatuses for chip-based DNA error reduction |
| WO2016160965A1 (en) * | 2015-03-30 | 2016-10-06 | Rubicon Genomics, Inc. | Methods and compositions for repair of dna ends by multiple enzymatic activities |
| US9464318B2 (en) * | 2015-02-11 | 2016-10-11 | Paragon Genomics, Inc. | Methods and compositions for reducing non-specific amplification products |
| US9486757B2 (en) | 2009-03-13 | 2016-11-08 | President And Fellows Of Harvard College | Scale-up of microfluidic devices |
| US9513253B2 (en) | 2011-07-11 | 2016-12-06 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based enzymatic assays |
| US9574189B2 (en) | 2005-12-01 | 2017-02-21 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
| US9618475B2 (en) | 2010-09-15 | 2017-04-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US9671363B2 (en) | 2013-03-15 | 2017-06-06 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
| EP3175914A1 (en) * | 2004-01-07 | 2017-06-07 | Illumina Cambridge Limited | Improvements in or relating to molecular arrays |
| US9752176B2 (en) | 2011-06-15 | 2017-09-05 | Ginkgo Bioworks, Inc. | Methods for preparative in vitro cloning |
| EP2599877B1 (en) * | 2010-06-30 | 2017-09-27 | BGI Genomics Co., Limited | New pcr sequencing method and use thereof in hla genotyping |
| US9816088B2 (en) | 2013-03-15 | 2017-11-14 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US9823217B2 (en) | 2013-03-15 | 2017-11-21 | Life Technologies Corporation | Chemical device with thin conductive element |
| US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
| US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
| WO2018049260A1 (en) * | 2016-09-09 | 2018-03-15 | Tl Biolabs Corp . | Reusable microarray compositions and methods |
| EP3208343A4 (en) * | 2014-10-13 | 2018-03-21 | BGI Shenzhen Co., Limited | Nucleic acid fragmentation method and sequence combination |
| US20180080020A1 (en) * | 2006-01-11 | 2018-03-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9951384B2 (en) | 2012-01-13 | 2018-04-24 | Data2Bio | Genotyping by next-generation sequencing |
| US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
| US20180148767A1 (en) * | 2015-05-29 | 2018-05-31 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
| US10081807B2 (en) | 2012-04-24 | 2018-09-25 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| CN108588200A (zh) * | 2018-05-06 | 2018-09-28 | 湖南大地同年生物科技有限公司 | 一种R-Loop高通量测序文库构建方法 |
| WO2018186930A1 (en) * | 2017-04-06 | 2018-10-11 | MyOmicsDx, Inc | Method and kit for constructing nucleic acid library |
| US10100357B2 (en) | 2013-05-09 | 2018-10-16 | Life Technologies Corporation | Windowed sequencing |
| US10100358B2 (en) | 2017-01-10 | 2018-10-16 | Paragon Genomics, Inc. | Methods and compositions for reducing redundant molecular barcodes created in primer extension reactions |
| EP3259372A4 (en) * | 2015-02-17 | 2018-11-07 | Complete Genomics, Inc. | Dna sequencing using controlled strand displacement |
| US10192024B2 (en) | 2012-05-18 | 2019-01-29 | 454 Life Sciences Corporation | System and method for generation and use of optimal nucleotide flow orders |
| US10191071B2 (en) | 2013-11-18 | 2019-01-29 | IntegenX, Inc. | Cartridges and instruments for sample analysis |
| US10202608B2 (en) | 2006-08-31 | 2019-02-12 | Gen9, Inc. | Iterative nucleic acid assembly using activation of vector-encoded traits |
| US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
| US10233494B2 (en) | 2005-09-29 | 2019-03-19 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
| US10308931B2 (en) | 2012-03-21 | 2019-06-04 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| CN109853047A (zh) * | 2019-04-10 | 2019-06-07 | 翌圣生物科技(上海)有限公司 | 一种基因组dna测序文库快速构建方法及配套试剂盒 |
| US10316364B2 (en) | 2005-09-29 | 2019-06-11 | Keygene N.V. | Method for identifying the source of an amplicon |
| US10344336B2 (en) | 2015-06-09 | 2019-07-09 | Life Technologies Corporation | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging |
| CN110062809A (zh) * | 2016-12-20 | 2019-07-26 | 豪夫迈·罗氏有限公司 | 用于环状共有序列测序的单链环状dna文库 |
| US10379079B2 (en) | 2014-12-18 | 2019-08-13 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US10421993B2 (en) | 2015-02-11 | 2019-09-24 | Paragon Genomics, Inc. | Methods and compositions for reducing non-specific amplification products |
| US10451585B2 (en) | 2009-05-29 | 2019-10-22 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| US10457935B2 (en) | 2010-11-12 | 2019-10-29 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| US10525467B2 (en) | 2011-10-21 | 2020-01-07 | Integenx Inc. | Sample preparation, processing and analysis systems |
| US10590483B2 (en) | 2014-09-15 | 2020-03-17 | Abvitro Llc | High-throughput nucleotide library sequencing |
| US10605767B2 (en) | 2014-12-18 | 2020-03-31 | Life Technologies Corporation | High data rate integrated circuit with transmitter configuration |
| US10612017B2 (en) | 2009-05-29 | 2020-04-07 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
| CN111133135A (zh) * | 2017-07-17 | 2020-05-08 | 希昆斯生物科学公司 | 用于高通量测序的快速文库构建 |
| US10690627B2 (en) | 2014-10-22 | 2020-06-23 | IntegenX, Inc. | Systems and methods for sample preparation, processing and analysis |
| CN111455469A (zh) * | 2020-04-07 | 2020-07-28 | 深圳易倍科华生物科技有限公司 | 一种单链快速建库方法及建库仪器 |
| US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
| US10941453B1 (en) | 2020-05-20 | 2021-03-09 | Paragon Genomics, Inc. | High throughput detection of pathogen RNA in clinical specimens |
| US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP2971168B1 (en) | 2013-03-15 | 2021-05-05 | Guardant Health, Inc. | Method of detecting cancer |
| US11072789B2 (en) | 2012-06-25 | 2021-07-27 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| US11084014B2 (en) | 2010-11-12 | 2021-08-10 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
| EP3901273A1 (en) * | 2012-08-14 | 2021-10-27 | 10X Genomics, Inc. | Microcapsule compositions and methods |
| US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US11193121B2 (en) | 2013-02-08 | 2021-12-07 | 10X Genomics, Inc. | Partitioning and processing of analytes and other species |
| US11231451B2 (en) | 2010-06-30 | 2022-01-25 | Life Technologies Corporation | Methods and apparatus for testing ISFET arrays |
| US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| EP3973070A1 (en) * | 2019-05-22 | 2022-03-30 | Oxford Nanopore Technologies PLC | Protocol for detecting interactions within one or more dna molecules within a cell |
| US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
| US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US11359239B2 (en) | 2012-08-14 | 2022-06-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11421274B2 (en) | 2012-12-14 | 2022-08-23 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11434531B2 (en) | 2013-12-28 | 2022-09-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11434523B2 (en) | 2012-09-04 | 2022-09-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US11441179B2 (en) | 2012-08-14 | 2022-09-13 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11473138B2 (en) | 2012-12-14 | 2022-10-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US11629344B2 (en) | 2014-06-26 | 2023-04-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| US11667952B2 (en) | 2017-08-24 | 2023-06-06 | Takara Bio Usa, Inc. | Methods of producing nucleic acids using oligonucleotides modified by a stimulus |
| US11680293B1 (en) | 2022-04-21 | 2023-06-20 | Paragon Genomics, Inc. | Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules |
| US11702662B2 (en) | 2011-08-26 | 2023-07-18 | Gen9, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
| US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
| WO2023175040A3 (en) * | 2022-03-15 | 2023-11-02 | Illumina, Inc. | Concurrent sequencing of forward and reverse complement strands on concatenated polynucleotides for methylation detection |
| US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| CN118086457A (zh) * | 2024-02-22 | 2024-05-28 | 纳昂达(南京)生物科技有限公司 | Dna文库的构建方法及应用 |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US12091710B2 (en) | 2006-05-11 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
| US12091715B2 (en) | 2022-04-21 | 2024-09-17 | Paragon Genomics, Inc. | Methods and compositions for reducing base errors of massive parallel sequencing using triseq sequencing |
| US12312640B2 (en) | 2014-06-26 | 2025-05-27 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| US12352673B2 (en) | 2009-03-23 | 2025-07-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
Families Citing this family (1098)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622294B2 (en) | 1997-03-14 | 2009-11-24 | Trustees Of Tufts College | Methods for detecting target analytes and enzymatic reactions |
| US20030027126A1 (en) | 1997-03-14 | 2003-02-06 | Walt David R. | Methods for detecting target analytes and enzymatic reactions |
| DK1019496T3 (da) | 1997-07-07 | 2005-01-10 | Medical Res Council | In vitro-sorteringsmetode |
| GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
| CA2290731A1 (en) * | 1999-11-26 | 2001-05-26 | D. Jed Harrison | Apparatus and method for trapping bead based reagents within microfluidic analysis system |
| US6432290B1 (en) | 1999-11-26 | 2002-08-13 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
| US7846733B2 (en) * | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
| EP1356094B1 (en) * | 2000-06-26 | 2010-01-13 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
| CA2430329A1 (en) | 2000-12-13 | 2002-06-20 | Nugen Technologies, Inc. | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
| NZ523167A (en) | 2001-03-09 | 2006-08-31 | Nugen Technologies Inc | Methods, compositions and kits for amplifying RNA sequences of interest which employ an RNA/DNA composite primer |
| US20030108664A1 (en) * | 2001-10-05 | 2003-06-12 | Kodas Toivo T. | Methods and compositions for the formation of recessed electrical features on a substrate |
| JP4192097B2 (ja) * | 2001-10-25 | 2008-12-03 | バル−イラン ユニバーシティ | 相互作用型透明個別細胞バイオチッププロセッサー |
| GB0127564D0 (en) * | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
| US20030217923A1 (en) * | 2002-05-24 | 2003-11-27 | Harrison D. Jed | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
| US7595883B1 (en) | 2002-09-16 | 2009-09-29 | The Board Of Trustees Of The Leland Stanford Junior University | Biological analysis arrangement and approach therefor |
| AU2003266932B2 (en) * | 2002-09-27 | 2009-04-09 | Mpm-Holding Aps | Spatially encoded polymer matrix |
| CA2512071A1 (en) * | 2002-12-30 | 2004-07-22 | The Regents Of The University Of California | Methods and apparatus for pathogen detection and analysis |
| US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
| AU2004214891B2 (en) | 2003-02-26 | 2010-01-07 | Complete Genomics, Inc. | Random array DNA analysis by hybridization |
| IL154677A0 (en) * | 2003-02-27 | 2003-09-17 | Univ Bar Ilan | A method and apparatus for manipulating an individual cell |
| GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
| US20060078893A1 (en) * | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
| JP2006523465A (ja) | 2003-04-14 | 2006-10-19 | ニューゲン テクノロジーズ, インコーポレイテッド | ランダムにプライミングされる複合プライマーを用いる大規模増幅 |
| FR2856498B1 (fr) * | 2003-06-19 | 2005-09-30 | Goulven Jean Alain Vernois | Distribution sous atmosphere controlee |
| US8597597B2 (en) * | 2003-06-26 | 2013-12-03 | Seng Enterprises Ltd. | Picoliter well holding device and method of making the same |
| US9200245B2 (en) | 2003-06-26 | 2015-12-01 | Seng Enterprises Ltd. | Multiwell plate |
| US7888110B2 (en) * | 2003-06-26 | 2011-02-15 | Seng Enterprises Ltd. | Pico liter well holding device and method of making the same |
| WO2005028109A2 (en) * | 2003-09-19 | 2005-03-31 | Applera Corporation | Microplates useful for conducting thermocycled nucleotide amplification |
| WO2005054431A2 (en) * | 2003-12-01 | 2005-06-16 | 454 Corporation | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US7972994B2 (en) | 2003-12-17 | 2011-07-05 | Glaxosmithkline Llc | Methods for synthesis of encoded libraries |
| US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| US7622281B2 (en) * | 2004-05-20 | 2009-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for clonal amplification of nucleic acid |
| WO2005118773A2 (en) | 2004-05-28 | 2005-12-15 | Wafergen, Inc. | Apparatus and methods for multiplex analyses |
| US7799553B2 (en) * | 2004-06-01 | 2010-09-21 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
| US7264934B2 (en) * | 2004-06-10 | 2007-09-04 | Ge Healthcare Bio-Sciences Corp. | Rapid parallel nucleic acid analysis |
| US20080063251A1 (en) * | 2004-07-07 | 2008-03-13 | Mordechai Deutsch | Method and Device for Identifying an Image of a Well in an Image of a Well-Bearing |
| EP1781404A2 (en) * | 2004-08-25 | 2007-05-09 | Seng Enterprises Limited | Method and device for isolating cells |
| US7485451B2 (en) * | 2004-11-18 | 2009-02-03 | Regents Of The University Of California | Storage stable compositions of biological materials |
| JP2008522628A (ja) * | 2004-12-11 | 2008-07-03 | サイトジェニックス, インコーポレイテッド | 高品質核酸のセルフリー生合成及びその使用 |
| DE602005023534D1 (de) | 2005-01-25 | 2010-10-21 | Seng Entpr Ltd | Mikrofluidische vorrichtung zur untersuchung zellen |
| EP2857523A1 (en) | 2005-02-01 | 2015-04-08 | Applied Biosystems, LLC | Method for identifying a sequence in a polynucleotide |
| JP2006211984A (ja) * | 2005-02-04 | 2006-08-17 | Univ Nagoya | エマルジョンを利用した核酸増幅方法、及び核酸増幅反応用キット |
| US8374887B1 (en) | 2005-02-11 | 2013-02-12 | Emily H. Alexander | System and method for remotely supervising and verifying pharmacy functions |
| EP1848819A4 (en) * | 2005-02-16 | 2010-01-06 | Genetic Technologies Ltd | GENETIC ANALYSIS METHODS COMPRISING THE AMPLIFICATION OF COMPLEMENTARY DUPLICONS |
| US7932081B2 (en) * | 2005-03-10 | 2011-04-26 | Gen-Probe Incorporated | Signal measuring system for conducting real-time amplification assays |
| US20060228721A1 (en) | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
| JP2008538496A (ja) * | 2005-04-12 | 2008-10-30 | 454 ライフ サイエンシーズ コーポレイション | ウルトラディープ配列決定を用いて配列変異体を決定するための方法 |
| CN101213311B (zh) * | 2005-04-29 | 2013-02-13 | 合成基因组股份有限公司 | 利用滚环扩增扩增和克隆单个dna分子 |
| DK1885882T3 (da) * | 2005-05-10 | 2011-04-11 | State Of Oregon Acting By & Through The State Board Of Higher Eduction On Behalf Of The University O | Fremgangsmåder til kortlægning af polymorfier og polymorfi-mikroarray |
| CA2615323A1 (en) * | 2005-06-06 | 2007-12-21 | 454 Life Sciences Corporation | Paired end sequencing |
| SI1910538T1 (sl) | 2005-06-09 | 2011-09-30 | Praecis Pharm Inc | POSTOPKI ZA SINTEZO KODIRANIH KNJIĹľNIC |
| CA2611671C (en) | 2005-06-15 | 2013-10-08 | Callida Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
| US20090264299A1 (en) * | 2006-02-24 | 2009-10-22 | Complete Genomics, Inc. | High throughput genome sequencing on DNA arrays |
| ATE465274T1 (de) * | 2005-06-23 | 2010-05-15 | Keygene Nv | Verbesserte strategien zur sequenzierung komplexer genome unter verwendung von sequenziertechniken mit hohem durchsatz |
| GB0514935D0 (en) * | 2005-07-20 | 2005-08-24 | Solexa Ltd | Methods for sequencing a polynucleotide template |
| GB0514910D0 (en) | 2005-07-20 | 2005-08-24 | Solexa Ltd | Method for sequencing a polynucleotide template |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US10083273B2 (en) * | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| CA2619686A1 (en) * | 2005-08-19 | 2007-02-22 | Commomwealth Scientific And Industrial Research Organisation | Arachnocampa luciferases |
| WO2007030759A2 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
| CA2624896C (en) | 2005-10-07 | 2017-11-07 | Callida Genomics, Inc. | Self-assembled single molecule arrays and uses thereof |
| WO2007133831A2 (en) | 2006-02-24 | 2007-11-22 | Callida Genomics, Inc. | High throughput genome sequencing on dna arrays |
| US20070141555A1 (en) * | 2005-10-11 | 2007-06-21 | Mordechai Deutsch | Current damper for the study of cells |
| PT1948816E (pt) * | 2005-10-24 | 2012-03-19 | Univ Johns Hopkins | Processos melhorados de focalização |
| KR100828714B1 (ko) | 2005-10-25 | 2008-05-09 | 주식회사 엘지화학 | 리보핵산을 이용한 멀티플렉스 증폭방법 |
| US7989395B2 (en) * | 2005-10-28 | 2011-08-02 | Glaxosmithkline Llc | Methods for identifying compounds of interest using encoded libraries |
| GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
| US8288120B2 (en) * | 2005-11-03 | 2012-10-16 | Seng Enterprises Ltd. | Method for studying floating, living cells |
| JP2009515192A (ja) * | 2005-11-08 | 2009-04-09 | インコム,インコーポレイテッド | 光ファイバ探査型マイクロスライド、マイクロスライドキット、およびその使用 |
| AU2006312378B2 (en) * | 2005-11-14 | 2012-02-16 | Keygene N.V. | Method for high throughput screening of transposon tagging populations and massive parallel sequence identification of insertion sites |
| GB0524069D0 (en) | 2005-11-25 | 2006-01-04 | Solexa Ltd | Preparation of templates for solid phase amplification |
| US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
| DK1966394T3 (da) * | 2005-12-22 | 2012-10-29 | Keygene Nv | Forbedrede strategier til transkriptprofilering under anvendelse af high throughput-sekventeringsteknologier |
| US20090203148A1 (en) * | 2006-01-19 | 2009-08-13 | Vera Gorfinkel | Methods and Devices For Detection and Identification of Encoded Beads and Biological Molecules |
| CN101360819A (zh) * | 2006-01-20 | 2009-02-04 | 凸版印刷株式会社 | 反应容器及dna的扩增反应方法 |
| US7749365B2 (en) | 2006-02-01 | 2010-07-06 | IntegenX, Inc. | Optimized sample injection structures in microfluidic separations |
| DE102006005287B4 (de) * | 2006-02-06 | 2012-12-27 | Siemens Ag | Verfahren zum Nachweis von Zielnukleinsäuren |
| CA2641851A1 (en) | 2006-02-08 | 2007-08-16 | Eric Hans Vermaas | Method for sequencing a polynucleotide template |
| EP2002367B1 (en) | 2006-02-16 | 2017-03-29 | 454 Life Sciences Corporation | System and method for correcting primer extension errors in nucleic acid sequence data |
| US8364417B2 (en) * | 2007-02-15 | 2013-01-29 | 454 Life Sciences Corporation | System and method to correct out of phase errors in DNA sequencing data by use of a recursive algorithm |
| US8492098B2 (en) * | 2006-02-21 | 2013-07-23 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of reaction components that affect a reaction |
| US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| US7766033B2 (en) * | 2006-03-22 | 2010-08-03 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
| EP4105644A3 (en) | 2006-03-31 | 2022-12-28 | Illumina, Inc. | Systems and devices for sequence by synthesis analysis |
| US7439014B2 (en) | 2006-04-18 | 2008-10-21 | Advanced Liquid Logic, Inc. | Droplet-based surface modification and washing |
| US8809068B2 (en) | 2006-04-18 | 2014-08-19 | Advanced Liquid Logic, Inc. | Manipulation of beads in droplets and methods for manipulating droplets |
| CN101495654A (zh) * | 2006-04-19 | 2009-07-29 | 阿普里拉股份有限公司 | 无凝胶珠基测序的试剂、方法和文库 |
| US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
| US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
| WO2007136736A2 (en) * | 2006-05-19 | 2007-11-29 | Codon Devices, Inc. | Methods for nucleic acid sorting and synthesis |
| US20080124726A1 (en) * | 2006-05-26 | 2008-05-29 | Althea Technologies, Inc. | Biochemical analysis of partitioned cells |
| US11001881B2 (en) | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
| US8569416B2 (en) | 2006-06-06 | 2013-10-29 | Dow Corning Corporation | Single phase silicone acrylate formulation |
| EP2024406B1 (en) * | 2006-06-06 | 2012-08-01 | Dow Corning Corporation | A silicone acrylate hybrid composition |
| US8614278B2 (en) | 2006-06-06 | 2013-12-24 | Dow Corning Corporation | Silicone acrylate hybrid composition and method of making same |
| US20080124707A1 (en) * | 2006-06-09 | 2008-05-29 | Agency For Science, Technology And Research | Nucleic acid concatenation |
| EP2366801B1 (en) | 2006-06-14 | 2016-10-19 | Verinata Health, Inc | Methods for the diagnosis of fetal abnormalities |
| US20080009007A1 (en) * | 2006-06-16 | 2008-01-10 | Pacific Biosciences Of California, Inc. | Controlled initiation of primer extension |
| EP2821506A1 (en) | 2006-07-12 | 2015-01-07 | Keygene N.V. | Identification of clones by sequencing of pool-specific adapters |
| US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
| WO2008014485A2 (en) | 2006-07-28 | 2008-01-31 | California Institute Of Technology | Multiplex q-pcr arrays |
| US9328378B2 (en) | 2006-07-31 | 2016-05-03 | Illumina Cambridge Limited | Method of library preparation avoiding the formation of adaptor dimers |
| EP2077912B1 (en) | 2006-08-07 | 2019-03-27 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
| US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
| US8399188B2 (en) | 2006-09-28 | 2013-03-19 | Illumina, Inc. | Compositions and methods for nucleotide sequencing |
| US7754429B2 (en) | 2006-10-06 | 2010-07-13 | Illumina Cambridge Limited | Method for pair-wise sequencing a plurity of target polynucleotides |
| WO2008045575A2 (en) * | 2006-10-13 | 2008-04-17 | J. Craig Venter Institute, Inc. | Sequencing method |
| US8841116B2 (en) * | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
| US7910302B2 (en) | 2006-10-27 | 2011-03-22 | Complete Genomics, Inc. | Efficient arrays of amplified polynucleotides |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| CN103173346B (zh) * | 2006-11-06 | 2017-04-19 | 科隆迪亚戈有限公司 | 使用结合元件用于分析的装置和方法 |
| US20090111706A1 (en) * | 2006-11-09 | 2009-04-30 | Complete Genomics, Inc. | Selection of dna adaptor orientation by amplification |
| US20080242560A1 (en) * | 2006-11-21 | 2008-10-02 | Gunderson Kevin L | Methods for generating amplified nucleic acid arrays |
| US7902345B2 (en) | 2006-12-05 | 2011-03-08 | Sequenom, Inc. | Detection and quantification of biomolecules using mass spectrometry |
| US7932034B2 (en) | 2006-12-20 | 2011-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Heat and pH measurement for sequencing of DNA |
| EP2121983A2 (en) | 2007-02-02 | 2009-11-25 | Illumina Cambridge Limited | Methods for indexing samples and sequencing multiple nucleotide templates |
| US9152150B1 (en) | 2007-02-22 | 2015-10-06 | Applied Biosystems, Llc | Compositions, systems, and methods for immiscible fluid discrete volume manipulation |
| WO2008109176A2 (en) | 2007-03-07 | 2008-09-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
| US8617816B2 (en) | 2007-03-16 | 2013-12-31 | 454 Life Sciences, A Roche Company | System and method for detection of HIV drug resistant variants |
| US20100151465A1 (en) | 2008-03-27 | 2010-06-17 | Jingyue Ju | Selective Capture and Release of Analytes |
| US20080243865A1 (en) * | 2007-03-28 | 2008-10-02 | Oracle International Corporation | Maintaining global state of distributed transaction managed by an external transaction manager for clustered database systems |
| US20080239867A1 (en) * | 2007-03-28 | 2008-10-02 | Gilbert Donna J | Adjustable stir |
| JP2008245612A (ja) * | 2007-03-30 | 2008-10-16 | Hitachi Ltd | 試料調製法および装置 |
| US7883265B2 (en) * | 2007-06-01 | 2011-02-08 | Applied Biosystems, Llc | Devices, systems, and methods for preparing emulsions |
| US8454906B2 (en) * | 2007-07-24 | 2013-06-04 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
| EP2173909A1 (en) | 2007-07-26 | 2010-04-14 | Roche Diagnostics GmbH | Target preparation for parallel sequencing of complex genomes |
| JP5020734B2 (ja) * | 2007-07-31 | 2012-09-05 | 株式会社日立ハイテクノロジーズ | 核酸解析方法及び装置 |
| EP2201021A4 (en) | 2007-08-29 | 2012-01-25 | Applied Biosystems Llc | METHOD OF ALTERNATING NUCLEIC ACID SEQUENCING |
| WO2009032167A1 (en) * | 2007-08-29 | 2009-03-12 | Illumina Cambridge | Method for sequencing a polynucleotide template |
| ATE549419T1 (de) | 2007-08-29 | 2012-03-15 | Sequenom Inc | Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion |
| WO2009029073A1 (en) | 2007-08-30 | 2009-03-05 | The Trustees Of Tufts College | Methods for determining the concentration of an analyte in solution. |
| WO2009035623A1 (en) * | 2007-09-11 | 2009-03-19 | Arryx, Inc. | Binding method and apparatus for sorting objects |
| WO2009036192A1 (en) * | 2007-09-13 | 2009-03-19 | Applied Precision, Inc. | Method of dispersing immersion liquid on a specimen substrate for high resolution imaging and lithographie |
| EP2185261A4 (en) * | 2007-09-13 | 2013-08-28 | Arryx Inc | METHODS AND APPARATUSES FOR SORTING OBJECTS IN MEDICO-LEGAL ANALYSIS OF RNA AND IN MEDICAL DIAGNOSES |
| US8716190B2 (en) | 2007-09-14 | 2014-05-06 | Affymetrix, Inc. | Amplification and analysis of selected targets on solid supports |
| US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
| EP2188386A2 (en) * | 2007-09-17 | 2010-05-26 | Universite De Strasbourg | Method for detecting or quantifying a truncating mutation |
| US20090118129A1 (en) * | 2007-09-28 | 2009-05-07 | Pacific Biosciences Of California, Inc. | Virtual reads for readlength enhancement |
| WO2009046149A1 (en) * | 2007-10-01 | 2009-04-09 | Applied Biosystems Inc. | Chase ligation sequencing |
| US20100086914A1 (en) * | 2008-10-03 | 2010-04-08 | Roche Molecular Systems, Inc. | High resolution, high throughput hla genotyping by clonal sequencing |
| EP2053132A1 (en) | 2007-10-23 | 2009-04-29 | Roche Diagnostics GmbH | Enrichment and sequence analysis of geomic regions |
| US20110015084A1 (en) * | 2007-10-25 | 2011-01-20 | Monsanto Technology Llc | Methods for Identifying Genetic Linkage |
| US9975118B2 (en) * | 2007-11-15 | 2018-05-22 | Seng Enterprises Ltd. | Device for the study of living cells |
| US9145540B1 (en) | 2007-11-15 | 2015-09-29 | Seng Enterprises Ltd. | Device for the study of living cells |
| US8592150B2 (en) | 2007-12-05 | 2013-11-26 | Complete Genomics, Inc. | Methods and compositions for long fragment read sequencing |
| CN101946010B (zh) | 2007-12-21 | 2014-08-20 | 哈佛大学 | 用于核酸测序的系统和方法 |
| US8189186B2 (en) * | 2007-12-27 | 2012-05-29 | Lawrence Livermore National Security, Llc. | Signal enhancement using a switchable magnetic trap |
| US20090181390A1 (en) * | 2008-01-11 | 2009-07-16 | Signosis, Inc. A California Corporation | High throughput detection of micrornas and use for disease diagnosis |
| EP3699291B1 (en) * | 2008-01-17 | 2024-08-07 | Sequenom, Inc. | Single molecule nucleic acid sequence analysis processes and compositions |
| US7767400B2 (en) * | 2008-02-03 | 2010-08-03 | Helicos Biosciences Corporation | Paired-end reads in sequencing by synthesis |
| US8034568B2 (en) | 2008-02-12 | 2011-10-11 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
| WO2009102896A2 (en) * | 2008-02-12 | 2009-08-20 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
| US12060554B2 (en) | 2008-03-10 | 2024-08-13 | Illumina, Inc. | Method for selecting and amplifying polynucleotides |
| US8709726B2 (en) * | 2008-03-11 | 2014-04-29 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
| BRPI0908734A2 (pt) | 2008-03-17 | 2015-07-28 | Expressive Res Bv | Métodos para a identificação de dna genômico em uma amostra e para a indentificação de polimorfismos, e, kit |
| US10745740B2 (en) * | 2008-03-19 | 2020-08-18 | Qiagen Sciences, Llc | Sample preparation |
| GB2470672B (en) | 2008-03-21 | 2012-09-12 | Nugen Technologies Inc | Methods of RNA amplification in the presence of DNA |
| EP3045542B1 (en) * | 2008-03-28 | 2016-11-16 | Pacific Biosciences of California, Inc. | Methods for nucleic acid sequencing |
| US8557742B2 (en) * | 2008-04-04 | 2013-10-15 | Novozymes A/S | Method of enhancing enzyme activity |
| JP5227062B2 (ja) | 2008-04-08 | 2013-07-03 | 株式会社日立製作所 | Dna分析装置 |
| TWI460602B (zh) * | 2008-05-16 | 2014-11-11 | Counsyl Inc | 廣用的懷孕前篩檢裝置 |
| EP2291553A4 (en) | 2008-05-28 | 2011-12-14 | Genomedx Biosciences Inc | SYSTEMS AND METHODS FOR THE EXPRESSION-BASED DISTINCTION OF DIFFERENT CLINICAL ILLICIT STADIAS IN PROSTATE CANCER |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| WO2010003132A1 (en) | 2008-07-02 | 2010-01-07 | Illumina Cambridge Ltd. | Using populations of beads for the fabrication of arrays on surfaces |
| WO2010009426A2 (en) * | 2008-07-17 | 2010-01-21 | Life Technologies Corporation | Devices and methods for reagent delivery |
| EP2315850B1 (en) | 2008-07-18 | 2015-02-25 | TrovaGene, Inc. | Methods for pcr-based detection of "ultra short" nucleic acid sequences |
| US20100035252A1 (en) * | 2008-08-08 | 2010-02-11 | Ion Torrent Systems Incorporated | Methods for sequencing individual nucleic acids under tension |
| US8795961B2 (en) | 2008-09-05 | 2014-08-05 | Pacific Biosciences Of California, Inc. | Preparations, compositions, and methods for nucleic acid sequencing |
| US8583380B2 (en) | 2008-09-05 | 2013-11-12 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US20110218123A1 (en) | 2008-09-19 | 2011-09-08 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
| US12162008B2 (en) | 2008-09-23 | 2024-12-10 | Bio-Rad Laboratories, Inc. | Partition-based method of analysis |
| US9399215B2 (en) | 2012-04-13 | 2016-07-26 | Bio-Rad Laboratories, Inc. | Sample holder with a well having a wicking promoter |
| US20100075862A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample |
| US12090480B2 (en) | 2008-09-23 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Partition-based method of analysis |
| US9492797B2 (en) | 2008-09-23 | 2016-11-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US11130128B2 (en) | 2008-09-23 | 2021-09-28 | Bio-Rad Laboratories, Inc. | Detection method for a target nucleic acid |
| US9132394B2 (en) | 2008-09-23 | 2015-09-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US9764322B2 (en) | 2008-09-23 | 2017-09-19 | Bio-Rad Laboratories, Inc. | System for generating droplets with pressure monitoring |
| US20100184045A1 (en) * | 2008-09-23 | 2010-07-22 | Helicos Biosciences Corporation | Methods for sequencing degraded or modified nucleic acids |
| US10512910B2 (en) | 2008-09-23 | 2019-12-24 | Bio-Rad Laboratories, Inc. | Droplet-based analysis method |
| US8222047B2 (en) * | 2008-09-23 | 2012-07-17 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
| US20100075439A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification |
| US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
| US8709762B2 (en) | 2010-03-02 | 2014-04-29 | Bio-Rad Laboratories, Inc. | System for hot-start amplification via a multiple emulsion |
| US8951939B2 (en) | 2011-07-12 | 2015-02-10 | Bio-Rad Laboratories, Inc. | Digital assays with multiplexed detection of two or more targets in the same optical channel |
| CA2738578C (en) | 2008-09-23 | 2021-05-04 | Quantalife, Inc. | Droplet-based assay system |
| WO2011120006A1 (en) | 2010-03-25 | 2011-09-29 | Auantalife, Inc. A Delaware Corporation | Detection system for droplet-based assays |
| US8633015B2 (en) | 2008-09-23 | 2014-01-21 | Bio-Rad Laboratories, Inc. | Flow-based thermocycling system with thermoelectric cooler |
| US9598725B2 (en) | 2010-03-02 | 2017-03-21 | Bio-Rad Laboratories, Inc. | Emulsion chemistry for encapsulated droplets |
| US9417190B2 (en) | 2008-09-23 | 2016-08-16 | Bio-Rad Laboratories, Inc. | Calibrations and controls for droplet-based assays |
| US8663920B2 (en) | 2011-07-29 | 2014-03-04 | Bio-Rad Laboratories, Inc. | Library characterization by digital assay |
| US20100087325A1 (en) * | 2008-10-07 | 2010-04-08 | Illumina, Inc. | Biological sample temperature control system and method |
| WO2010048337A2 (en) | 2008-10-22 | 2010-04-29 | Illumina, Inc. | Preservation of information related to genomic dna methylation |
| EP2664678B1 (en) | 2008-10-24 | 2014-10-08 | Epicentre Technologies Corporation | Transposon end compositions and methods for modifying nucleic acids |
| US9080211B2 (en) | 2008-10-24 | 2015-07-14 | Epicentre Technologies Corporation | Transposon end compositions and methods for modifying nucleic acids |
| WO2010062546A1 (en) * | 2008-10-27 | 2010-06-03 | Qiagen Gaithersburg Inc. | Fast results hybrid capture assay on an automated platform |
| CA2742298C (en) * | 2008-11-03 | 2019-09-10 | The Regents Of The University Of California | Methods for detecting modification resistant nucleic acids |
| JP2010110262A (ja) * | 2008-11-06 | 2010-05-20 | Hitachi Maxell Ltd | ウェルプレートを用いた核酸増幅法 |
| US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
| US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
| US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US8691510B2 (en) | 2008-11-07 | 2014-04-08 | Sequenta, Inc. | Sequence analysis of complex amplicons |
| US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
| CN102272327B (zh) | 2008-11-07 | 2015-11-25 | 赛昆塔公司 | 通过序列分析监测状况的方法 |
| US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US9394567B2 (en) | 2008-11-07 | 2016-07-19 | Adaptive Biotechnologies Corporation | Detection and quantification of sample contamination in immune repertoire analysis |
| CA2743473C (en) * | 2008-11-17 | 2022-06-14 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| MX2011005872A (es) | 2008-12-05 | 2011-08-17 | Keygene Nv | Farneseno sintasa. |
| EP3290531B1 (en) | 2008-12-19 | 2019-07-24 | President and Fellows of Harvard College | Particle-assisted nucleic acid sequencing |
| US8236532B2 (en) * | 2008-12-23 | 2012-08-07 | Illumina, Inc. | Multibase delivery for long reads in sequencing by synthesis protocols |
| ES2403312T3 (es) | 2009-01-13 | 2013-05-17 | Keygene N.V. | Nuevas estrategias para la secuenciación del genoma |
| DK2387627T3 (en) | 2009-01-15 | 2016-07-04 | Adaptive Biotechnologies Corp | Adaptive immunity profiling and methods for producing monoclonal antibodies |
| US20100179074A1 (en) * | 2009-01-15 | 2010-07-15 | Honeywell International Inc. | Methods and apparatus for fluid delivery and removal of micron scale structures |
| CN102333891A (zh) * | 2009-01-20 | 2012-01-25 | 利兰·斯坦福青年大学托管委员会 | 用于药靶诊断、预后和鉴别的单细胞基因表达 |
| US20100331204A1 (en) | 2009-02-13 | 2010-12-30 | Jeff Jeddeloh | Methods and systems for enrichment of target genomic sequences |
| US9347092B2 (en) | 2009-02-25 | 2016-05-24 | Roche Molecular System, Inc. | Solid support for high-throughput nucleic acid analysis |
| JP5457222B2 (ja) | 2009-02-25 | 2014-04-02 | エフ.ホフマン−ラ ロシュ アーゲー | 小型化ハイスループット核酸分析 |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| CN102428191A (zh) * | 2009-03-18 | 2012-04-25 | 塞昆纳姆股份有限公司 | 热稳定性内切核酸酶在产生报道分子中的应用 |
| GB0904957D0 (en) | 2009-03-23 | 2009-05-06 | Univ Erasmus Medical Ct | Tumour gene profile |
| GB0904934D0 (en) | 2009-03-23 | 2009-05-06 | Geneseqe As | Method and apparatus for detecting molecules |
| WO2010115100A1 (en) | 2009-04-03 | 2010-10-07 | L&C Diagment, Inc. | Multiplex nucleic acid detection methods and systems |
| WO2010117457A2 (en) * | 2009-04-08 | 2010-10-14 | Applied Biosystems, Llc | System comprising dual-sided thermal cycler and emulsion pcr in pouch |
| US9090663B2 (en) * | 2009-04-21 | 2015-07-28 | The Trustees Of Columbia University In The City Of New York | Systems and methods for the capture and separation of microparticles |
| US12129514B2 (en) | 2009-04-30 | 2024-10-29 | Molecular Loop Biosolutions, Llc | Methods and compositions for evaluating genetic markers |
| AU2010242073C1 (en) | 2009-04-30 | 2015-12-24 | Good Start Genetics, Inc. | Methods and compositions for evaluating genetic markers |
| EP2248914A1 (en) | 2009-05-05 | 2010-11-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | The use of class IIB restriction endonucleases in 2nd generation sequencing applications |
| JP6078339B2 (ja) | 2009-05-07 | 2017-02-08 | ベラサイト インコーポレイテッド | 甲状腺状態の診断のための方法および組成物 |
| US8003329B2 (en) * | 2009-05-12 | 2011-08-23 | Becton Dickinson & Company | Molecular counting by color-coded micelles |
| EP3663750B1 (en) | 2009-05-29 | 2021-11-03 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
| US9524369B2 (en) | 2009-06-15 | 2016-12-20 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
| RU2539032C2 (ru) | 2009-06-25 | 2015-01-10 | Фред Хатчинсон Кансэр Рисёч Сентер | Способ измерения искусственного иммунитета |
| WO2011002319A2 (en) * | 2009-07-02 | 2011-01-06 | Zygem Corporation Limited | Combined nucleic acid blocking, extraction, and detection in a single reaction vessel |
| JP5099455B2 (ja) * | 2009-07-16 | 2012-12-19 | 独立行政法人科学技術振興機構 | エマルジョンを用いたrnaの選択的増幅法 |
| WO2011011175A2 (en) * | 2009-07-24 | 2011-01-27 | Illumina, Inc. | Method for sequencing a polynucleotide template |
| NZ598226A (en) * | 2009-07-29 | 2013-09-27 | Pyrobett Pte Ltd | Method and apparatus for conducting an assay |
| US9416409B2 (en) | 2009-07-31 | 2016-08-16 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| SI2669387T1 (sl) | 2009-08-25 | 2017-01-31 | Illumina, Inc. | Metode za izbiro in pomnoževanje polinukleotidov |
| WO2011028764A2 (en) | 2009-09-02 | 2011-03-10 | President And Fellows Of Harvard College | Multiple emulsions created using jetting and other techniques |
| EP2473618B1 (en) | 2009-09-02 | 2015-03-04 | Bio-Rad Laboratories, Inc. | System for mixing fluids by coalescence of multiple emulsions |
| US10174368B2 (en) | 2009-09-10 | 2019-01-08 | Centrillion Technology Holdings Corporation | Methods and systems for sequencing long nucleic acids |
| US10072287B2 (en) | 2009-09-10 | 2018-09-11 | Centrillion Technology Holdings Corporation | Methods of targeted sequencing |
| CA2774618C (en) | 2009-09-23 | 2020-10-27 | Celmatix, Inc. | Methods and devices for assessing infertility and/or egg quality |
| EP2473638B1 (en) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2486409A1 (en) | 2009-10-09 | 2012-08-15 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| CA2778816C (en) | 2009-10-27 | 2018-07-31 | President And Fellows Of Harvard College | Droplet creation techniques |
| WO2011050981A2 (en) | 2009-10-30 | 2011-05-05 | Roche Diagnostics Gmbh | Method for detecting balanced chromosomal aberrations in a genome |
| US8524450B2 (en) | 2009-10-30 | 2013-09-03 | Illumina, Inc. | Microvessels, microparticles, and methods of manufacturing and using the same |
| GB2488289A (en) | 2009-11-06 | 2012-08-22 | Univ Leland Stanford Junior | Non-invasive diagnosis of graft rejection in organ transplant patients |
| US20120276524A1 (en) * | 2009-11-16 | 2012-11-01 | Genomictree, Inc. | Genotyping method |
| JP2013511991A (ja) * | 2009-11-25 | 2013-04-11 | クアンタライフ, インコーポレイテッド | 遺伝子材料を検出する方法および組成物 |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| WO2011071382A1 (en) | 2009-12-10 | 2011-06-16 | Keygene N.V. | Polymorfphic whole genome profiling |
| WO2011074960A1 (en) | 2009-12-17 | 2011-06-23 | Keygene N.V. | Restriction enzyme based whole genome sequencing |
| US20130004951A1 (en) | 2009-12-18 | 2013-01-03 | Keygene N.V. | Bulked mutant analysis |
| EP2516680B1 (en) | 2009-12-22 | 2016-04-06 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| WO2011079176A2 (en) | 2009-12-23 | 2011-06-30 | Raindance Technologies, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
| EP2848704B1 (en) | 2010-01-19 | 2018-08-29 | Verinata Health, Inc | Sequencing methods for prenatal diagnoses |
| US20120100548A1 (en) | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
| EP2531880B1 (en) | 2010-02-01 | 2016-08-03 | Illumina Inc. | Focusing methods and optical systems and assemblies using the same |
| US20110195457A1 (en) * | 2010-02-09 | 2011-08-11 | General Electric Company | Isothermal amplification of nucleic acid using primers comprising a randomized sequence and specific primers and uses thereof |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US8575124B2 (en) | 2010-02-18 | 2013-11-05 | Anthony P. Shuber | Compositions and methods for treating cancer |
| WO2011106629A2 (en) | 2010-02-26 | 2011-09-01 | Life Technologies Corporation | Modified proteins and methods of making and using same |
| WO2011109379A1 (en) | 2010-03-01 | 2011-09-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| US8415171B2 (en) * | 2010-03-01 | 2013-04-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| US9678068B2 (en) * | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
| DE202011003570U1 (de) | 2010-03-06 | 2012-01-30 | Illumina, Inc. | Systeme und Vorrichtungen zum Detektieren optischer Signale aus einer Probe |
| US20110311963A1 (en) * | 2010-03-16 | 2011-12-22 | Life Technologies Corporation | Method and Apparatus for Addressable Flow Cells in Single Molecule Sequencing |
| EP2550528B1 (en) | 2010-03-25 | 2019-09-11 | Bio-Rad Laboratories, Inc. | Droplet generation for droplet-based assays |
| EP2556170A4 (en) | 2010-03-25 | 2014-01-01 | Quantalife Inc | TRAPPING TRANSPORT AND DETECTION SYSTEM |
| US8951940B2 (en) | 2010-04-01 | 2015-02-10 | Illumina, Inc. | Solid-phase clonal amplification and related methods |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| SI2556171T1 (sl) | 2010-04-05 | 2016-03-31 | Prognosys Biosciences, Inc. | Prostorsko kodirane biološke analize |
| US11225655B2 (en) | 2010-04-16 | 2022-01-18 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
| US20110269194A1 (en) * | 2010-04-20 | 2011-11-03 | Swift Biosciences, Inc. | Materials and methods for nucleic acid fractionation by solid phase entrapment and enzyme-mediated detachment |
| WO2011135041A1 (en) | 2010-04-30 | 2011-11-03 | Roche Diagnostics Gmbh | System and method for purification and use of inorganic pyrophosphatase from aquifex aeolicus |
| US9930297B2 (en) | 2010-04-30 | 2018-03-27 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
| EP2388337B1 (en) * | 2010-04-30 | 2014-07-02 | Nxp B.V. | Sensing device and manufacturing method thereof |
| SG10201503534RA (en) | 2010-05-06 | 2015-06-29 | Sequenta Inc | Monitoring health and disease status using clonotype profiles |
| SG185438A1 (en) * | 2010-05-06 | 2012-12-28 | Ibis Biosciences Inc | Integrated sample preparation systems and stabilized enzyme mixtures |
| CA2796822C (en) | 2010-05-07 | 2021-10-05 | The Board Of Trustees Of The Leland Standford Junior University | Measurement and comparison of immune diversity by high-throughput sequencing |
| WO2011143194A2 (en) | 2010-05-10 | 2011-11-17 | Life Technologies Corporation | System and method for processing a biological sample |
| EP2569626B1 (en) | 2010-05-11 | 2019-11-27 | Veracyte, Inc. | Methods and compositions for diagnosing conditions |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US8825412B2 (en) | 2010-05-18 | 2014-09-02 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US20110287432A1 (en) | 2010-05-21 | 2011-11-24 | 454 Life Science Corporation | System and method for tailoring nucleotide concentration to enzymatic efficiencies in dna sequencing technologies |
| EP3290529B1 (en) | 2010-06-11 | 2019-05-22 | Life Technologies Corporation | Alternative nucleotide flows in sequencing-by-synthesis methods |
| US9353412B2 (en) | 2010-06-18 | 2016-05-31 | Illumina, Inc. | Conformational probes and methods for sequencing nucleic acids |
| US9650629B2 (en) | 2010-07-07 | 2017-05-16 | Roche Molecular Systems, Inc. | Clonal pre-amplification in emulsion |
| WO2012008831A1 (en) | 2010-07-13 | 2012-01-19 | Keygene N.V. | Simplified de novo physical map generation from clone libraries |
| CN103153466B (zh) | 2010-07-22 | 2016-04-13 | 基因细胞生物系统有限公司 | 复合液体池 |
| EP2601609B1 (en) | 2010-08-02 | 2017-05-17 | Population Bio, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
| US20130040375A1 (en) * | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
| US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
| US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
| US20120034603A1 (en) * | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
| US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
| US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
| US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
| US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| CA2810520C (en) | 2010-09-10 | 2019-03-12 | Bio-Rad Laboratories, Inc. | Size selection of dna for chromatin analysis |
| WO2012040387A1 (en) | 2010-09-24 | 2012-03-29 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target dna using immobilized primers |
| WO2012050920A1 (en) | 2010-09-29 | 2012-04-19 | Illumina, Inc. | Compositions and methods for sequencing nucleic acids |
| US20120077716A1 (en) | 2010-09-29 | 2012-03-29 | 454 Life Sciences Corporation | System and method for producing functionally distinct nucleic acid library ends through use of deoxyinosine |
| GB201016484D0 (en) | 2010-09-30 | 2010-11-17 | Geneseque As | Method |
| US9399217B2 (en) | 2010-10-04 | 2016-07-26 | Genapsys, Inc. | Chamber free nanoreactor system |
| US9184099B2 (en) | 2010-10-04 | 2015-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Biosensor devices, systems and methods therefor |
| CN103328981B (zh) | 2010-10-04 | 2017-04-12 | 吉纳普赛斯股份有限公司 | 用于自动化可重复使用的平行生物反应的系统和方法 |
| US20120322665A1 (en) | 2010-10-08 | 2012-12-20 | 454 Life Sciences Corporation | System and method for detection of hiv-1 clades and recombinants of the reverse transcriptase and protease regions |
| US9689012B2 (en) | 2010-10-12 | 2017-06-27 | Cornell University | Method of dual-adapter recombination for efficient concatenation of multiple DNA fragments in shuffled or specified arrangements |
| US20150218639A1 (en) | 2014-01-17 | 2015-08-06 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
| US10093981B2 (en) | 2010-10-19 | 2018-10-09 | Northwestern University | Compositions and methods for identifying depressive disorders |
| US20150225792A1 (en) | 2014-01-17 | 2015-08-13 | Northwestern University | Compositions and methods for identifying depressive disorders |
| US10233501B2 (en) | 2010-10-19 | 2019-03-19 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
| US8753816B2 (en) | 2010-10-26 | 2014-06-17 | Illumina, Inc. | Sequencing methods |
| US10273540B2 (en) | 2010-10-27 | 2019-04-30 | Life Technologies Corporation | Methods and apparatuses for estimating parameters in a predictive model for use in sequencing-by-synthesis |
| US9096899B2 (en) | 2010-10-27 | 2015-08-04 | Illumina, Inc. | Microdevices and biosensor cartridges for biological or chemical analysis and systems and methods for the same |
| US9387476B2 (en) | 2010-10-27 | 2016-07-12 | Illumina, Inc. | Flow cells for biological or chemical analysis |
| EP3141614B1 (en) | 2010-10-27 | 2018-11-28 | Life Technologies Corporation | Predictive model for use in sequencing-by-synthesis |
| EP4016086A1 (en) | 2010-11-01 | 2022-06-22 | Bio-Rad Laboratories, Inc. | System for forming emulsions |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2643484A4 (en) | 2010-11-22 | 2014-04-16 | Univ California | METHOD OF IDENTIFYING AN RNA TRANSCRIPTION OF CELLULAR ORIGIN |
| US20140011698A1 (en) | 2010-12-01 | 2014-01-09 | Morphosys Ag | Simultaneous detection of biomolecules in single cells |
| US9727032B2 (en) | 2010-12-14 | 2017-08-08 | Life Technologies Corporation | Systems and methods for run-time sequencing run quality monitoring |
| CA2821906C (en) | 2010-12-22 | 2020-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
| WO2012118555A1 (en) | 2010-12-29 | 2012-09-07 | Life Technologies Corporation | Time-warped background signal for sequencing-by-synthesis operations |
| BR112013016708B1 (pt) | 2010-12-30 | 2021-08-17 | Foundation Medicine, Inc | Otimização de análise multigene de amostras de tumor |
| US10241075B2 (en) | 2010-12-30 | 2019-03-26 | Life Technologies Corporation | Methods, systems, and computer readable media for nucleic acid sequencing |
| US20130060482A1 (en) | 2010-12-30 | 2013-03-07 | Life Technologies Corporation | Methods, systems, and computer readable media for making base calls in nucleic acid sequencing |
| WO2013025998A1 (en) | 2011-08-18 | 2013-02-21 | Life Technologies Corporation | Methods, systems, and computer readable media for making base calls in nucleic acid sequencing |
| EP2658999B1 (en) | 2010-12-30 | 2019-03-13 | Life Technologies Corporation | Models for analyzing data from sequencing-by-synthesis operations |
| US8951781B2 (en) | 2011-01-10 | 2015-02-10 | Illumina, Inc. | Systems, methods, and apparatuses to image a sample for biological or chemical analysis |
| US20130005591A1 (en) * | 2011-01-13 | 2013-01-03 | Halgen Corporation | Method for parallel amplification of nucleic acids |
| CA2823815A1 (en) | 2011-01-14 | 2012-07-19 | Keygene N.V. | Paired end random sequence based genotyping |
| WO2012100194A1 (en) | 2011-01-20 | 2012-07-26 | Ibis Biosciences, Inc. | Microfluidic transducer |
| US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
| US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
| US8756020B2 (en) | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
| US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
| US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
| EP2670863B1 (en) | 2011-01-31 | 2018-06-27 | H. Hoffnabb-La Roche Ag | Methods of identifying multiple epitopes in cells |
| WO2012104851A1 (en) | 2011-01-31 | 2012-08-09 | Yeda Research And Development Co. Ltd. | Methods of diagnosing disease using overlap extension pcr |
| CA2824387C (en) | 2011-02-09 | 2019-09-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12097495B2 (en) | 2011-02-18 | 2024-09-24 | Bio-Rad Laboratories, Inc. | Methods and compositions for detecting genetic material |
| WO2012129187A1 (en) | 2011-03-18 | 2012-09-27 | Bio-Rad Laboratories, Inc. | Multiplexed digital assays with combinatorial use of signals |
| US20120252682A1 (en) | 2011-04-01 | 2012-10-04 | Maples Corporate Services Limited | Methods and systems for sequencing nucleic acids |
| US9017993B2 (en) | 2011-04-07 | 2015-04-28 | Life Technologies Corporation | System and methods for making and processing emulsions |
| US9121047B2 (en) * | 2011-04-07 | 2015-09-01 | Life Technologies Corporation | System and methods for making and processing emulsions |
| EP3366782B1 (en) | 2011-04-08 | 2021-03-10 | Life Technologies Corporation | Phase-protecting reagent flow orderings for use in sequencing-by-synthesis |
| US20140302532A1 (en) | 2011-04-12 | 2014-10-09 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| AU2012242847B2 (en) | 2011-04-15 | 2017-01-19 | The Johns Hopkins University | Safe sequencing system |
| WO2012149042A2 (en) * | 2011-04-25 | 2012-11-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
| CA2834218C (en) | 2011-04-29 | 2021-02-16 | Sequenom, Inc. | Quantification of a minority nucleic acid species using inhibitory oligonucleotides |
| WO2012158603A2 (en) | 2011-05-13 | 2012-11-22 | Bioo Scientific Corporation | Pooled adapter strategy for reducing bias in small rna characterization |
| EP2710172B1 (en) * | 2011-05-20 | 2017-03-29 | Fluidigm Corporation | Nucleic acid encoding reactions |
| BR112013029729A2 (pt) | 2011-05-23 | 2017-01-24 | Basf Se | controle de emulsões, incluindo emulsões múltiplas |
| US8585973B2 (en) | 2011-05-27 | 2013-11-19 | The Board Of Trustees Of The Leland Stanford Junior University | Nano-sensor array |
| US9926596B2 (en) | 2011-05-27 | 2018-03-27 | Genapsys, Inc. | Systems and methods for genetic and biological analysis |
| EP2714928B1 (en) * | 2011-05-27 | 2017-08-02 | Life Technologies Corporation | Methods for manipulating biomolecules |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| WO2012169893A1 (en) | 2011-06-10 | 2012-12-13 | Stichting Technologisch Topinstituut Groene Genetica (Foundation Technological Top Institute Green Genetics) | Transcription factor modulating terpene biosynthesis |
| CN103732744A (zh) | 2011-06-15 | 2014-04-16 | Gen9股份有限公司 | 制备性体外克隆的方法 |
| CA2840929C (en) | 2011-07-08 | 2020-03-24 | Keygene N.V. | Sequence based genotyping based on oligonucleotide ligation assays |
| US8920751B2 (en) | 2011-07-08 | 2014-12-30 | Life Technologies Corporation | Automated enrichment for nucleic acid sequencing |
| WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
| WO2013022778A1 (en) | 2011-08-05 | 2013-02-14 | Ibis Biosciences, Inc. | Nucleic acid sequencing by electrochemical detection |
| CA2846197C (en) | 2011-08-23 | 2024-01-16 | Foundation Medicine, Inc. | Kif5b-ret fusion molecules and uses thereof |
| US20150087537A1 (en) | 2011-08-31 | 2015-03-26 | Life Technologies Corporation | Methods, Systems, Computer Readable Media, and Kits for Sample Identification |
| US10704164B2 (en) | 2011-08-31 | 2020-07-07 | Life Technologies Corporation | Methods, systems, computer readable media, and kits for sample identification |
| US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
| AU2012304328B2 (en) | 2011-09-09 | 2017-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for obtaining a sequence |
| US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
| WO2013044217A1 (en) * | 2011-09-23 | 2013-03-28 | The Trustees Of Columbia University In The City Of New York | Isolation and enrichment of nucleic acids on microchip |
| WO2013044018A1 (en) | 2011-09-23 | 2013-03-28 | Illumina, Inc. | Methods and compositions for nucleic acid sequencing |
| AU2012316218B2 (en) | 2011-09-26 | 2016-03-17 | Gen-Probe Incorporated | Algorithms for sequence determinations |
| US10378051B2 (en) | 2011-09-29 | 2019-08-13 | Illumina Cambridge Limited | Continuous extension and deblocking in reactions for nucleic acids synthesis and sequencing |
| US11008611B2 (en) | 2011-09-30 | 2021-05-18 | Unm Rainforest Innovations | Double gate ion sensitive field effect transistor |
| DE102011054101A1 (de) | 2011-09-30 | 2013-04-04 | Albert-Ludwigs-Universität Freiburg | Verfahren zur räumlichen Anordnung von Probenfragmenten zur Amplifikation und Immobilisierung für weitere Derivatisierungen |
| US10221454B2 (en) | 2011-10-10 | 2019-03-05 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| EP2766498B1 (en) | 2011-10-14 | 2019-06-19 | President and Fellows of Harvard College | Sequencing by structure assembly |
| CN102329876B (zh) * | 2011-10-14 | 2014-04-02 | 深圳华大基因科技有限公司 | 一种测定待检测样本中疾病相关核酸分子的核苷酸序列的方法 |
| WO2013056178A2 (en) | 2011-10-14 | 2013-04-18 | Foundation Medicine, Inc. | Novel estrogen receptor mutations and uses thereof |
| US9228233B2 (en) | 2011-10-17 | 2016-01-05 | Good Start Genetics, Inc. | Analysis methods |
| GB2497838A (en) | 2011-10-19 | 2013-06-26 | Nugen Technologies Inc | Compositions and methods for directional nucleic acid amplification and sequencing |
| HK1201565A1 (en) | 2011-10-21 | 2015-09-04 | Adaptive Biotechnologies Corporation | Quantification of adaptive immune cell genomes in a complex mixture of cells |
| DE102011085473A1 (de) | 2011-10-28 | 2013-05-02 | Albert-Ludwigs-Universität Freiburg | Verfahren zur Identifikation von Aptameren |
| US11180807B2 (en) | 2011-11-04 | 2021-11-23 | Population Bio, Inc. | Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease |
| AU2012336040B2 (en) | 2011-11-07 | 2015-12-10 | Illumina, Inc. | Integrated sequencing apparatuses and methods of use |
| CN104094266A (zh) | 2011-11-07 | 2014-10-08 | 独创系统公司 | 用于识别原因性基因组变体的方法和系统 |
| GB201120711D0 (en) | 2011-12-01 | 2012-01-11 | Univ Erasmus Medical Ct | Method for classifying tumour cells |
| CN104105797B (zh) | 2011-12-01 | 2016-08-31 | 吉纳普赛斯股份有限公司 | 用于高效电子测序与检测的系统和方法 |
| WO2013085918A1 (en) * | 2011-12-05 | 2013-06-13 | The Regents Of The University Of California | Methods and compostions for generating polynucleic acid fragments |
| WO2013085710A2 (en) | 2011-12-09 | 2013-06-13 | Illumina, Inc. | Expanded radix for polymeric tags |
| EP2788509B1 (en) | 2011-12-09 | 2018-07-11 | Adaptive Biotechnologies Corporation | Diagnosis of lymphoid malignancies and minimal residual disease detection |
| KR101830778B1 (ko) | 2011-12-09 | 2018-02-22 | 삼성전자주식회사 | 발열 입자를 포함하는 오일 층을 이용하는 핵산 증폭 장치 및 방법 |
| US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
| US10513737B2 (en) | 2011-12-13 | 2019-12-24 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| US20130189679A1 (en) | 2011-12-20 | 2013-07-25 | The Regents Of The University Of Michigan | Pseudogenes and uses thereof |
| ES2991004T3 (es) | 2011-12-22 | 2024-12-02 | Harvard College | Métodos para la detección de analitos |
| WO2013096819A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Macromolecule positioning by electrical potential |
| WO2013096838A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids |
| EP4108782B1 (en) | 2011-12-22 | 2023-06-07 | President and Fellows of Harvard College | Compositions and methods for analyte detection |
| US9334491B2 (en) | 2011-12-22 | 2016-05-10 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids from cellular samples |
| US9506113B2 (en) | 2011-12-28 | 2016-11-29 | Ibis Biosciences, Inc. | Nucleic acid ligation systems and methods |
| US9823246B2 (en) | 2011-12-28 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon |
| WO2013102081A2 (en) | 2011-12-29 | 2013-07-04 | Ibis Biosciences, Inc. | Macromolecule delivery to nanowells |
| ES2665252T3 (es) | 2011-12-30 | 2018-04-25 | Abbott Molecular Inc. | Purificación de ácido nucleico de microorganismos a partir de muestras del hospedador |
| JP2015503923A (ja) | 2012-01-09 | 2015-02-05 | オスロ ウニヴェルスィテーツスィーケフース ハーエフOslo Universitetssykehus Hf | 結腸直腸癌の解析のための方法およびバイオマーカー |
| BR112014018187A8 (pt) | 2012-01-25 | 2017-07-11 | Gencell Biosystems Ltd | Métodos para manusear líquidos de amostra contendo partículas magnéticas e um líquido de encapsulação, bem como sistema de manuseio de líquido |
| CA2862552A1 (en) * | 2012-01-26 | 2013-08-01 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
| WO2013116698A2 (en) | 2012-02-02 | 2013-08-08 | Invenra, Inc. | High throughput screen for biologically active polypeptides |
| US8597882B2 (en) | 2012-02-03 | 2013-12-03 | Pyrobett Pte. Ltd. | Method and apparatus for conducting an assay |
| WO2013117595A2 (en) * | 2012-02-07 | 2013-08-15 | Illumina Cambridge Limited | Targeted enrichment and amplification of nucleic acids on a support |
| EP2812452B1 (en) | 2012-02-09 | 2020-05-27 | Population Bio, Inc. | Methods and compositions for screening and treating developmental disorders |
| HK1205558A1 (en) | 2012-02-21 | 2015-12-18 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection and prognosis of cervical cancer |
| US20130217023A1 (en) | 2012-02-22 | 2013-08-22 | 454 Life Sciences Corporation | System And Method For Generation And Use Of Compact Clonally Amplified Products |
| US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| ES2662128T3 (es) | 2012-03-05 | 2018-04-05 | Adaptive Biotechnologies Corporation | Determinación de cadenas de receptor inmunitario emparejadas a partir de la frecuencia de subunidades coincidentes |
| NO2694769T3 (enExample) | 2012-03-06 | 2018-03-03 | ||
| WO2013132354A2 (en) | 2012-03-06 | 2013-09-12 | Oslo Universitetssykehus Hf | Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer |
| US20130261984A1 (en) | 2012-03-30 | 2013-10-03 | Illumina, Inc. | Methods and systems for determining fetal chromosomal abnormalities |
| WO2013152114A1 (en) | 2012-04-03 | 2013-10-10 | The Regents Of The University Of Michigan | Biomarker associated with irritable bowel syndrome and crohn's disease |
| EP2834622B1 (en) | 2012-04-03 | 2023-04-12 | Illumina, Inc. | Integrated optoelectronic read head and fluidic cartridge useful for nucleic acid sequencing |
| US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
| US8812422B2 (en) | 2012-04-09 | 2014-08-19 | Good Start Genetics, Inc. | Variant database |
| US20130274148A1 (en) | 2012-04-11 | 2013-10-17 | Illumina, Inc. | Portable genetic detection and analysis system and method |
| CN108485940B (zh) * | 2012-04-12 | 2022-01-28 | 维里纳塔健康公司 | 拷贝数变异的检测和分类 |
| US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
| CN114854832A (zh) | 2012-04-19 | 2022-08-05 | 生命技术公司 | 核酸扩增 |
| EP2839026B1 (en) | 2012-04-19 | 2016-08-10 | Life Technologies Corporation | Nucleic acid amplification |
| WO2013163210A1 (en) * | 2012-04-23 | 2013-10-31 | Philip Alexander Rolfe | Method and system for detection of an organism |
| CN107617511B (zh) * | 2012-04-30 | 2020-06-12 | 生命技术公司 | 离心机装置和系统 |
| EP2844767A4 (en) | 2012-05-02 | 2015-11-18 | Ibis Biosciences Inc | SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING |
| US9150905B2 (en) | 2012-05-08 | 2015-10-06 | Adaptive Biotechnologies Corporation | Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions |
| US9646132B2 (en) | 2012-05-11 | 2017-05-09 | Life Technologies Corporation | Models for analyzing data from sequencing-by-synthesis operations |
| WO2013177220A1 (en) * | 2012-05-21 | 2013-11-28 | The Scripps Research Institute | Methods of sample preparation |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
| CN102766574B (zh) * | 2012-05-24 | 2013-12-25 | 中国科学院北京基因组研究所 | 用于dna测序仪的反应仓 |
| US9617589B2 (en) * | 2012-05-25 | 2017-04-11 | The University Of North Carolina At Chapel Hill | Microfluidic devices, solid supports for reagents and related methods |
| US9914967B2 (en) | 2012-06-05 | 2018-03-13 | President And Fellows Of Harvard College | Spatial sequencing of nucleic acids using DNA origami probes |
| US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
| US8895249B2 (en) | 2012-06-15 | 2014-11-25 | Illumina, Inc. | Kinetic exclusion amplification of nucleic acid libraries |
| JP6181751B2 (ja) | 2012-06-18 | 2017-08-16 | ニューゲン テクノロジーズ, インコーポレイテッド | 望まれない核酸配列のネガティブ選択のための組成物および方法 |
| WO2014005076A2 (en) | 2012-06-29 | 2014-01-03 | The Regents Of The University Of Michigan | Methods and biomarkers for detection of kidney disorders |
| WO2014008448A1 (en) | 2012-07-03 | 2014-01-09 | Sloan Kettering Institute For Cancer Research | Quantitative assessment of human t-cell repertoire recovery after allogeneic hematopoietic stem cell transplantation |
| US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
| US20140093873A1 (en) | 2012-07-13 | 2014-04-03 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US9092401B2 (en) | 2012-10-31 | 2015-07-28 | Counsyl, Inc. | System and methods for detecting genetic variation |
| US9977861B2 (en) | 2012-07-18 | 2018-05-22 | Illumina Cambridge Limited | Methods and systems for determining haplotypes and phasing of haplotypes |
| GB201212775D0 (en) * | 2012-07-18 | 2012-08-29 | Dna Electronics Ltd | Sensing apparatus and method |
| WO2014015269A1 (en) | 2012-07-19 | 2014-01-23 | Ariosa Diagnostics, Inc. | Multiplexed sequential ligation-based detection of genetic variants |
| JP6392222B2 (ja) * | 2012-07-24 | 2018-09-19 | ナテラ, インコーポレイテッド | 高度多重pcr法および組成物 |
| HK1213044A1 (zh) | 2012-08-03 | 2016-06-24 | Foundation Medicine, Inc. | 人乳头瘤病毒作为肿瘤预後的预测因子 |
| JP6525872B2 (ja) | 2012-08-08 | 2019-06-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 細胞中の複数のエピトープを同定するためのダイナミックレンジを高めること |
| CN110643681A (zh) | 2012-08-13 | 2020-01-03 | 加利福尼亚大学董事会 | 用于检测生物组分的方法和系统 |
| US20140378322A1 (en) * | 2012-08-14 | 2014-12-25 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US20150005199A1 (en) * | 2012-08-14 | 2015-01-01 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US20140378345A1 (en) * | 2012-08-14 | 2014-12-25 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US20150005200A1 (en) * | 2012-08-14 | 2015-01-01 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| EP2885640B1 (en) | 2012-08-16 | 2018-07-18 | Genomedx Biosciences, Inc. | Prostate cancer prognostics using biomarkers |
| NL2017959B1 (en) | 2016-12-08 | 2018-06-19 | Illumina Inc | Cartridge assembly |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| EP2895620B1 (en) | 2012-09-11 | 2017-08-02 | Life Technologies Corporation | Nucleic acid amplification |
| WO2014043143A1 (en) | 2012-09-11 | 2014-03-20 | Life Technologies Corporation | Nucleic acid amplification |
| WO2014043519A1 (en) | 2012-09-14 | 2014-03-20 | Population Diagnostics Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
| WO2014052855A1 (en) | 2012-09-27 | 2014-04-03 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
| JP6449160B2 (ja) | 2012-10-01 | 2019-01-09 | アダプティブ バイオテクノロジーズ コーポレイション | 適応免疫受容体多様性およびクローン性特性決定による免疫能力評価関連出願の相互参照 |
| US10329608B2 (en) | 2012-10-10 | 2019-06-25 | Life Technologies Corporation | Methods, systems, and computer readable media for repeat sequencing |
| US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| US10162800B2 (en) | 2012-10-17 | 2018-12-25 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| EP4592400A3 (en) | 2012-10-17 | 2025-10-29 | 10x Genomics Sweden AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| WO2015160439A2 (en) | 2014-04-17 | 2015-10-22 | Adaptive Biotechnologies Corporation | Quantification of adaptive immune cell genomes in a complex mixture of cells |
| US9651539B2 (en) | 2012-10-28 | 2017-05-16 | Quantapore, Inc. | Reducing background fluorescence in MEMS materials by low energy ion beam treatment |
| EP2912468B1 (en) | 2012-10-29 | 2018-09-12 | The Johns Hopkins University | Papanicolaou test for ovarian and endometrial cancers |
| WO2014071358A2 (en) | 2012-11-05 | 2014-05-08 | Foundation Medicine, Inc. | Novel ntrk1 fusion molecules and uses thereof |
| AU2013337264B2 (en) | 2012-11-05 | 2018-03-08 | Foundation Medicine, Inc. | Novel fusion molecules and uses thereof |
| KR20150090037A (ko) | 2012-11-27 | 2015-08-05 | 젠셀 바이오시스템즈 리미티드 | 액체 샘플의 취급 |
| HK1217518A1 (zh) * | 2012-12-03 | 2017-01-13 | 以琳生物药物有限公司 | 核酸制备和分析的组合物和方法 |
| WO2014093676A1 (en) | 2012-12-14 | 2014-06-19 | 10X Technologies, Inc. | Methods and systems for processing polynucleotides |
| US9836577B2 (en) | 2012-12-14 | 2017-12-05 | Celmatix, Inc. | Methods and devices for assessing risk of female infertility |
| EP2746405B1 (en) | 2012-12-23 | 2015-11-04 | HS Diagnomics GmbH | Methods and primer sets for high throughput PCR sequencing |
| WO2014113502A1 (en) | 2013-01-15 | 2014-07-24 | Quanterix Corporation | Detection of dna or rna using single molecule arrays and other techniques |
| CN105190656B (zh) | 2013-01-17 | 2018-01-16 | 佩索纳里斯公司 | 用于遗传分析的方法和系统 |
| EP3939614A1 (en) | 2013-01-18 | 2022-01-19 | Foundation Medicine, Inc. | Methods of treating cholangiocarcinoma |
| US9562269B2 (en) | 2013-01-22 | 2017-02-07 | The Board Of Trustees Of The Leland Stanford Junior University | Haplotying of HLA loci with ultra-deep shotgun sequencing |
| CA3209385A1 (en) | 2013-02-01 | 2014-08-07 | The Regents Of The University Of California | Methods for genome assembly and haplotype phasing |
| US9411930B2 (en) | 2013-02-01 | 2016-08-09 | The Regents Of The University Of California | Methods for genome assembly and haplotype phasing |
| US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
| CA2902099C (en) | 2013-03-08 | 2020-06-02 | F. Hoffmann-La Roche Ag | Egfr mutation blood testing |
| EP3578666A1 (en) | 2013-03-12 | 2019-12-11 | President and Fellows of Harvard College | Method of generating a three-dimensional nucleic acid containing matrix |
| US20140272967A1 (en) | 2013-03-13 | 2014-09-18 | Abbott Molecular Inc. | Systems and methods for isolating nucleic acids |
| EP2971100A1 (en) | 2013-03-13 | 2016-01-20 | Sequenom, Inc. | Primers for dna methylation analysis |
| WO2014164716A1 (en) * | 2013-03-13 | 2014-10-09 | President And Fellows Of Harvard College | Methods of elongating dna |
| US20140296080A1 (en) | 2013-03-14 | 2014-10-02 | Life Technologies Corporation | Methods, Systems, and Computer Readable Media for Evaluating Variant Likelihood |
| US20140287946A1 (en) | 2013-03-14 | 2014-09-25 | Ibis Biosciences, Inc. | Nucleic acid control panels |
| EP2971159B1 (en) | 2013-03-14 | 2019-05-08 | Molecular Loop Biosolutions, LLC | Methods for analyzing nucleic acids |
| EP2971171A4 (en) | 2013-03-14 | 2016-11-02 | Abbott Molecular Inc | SYSTEMS AND METHODS FOR MULTIPLEX AMPLIFICATION SPECIFIC TO METHYLATION |
| US9146248B2 (en) | 2013-03-14 | 2015-09-29 | Intelligent Bio-Systems, Inc. | Apparatus and methods for purging flow cells in nucleic acid sequencing instruments |
| CN105378104A (zh) | 2013-03-15 | 2016-03-02 | 威拉赛特公司 | 用于样品分类的方法和组合物 |
| WO2014150910A1 (en) | 2013-03-15 | 2014-09-25 | Ibis Biosciences, Inc. | Dna sequences to assess contamination in dna sequencing |
| US9890425B2 (en) | 2013-03-15 | 2018-02-13 | Abbott Molecular Inc. | Systems and methods for detection of genomic copy number changes |
| WO2014142981A1 (en) | 2013-03-15 | 2014-09-18 | Illumina, Inc. | Enzyme-linked nucleotides |
| US9591268B2 (en) | 2013-03-15 | 2017-03-07 | Qiagen Waltham, Inc. | Flow cell alignment methods and systems |
| CN105051214B (zh) | 2013-03-15 | 2018-12-28 | 吉纳普赛斯股份有限公司 | 用于生物分析的系统和方法 |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US20140274738A1 (en) | 2013-03-15 | 2014-09-18 | Nugen Technologies, Inc. | Sequential sequencing |
| CA2905517C (en) | 2013-03-15 | 2024-11-12 | Lineage Biosciences, Inc. | METHODS AND COMPOSITIONS FOR LABELING AND ANALYZING SAMPLES |
| EP3421613B1 (en) | 2013-03-15 | 2020-08-19 | The Board of Trustees of the Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| CN105392897B (zh) * | 2013-03-19 | 2020-03-20 | 定向基因组学公司 | 靶序列的富集 |
| EP2986741B1 (en) | 2013-04-17 | 2019-07-24 | Agency For Science, Technology And Research | Method for generating extended sequence reads |
| WO2014172152A1 (en) * | 2013-04-19 | 2014-10-23 | Siemens Healthcare Diagnostics Inc. | Non-contact micro droplet dispenser and method |
| RU2578009C2 (ru) * | 2013-05-08 | 2016-03-20 | Закрытое акционерное общество "ЕВРОГЕН" | Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках |
| US10160995B2 (en) * | 2013-05-13 | 2018-12-25 | Qiagen Waltham, Inc. | Analyte enrichment methods and compositions |
| WO2014190322A2 (en) | 2013-05-24 | 2014-11-27 | Quantapore, Inc. | Nanopore-based nucleic acid analysis with mixed fret detection |
| EP3005200A2 (en) | 2013-06-03 | 2016-04-13 | Good Start Genetics, Inc. | Methods and systems for storing sequence read data |
| SG10201710030QA (en) | 2013-06-04 | 2018-01-30 | Harvard College | Rna-guided transcriptional regulation |
| KR101648252B1 (ko) * | 2014-01-28 | 2016-08-16 | 연세대학교 산학협력단 | 염기서열 확인 과정에서 분리된 핵산 단편들을 회수하는 방법 |
| US10526640B2 (en) | 2013-06-19 | 2020-01-07 | Industry-Academic Cooperation Foundation, Yonsei University | Methods for retrieving sequence-verified nucleic acid fragments and apparatuses for amplifying sequence verified nucleic acid fragments |
| EP4219745B1 (en) | 2013-06-25 | 2025-09-03 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
| US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
| KR102177225B1 (ko) | 2013-07-01 | 2020-11-10 | 일루미나, 인코포레이티드 | 촉매-무함유 표면 작용화 및 중합체 그라프팅 |
| EP3241913B1 (en) | 2013-07-03 | 2019-02-20 | Illumina, Inc. | System for sequencing by orthogonal synthesis |
| US9926597B2 (en) | 2013-07-26 | 2018-03-27 | Life Technologies Corporation | Control nucleic acid sequences for use in sequencing-by-synthesis and methods for designing the same |
| TWI707038B (zh) | 2013-08-05 | 2020-10-11 | 美商扭轉生物科技有限公司 | 重新合成之基因庫 |
| CA3091557C (en) | 2013-08-08 | 2022-10-18 | Illumina, Inc. | Fluidic system for reagent delivery to a flow cell |
| US20150051117A1 (en) * | 2013-08-16 | 2015-02-19 | President And Fellows Of Harvard College | Assembly of Nucleic Acid Sequences in Emulsions |
| CA2920390A1 (en) | 2013-08-30 | 2015-03-05 | Illumina, Inc. | Manipulation of droplets on hydrophilic or variegated-hydrophilic surfaces |
| US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
| EP4567682A3 (en) | 2013-08-30 | 2025-09-03 | Personalis, Inc. | Methods for genomic analysis |
| JP6700173B2 (ja) * | 2013-09-24 | 2020-05-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ターゲット検出方法及びシステム |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| WO2015051275A1 (en) | 2013-10-03 | 2015-04-09 | Personalis, Inc. | Methods for analyzing genotypes |
| WO2015051338A1 (en) | 2013-10-04 | 2015-04-09 | Life Technologies Corporation | Methods and systems for modeling phasing effects in sequencing using termination chemistry |
| HUE045954T2 (hu) | 2013-10-17 | 2020-01-28 | Illumina Inc | Eljárások és készítmények nukleinsavkönyvtárak elõállítására |
| US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
| WO2015057565A1 (en) | 2013-10-18 | 2015-04-23 | Good Start Genetics, Inc. | Methods for assessing a genomic region of a subject |
| US9897986B2 (en) | 2013-10-29 | 2018-02-20 | Regal Beloit America, Inc. | System and method for enabling a motor controller to communicate using multiple different communication protocols |
| CN103540672B (zh) * | 2013-10-29 | 2015-04-08 | 中国科学技术大学 | 一种亲和核酸分子的快速鉴定和分离方法 |
| US10947587B2 (en) * | 2013-11-05 | 2021-03-16 | The Regents Of The University Of California | Single-cell forensic short tandem repeat typing within microfluidic droplets |
| EP4130350A1 (en) | 2013-11-07 | 2023-02-08 | The Board of Trustees of the Leland Stanford Junior University | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
| US20160279068A1 (en) | 2013-11-08 | 2016-09-29 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
| US9533240B2 (en) | 2013-11-12 | 2017-01-03 | Life Technologies Corporation | System and method for emulsion breaking |
| DK2891722T3 (en) | 2013-11-12 | 2019-01-07 | Population Bio Inc | METHODS AND COMPOSITIONS FOR DIAGNOSTICING, PROGRAMMING AND TREATMENT OF ENDOMETRIOSIS |
| EP3068883B1 (en) | 2013-11-13 | 2020-04-29 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
| CN104630202A (zh) * | 2013-11-13 | 2015-05-20 | 北京大学 | 一种能够减小微量核酸物质整体扩增时产生偏倚的扩增方法 |
| WO2015085268A1 (en) | 2013-12-05 | 2015-06-11 | Centrillion Technology Holdings Corporation | Modified surfaces |
| EP3628747B1 (en) | 2013-12-05 | 2022-10-05 | Centrillion Technology Holdings Corporation | Fabrication of patterned arrays |
| EP3077545B1 (en) | 2013-12-05 | 2020-09-16 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
| US10100355B2 (en) | 2013-12-09 | 2018-10-16 | Illumina, Inc. | Methods and compositions for targeted nucleic acid sequencing |
| EP3080300B1 (en) * | 2013-12-11 | 2020-09-02 | Genapsys Inc. | Systems and methods for biological analysis and computation |
| CA2933387C (en) | 2013-12-11 | 2023-05-02 | The Regents Of The University Of California | Methods for labeling dna fragments to reconstruct physical linkage and phase |
| WO2015089438A1 (en) | 2013-12-13 | 2015-06-18 | Northwestern University | Biomarkers for post-traumatic stress states |
| US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
| WO2015095355A2 (en) | 2013-12-17 | 2015-06-25 | The Brigham And Women's Hospital, Inc. | Detection of an antibody against a pathogen |
| WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
| WO2015103225A1 (en) | 2013-12-31 | 2015-07-09 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
| WO2015107430A2 (en) | 2014-01-16 | 2015-07-23 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection and prognosis of cervical cancer |
| CN106661612A (zh) | 2014-01-27 | 2017-05-10 | 通用医疗公司 | 制备用于测序的核酸的方法 |
| US9587268B2 (en) | 2014-01-29 | 2017-03-07 | Agilent Technologies Inc. | Fast hybridization for next generation sequencing target enrichment |
| US9387451B2 (en) | 2014-02-03 | 2016-07-12 | International Business Machines Corporation | Flow cell array and uses thereof |
| US10384187B2 (en) | 2014-02-10 | 2019-08-20 | Gencell Biosystems Ltd | Composite liquid cell (CLC) mediated nucleic acid library preparation device, and methods for using the same |
| US9745614B2 (en) | 2014-02-28 | 2017-08-29 | Nugen Technologies, Inc. | Reduced representation bisulfite sequencing with diversity adaptors |
| ES2741740T3 (es) | 2014-03-05 | 2020-02-12 | Adaptive Biotechnologies Corp | Métodos que usan moléculas sintéticas que contienen segmentos de nucleótidos aleatorios |
| US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| JP6607846B2 (ja) * | 2014-03-20 | 2019-11-20 | ユニバーサル・バイオ・リサーチ株式会社 | 核酸増幅自動化装置、及び核酸増幅分析自動化装置 |
| US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
| US11390921B2 (en) | 2014-04-01 | 2022-07-19 | Adaptive Biotechnologies Corporation | Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| US20150284715A1 (en) * | 2014-04-07 | 2015-10-08 | Qiagen Gmbh | Enrichment Methods |
| CA2943624A1 (en) | 2014-04-10 | 2015-10-15 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
| US9822401B2 (en) | 2014-04-18 | 2017-11-21 | Genapsys, Inc. | Methods and systems for nucleic acid amplification |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| EP3957749A1 (en) | 2014-04-21 | 2022-02-23 | Natera, Inc. | Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples |
| WO2015175530A1 (en) | 2014-05-12 | 2015-11-19 | Gore Athurva | Methods for detecting aneuploidy |
| US20180173846A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| EP3151733B1 (en) | 2014-06-06 | 2020-04-15 | The Regents Of The University Of Michigan | Compositions and methods for characterizing and diagnosing periodontal disease |
| WO2015191877A1 (en) | 2014-06-11 | 2015-12-17 | Life Technologies Corporation | Systems and methods for substrate enrichment |
| US20150361481A1 (en) * | 2014-06-13 | 2015-12-17 | Life Technologies Corporation | Multiplex nucleic acid amplification |
| US11155809B2 (en) | 2014-06-24 | 2021-10-26 | Bio-Rad Laboratories, Inc. | Digital PCR barcoding |
| AU2015279617A1 (en) | 2014-06-26 | 2017-01-12 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| EP3161700B1 (en) | 2014-06-26 | 2023-03-29 | 10X Genomics, Inc. | Processes and systems for nucleic acid sequence assembly |
| JP2017521654A (ja) | 2014-06-27 | 2017-08-03 | アボット・ラボラトリーズAbbott Laboratories | ヒトペギウイルス2(HPgV−2)を検出するための組成物および方法 |
| US10697007B2 (en) | 2014-06-27 | 2020-06-30 | The Regents Of The University Of California | PCR-activated sorting (PAS) |
| WO2016007839A1 (en) | 2014-07-11 | 2016-01-14 | President And Fellows Of Harvard College | Methods for high-throughput labelling and detection of biological features in situ using microscopy |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| SG11201700303UA (en) | 2014-07-17 | 2017-02-27 | Celmatix Inc | Methods and systems for assessing infertility and related pathologies |
| EP3191607B1 (en) | 2014-07-24 | 2019-08-21 | Abbott Molecular Inc. | Compositions for the detection and analysis of mycobacterium tuberculosis |
| WO2016019360A1 (en) | 2014-08-01 | 2016-02-04 | Dovetail Genomics Llc | Tagging nucleic acids for sequence assembly |
| WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
| JP6803327B2 (ja) | 2014-08-06 | 2020-12-23 | ニューゲン テクノロジーズ, インコーポレイテッド | 標的化されたシークエンシングからのデジタル測定値 |
| GB201413929D0 (en) | 2014-08-06 | 2014-09-17 | Geneseque As | Method |
| WO2016025452A1 (en) | 2014-08-11 | 2016-02-18 | Luminex Corporation | Probes for improved melt discrimination and multiplexing in nucleic acids assays |
| CN106796212A (zh) | 2014-08-12 | 2017-05-31 | 新生代吉恩公司 | 用于基于收集的体液而监测健康的系统和方法 |
| WO2016025818A1 (en) | 2014-08-15 | 2016-02-18 | Good Start Genetics, Inc. | Systems and methods for genetic analysis |
| US10435685B2 (en) * | 2014-08-19 | 2019-10-08 | Pacific Biosciences Of California, Inc. | Compositions and methods for enrichment of nucleic acids |
| US9982250B2 (en) | 2014-08-21 | 2018-05-29 | Illumina Cambridge Limited | Reversible surface functionalization |
| US10724096B2 (en) | 2014-09-05 | 2020-07-28 | Population Bio, Inc. | Methods and compositions for inhibiting and treating neurological conditions |
| AU2015315351B2 (en) | 2014-09-08 | 2018-06-21 | Becton, Dickinson And Company | Enhanced platen for pharmaceutical compounding |
| US11408024B2 (en) | 2014-09-10 | 2022-08-09 | Molecular Loop Biosciences, Inc. | Methods for selectively suppressing non-target sequences |
| CN105400864B (zh) * | 2014-09-12 | 2020-04-14 | 深圳华大基因股份有限公司 | 用于基于血液样品构建测序文库的方法及其在确定胎儿遗传异常中的用途 |
| CN106715713B (zh) * | 2014-09-12 | 2020-11-03 | 深圳华大智造科技有限公司 | 试剂盒及其在核酸测序中的用途 |
| JP6483249B2 (ja) * | 2014-09-12 | 2019-03-13 | エムジーアイ テック カンパニー リミテッドMGI Tech Co., Ltd. | 単離されたオリゴヌクレオチドおよび核酸の配列決定におけるその使用 |
| ES2788692T3 (es) | 2014-09-17 | 2020-10-22 | Ibis Biosciences Inc | Secuenciación por síntesis usando óptica de lectura por pulsos |
| JP6802154B2 (ja) | 2014-09-18 | 2020-12-16 | イラミーナ インコーポレーテッド | 核酸シーケンシングデータを解析するための方法およびシステム |
| EP3224595A4 (en) | 2014-09-24 | 2018-06-13 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
| WO2016057829A1 (en) | 2014-10-10 | 2016-04-14 | Quantapore, Inc. | Nanopore-based polymer analysis with mutually-quenching fluorescent labels |
| WO2016060974A1 (en) | 2014-10-13 | 2016-04-21 | Life Technologies Corporation | Methods, systems, and computer-readable media for accelerated base calling |
| CA3001986C (en) | 2014-10-22 | 2023-02-21 | The Regents Of The University Of California | High definition microdroplet printer |
| AU2015335616B2 (en) | 2014-10-24 | 2019-09-12 | Quantapore, Inc. | Efficient optical analysis of polymers using arrays of nanostructures |
| EP3715455A1 (en) | 2014-10-29 | 2020-09-30 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| MX2017005267A (es) | 2014-10-29 | 2017-07-26 | 10X Genomics Inc | Metodos y composiciones para la secuenciacion de acidos nucleicos seleccionados como diana. |
| WO2016070131A1 (en) | 2014-10-30 | 2016-05-06 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| LT3212684T (lt) | 2014-10-31 | 2020-04-10 | Illumina Cambridge Limited | Polimerai ir dnr kopolimero dangos |
| CN107109320B (zh) * | 2014-11-04 | 2021-08-06 | 凸版印刷株式会社 | 核酸导入方法、核酸检测方法、生物体成分解析方法及试剂盒、生物体成分定量用阵列器件 |
| US10000799B2 (en) * | 2014-11-04 | 2018-06-19 | Boreal Genomics, Inc. | Methods of sequencing with linked fragments |
| WO2016073778A2 (en) | 2014-11-05 | 2016-05-12 | Nirmidas Biotech, Inc. | Metal composites for enhanced imaging |
| US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
| US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| WO2016073237A1 (en) | 2014-11-05 | 2016-05-12 | Illumina Cambridge Limited | Reducing dna damage during sample preparation and sequencing using siderophore chelators |
| US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
| US11789906B2 (en) | 2014-11-19 | 2023-10-17 | Arc Bio, Llc | Systems and methods for genomic manipulations and analysis |
| CN114606228B (zh) * | 2014-11-20 | 2025-01-07 | 杭州智灵龙生物科技有限公司 | 用于核酸扩增的组合物和方法 |
| US10233490B2 (en) | 2014-11-21 | 2019-03-19 | Metabiotech Corporation | Methods for assembling and reading nucleic acid sequences from mixed populations |
| CA2968543C (en) | 2014-11-25 | 2024-04-02 | Adaptive Biotechnologies Corporation | Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing |
| AU2015357573B2 (en) | 2014-12-05 | 2022-04-07 | Foundation Medicine, Inc. | Multigene analysis of tumor samples |
| US20160177386A1 (en) | 2014-12-18 | 2016-06-23 | Life Technologies Corporation | Calibration panels and methods for designing the same |
| WO2016105199A1 (en) | 2014-12-24 | 2016-06-30 | Keygene N.V. | Backbone mediated mate pair sequencing |
| WO2016112073A1 (en) | 2015-01-06 | 2016-07-14 | Good Start Genetics, Inc. | Screening for structural variants |
| CN107427808B (zh) | 2015-01-12 | 2020-10-23 | 10X基因组学有限公司 | 用于制备核酸测序文库的方法和系统以及用其制备的文库 |
| KR20170106979A (ko) | 2015-01-13 | 2017-09-22 | 10엑스 제노믹스, 인크. | 구조 변이 및 위상 조정 정보를 시각화하기 위한 시스템 및 방법 |
| GB201501012D0 (en) * | 2015-01-21 | 2015-03-04 | Base4 Innovation Ltd | Improved droplet sequencing apparatus and method |
| WO2016122582A1 (en) * | 2015-01-30 | 2016-08-04 | Hewlett Packard Enterprise Development Lp | Relationship preserving projection of digital objects |
| CN107209120B (zh) | 2015-02-02 | 2020-05-15 | 株式会社日立高新技术 | 多色荧光分析装置 |
| WO2016125251A1 (ja) * | 2015-02-03 | 2016-08-11 | 株式会社日立製作所 | 単一細胞解析用フローセルデバイス及び単一細胞解析装置 |
| WO2016126871A2 (en) | 2015-02-04 | 2016-08-11 | The Regents Of The University Of California | Sequencing of nucleic acids via barcoding in discrete entities |
| CA2975855C (en) | 2015-02-04 | 2025-09-23 | Twist Bioscience Corporation | SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| EP3256606B1 (en) | 2015-02-09 | 2019-05-22 | 10X Genomics, Inc. | Systems and methods for determining structural variation |
| WO2016134034A1 (en) | 2015-02-17 | 2016-08-25 | Dovetail Genomics Llc | Nucleic acid sequence assembly |
| CN107407685B (zh) | 2015-02-20 | 2021-08-03 | 宝生物工程(美国)有限公司 | 快速精确分配、可视化和分析单个细胞的方法 |
| US11047008B2 (en) | 2015-02-24 | 2021-06-29 | Adaptive Biotechnologies Corporation | Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing |
| US10697000B2 (en) | 2015-02-24 | 2020-06-30 | 10X Genomics, Inc. | Partition processing methods and systems |
| AU2016222719B2 (en) | 2015-02-24 | 2022-03-31 | 10X Genomics, Inc. | Methods for targeted nucleic acid sequence coverage |
| CN107614096A (zh) | 2015-03-13 | 2018-01-19 | 哈佛学院院长及董事 | 使用扩增测定细胞 |
| JP6567685B2 (ja) | 2015-03-24 | 2019-08-28 | イラミーナ インコーポレーテッド | 生物学的又は化学的な解析用のサンプルを撮像する方法、キャリヤ組立体、及びシステム |
| WO2016154540A1 (en) | 2015-03-26 | 2016-09-29 | Dovetail Genomics Llc | Physical linkage preservation in dna storage |
| WO2016160822A1 (en) * | 2015-03-30 | 2016-10-06 | Verily Life Sciences Llc | Functionalized nanoparticles, methods and in vivo diagnostic system |
| WO2016161273A1 (en) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Method of identifying human compatible t cell receptors specific for an antigenic target |
| JP2018509928A (ja) | 2015-04-02 | 2018-04-12 | ザ ジャクソン ラボラトリー | 環状化メイトペアライブラリーおよびショットガン配列決定を用いて、ゲノム変異を検出するための方法 |
| DK3901281T4 (da) | 2015-04-10 | 2025-10-20 | Illumina Inc | Rumligt adskilt, multipleks nukleinsyreanalyse af biologiske prøver |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| US11180522B2 (en) | 2015-05-08 | 2021-11-23 | Centrillion Technology Holdings Corporation | Disulfide-linked reversible terminators |
| US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
| CA3160383A1 (en) | 2015-05-11 | 2016-11-17 | Illumina, Inc. | Platform for discovery and analysis of therapeutic agents |
| WO2016183478A1 (en) | 2015-05-14 | 2016-11-17 | Life Technologies Corporation | Barcode sequences, and related systems and methods |
| EP3527672B1 (en) | 2015-06-09 | 2022-10-05 | Centrillion Technology Holdings Corporation | Oligonucleotide arrays for sequencing nucleic acids |
| US12157910B2 (en) * | 2015-07-06 | 2024-12-03 | Illumina Cambridge Limited | Sample preparation for nucleic acid amplification |
| EP3320399A1 (en) | 2015-07-07 | 2018-05-16 | Illumina, Inc. | Selective surface patterning via nanoimprinting |
| US10392613B2 (en) | 2015-07-14 | 2019-08-27 | Abbott Molecular Inc. | Purification of nucleic acids using copper-titanium oxides |
| WO2017011565A1 (en) | 2015-07-14 | 2017-01-19 | Abbott Molecular Inc. | Compositions and methods for identifying drug resistant tuberculosis |
| ES2945607T3 (es) | 2015-07-17 | 2023-07-04 | Illumina Inc | Láminas de polímero para aplicaciones de secuenciación |
| US10150994B2 (en) | 2015-07-22 | 2018-12-11 | Qiagen Waltham, Inc. | Modular flow cells and methods of sequencing |
| IL294145B2 (en) | 2015-07-30 | 2024-02-01 | Illumina Inc | Removal of orthogonal blocking of nucleotides |
| US11929149B2 (en) | 2015-08-06 | 2024-03-12 | Arc Bio, Llc | Systems and methods for genomic analysis |
| WO2017027653A1 (en) | 2015-08-11 | 2017-02-16 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| CN108474805A (zh) | 2015-08-24 | 2018-08-31 | 亿明达股份有限公司 | 用于生物和化学测定的线路内蓄压器和流量控制系统 |
| EP3344389B1 (en) | 2015-09-02 | 2020-06-10 | Illumina Cambridge Limited | Method of fixing defects in a hydrophobic surface of a droplet actuator |
| US9938572B1 (en) | 2015-09-08 | 2018-04-10 | Raindance Technologies, Inc. | System and method for forming an emulsion |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| HK1258869A1 (zh) | 2015-09-18 | 2019-11-22 | Twist Bioscience Corporation | 寡核酸变体文库及其合成 |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| US10465232B1 (en) | 2015-10-08 | 2019-11-05 | Trace Genomics, Inc. | Methods for quantifying efficiency of nucleic acid extraction and detection |
| CA3001679A1 (en) | 2015-10-13 | 2017-04-20 | President And Fellows Of Harvard College | Systems and methods for making and using gel microspheres |
| CN108368542B (zh) | 2015-10-19 | 2022-04-08 | 多弗泰尔基因组学有限责任公司 | 用于基因组组装、单元型定相以及独立于靶标的核酸检测的方法 |
| CN108474022A (zh) | 2015-11-03 | 2018-08-31 | 哈佛学院董事及会员团体 | 用于包含三维核酸的基质容积成像的设备和方法 |
| US11371094B2 (en) | 2015-11-19 | 2022-06-28 | 10X Genomics, Inc. | Systems and methods for nucleic acid processing using degenerate nucleotides |
| US9895673B2 (en) | 2015-12-01 | 2018-02-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
| KR20240161696A (ko) | 2015-12-04 | 2024-11-12 | 10엑스 제노믹스, 인크. | 핵산 분석을 위한 방법 및 조성물 |
| WO2017096110A1 (en) * | 2015-12-04 | 2017-06-08 | Siemens Healthcare Diagnostics Inc. | Method and device for optimizing the process of identification of pathogens |
| CN108431223A (zh) | 2016-01-08 | 2018-08-21 | 生物辐射实验室股份有限公司 | 每液滴分辨率下的多个珠 |
| AU2017207259B2 (en) | 2016-01-11 | 2019-06-27 | Illumina Singapore Pte Ltd | Detection apparatus having a microfluorometer, a fluidic system, and a flow cell latch clamp module |
| US10612089B2 (en) * | 2016-01-12 | 2020-04-07 | Bio-Rad Laboratories, Inc. | Synthesizing barcoding sequences utilizing phase-shift blocks and uses thereof |
| US20190169602A1 (en) | 2016-01-12 | 2019-06-06 | Seqwell, Inc. | Compositions and methods for sequencing nucleic acids |
| KR102641264B1 (ko) | 2016-01-22 | 2024-02-26 | 퍼듀 리서치 파운데이션 | 하전된 질량 표지 시스템 |
| JP6685138B2 (ja) | 2016-01-27 | 2020-04-22 | シスメックス株式会社 | 核酸増幅の精度管理方法、精度管理用試薬およびその試薬キット |
| EP3848457B1 (en) | 2016-02-08 | 2025-08-13 | Rgene, Inc. | Multiple ligase compositions, systems, and methods |
| CN108779491B (zh) | 2016-02-11 | 2021-03-09 | 10X基因组学有限公司 | 用于全基因组序列数据的从头组装的系统、方法和介质 |
| JP2017143783A (ja) * | 2016-02-17 | 2017-08-24 | 国立大学法人 筑波大学 | 並列反応用懸濁液、並列反応方法、スクリーニング方法および検査方法 |
| EP3420108A4 (en) | 2016-02-23 | 2019-11-06 | Dovetail Genomics LLC | GENERATION OF LIVE PHASES FOR THE GENERATION ARRANGEMENT AND HAPLOTYPE PHASE RULES |
| WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
| WO2017160788A2 (en) | 2016-03-14 | 2017-09-21 | RGENE, Inc. | HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES |
| EP4574992A3 (en) | 2016-03-22 | 2025-07-16 | Myriad Women's Health, Inc. | Combinatorial dna screening |
| CN116987777A (zh) | 2016-03-25 | 2023-11-03 | 凯锐思公司 | 合成核酸掺入物 |
| DK3377226T3 (da) | 2016-03-28 | 2021-04-26 | Illumina Inc | Mikrorækker i flere niveauer |
| US10961573B2 (en) | 2016-03-28 | 2021-03-30 | Boreal Genomics, Inc. | Linked duplex target capture |
| WO2017180909A1 (en) | 2016-04-13 | 2017-10-19 | Nextgen Jane, Inc. | Sample collection and preservation devices, systems and methods |
| WO2017180871A1 (en) | 2016-04-13 | 2017-10-19 | Purdue Research Foundation | Systems and methods for isolating a target in an ion trap |
| ITUA20162640A1 (it) * | 2016-04-15 | 2017-10-15 | Menarini Silicon Biosystems Spa | Metodo e kit per la generazione di librerie di dna per sequenziamento massivo parallelo |
| JP7280044B2 (ja) | 2016-04-15 | 2023-05-23 | ナテラ, インコーポレイテッド | 肺癌の検出方法 |
| CA3022290A1 (en) | 2016-04-25 | 2017-11-02 | President And Fellows Of Harvard College | Hybridization chain reaction methods for in situ molecular detection |
| CN105821482B (zh) * | 2016-04-29 | 2018-04-10 | 李星军 | 一种生化微反应体系、高通量测序的建库仪及应用 |
| US10077459B2 (en) | 2016-05-04 | 2018-09-18 | General Electric Company | Cell-free protein expression using rolling circle amplification product |
| US10619205B2 (en) | 2016-05-06 | 2020-04-14 | Life Technologies Corporation | Combinatorial barcode sequences, and related systems and methods |
| WO2017197343A2 (en) | 2016-05-12 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic on-chip filters |
| WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
| KR102412442B1 (ko) | 2016-05-13 | 2022-06-22 | 더브테일 제노믹스 엘엘씨 | 보존된 샘플로부터의 장범위 링키지 정보의 회수 |
| AU2017267653B2 (en) | 2016-05-18 | 2021-05-13 | Illumina, Inc. | Self assembled patterning using patterned Hydrophobic surfaces |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| WO2017214417A1 (en) * | 2016-06-10 | 2017-12-14 | Takara Bio Usa, Inc. | Methods and compositions employing blocked primers |
| US11268117B2 (en) | 2016-06-10 | 2022-03-08 | Life Technologies Corporation | Methods and compositions for nucleic acid amplification |
| JP2019528675A (ja) * | 2016-06-14 | 2019-10-17 | ベース4 イノベーション リミテッド | ポリヌクレオチド分離法 |
| US11091795B2 (en) | 2016-07-11 | 2021-08-17 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for diagnosing and treating arrhythmias |
| CN109790575A (zh) | 2016-07-20 | 2019-05-21 | 吉纳普赛斯股份有限公司 | 用于核酸测序的系统和方法 |
| WO2018017892A1 (en) | 2016-07-21 | 2018-01-25 | Takara Bio Usa, Inc. | Multi-z imaging and dispensing with multi-well devices |
| WO2018031691A1 (en) | 2016-08-10 | 2018-02-15 | The Regents Of The University Of California | Combined multiple-displacement amplification and pcr in an emulsion microdroplet |
| AU2017315252B2 (en) | 2016-08-22 | 2023-03-16 | Biolumic Limited | System, device and methods of seed treatment |
| SG11201901563UA (en) | 2016-08-22 | 2019-03-28 | Twist Bioscience Corp | De novo synthesized nucleic acid libraries |
| US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| MX2019002376A (es) * | 2016-08-31 | 2019-06-20 | Harvard College | Metodos de amplificacion digital del genoma completo. |
| CN109983125B (zh) | 2016-08-31 | 2024-06-04 | 哈佛学院董事及会员团体 | 生成用于通过荧光原位测序检测的核酸序列文库的方法 |
| CN118853848A (zh) | 2016-08-31 | 2024-10-29 | 哈佛学院董事及会员团体 | 将生物分子的检测组合到使用荧光原位测序的单个试验的方法 |
| WO2018045162A1 (en) | 2016-09-01 | 2018-03-08 | Biogen Ma Inc. | Biomarkers predictive of primary progressive multiple sclerosis and uses thereof |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
| US11572555B2 (en) | 2016-09-27 | 2023-02-07 | Psomagen, Inc. | Method and system for CRISPR-based library preparation and sequencing |
| WO2018064116A1 (en) | 2016-09-28 | 2018-04-05 | Illumina, Inc. | Methods and systems for data compression |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| CN111781139B (zh) | 2016-10-14 | 2023-09-12 | 亿明达股份有限公司 | 夹盒组件 |
| US10190155B2 (en) | 2016-10-14 | 2019-01-29 | Nugen Technologies, Inc. | Molecular tag attachment and transfer |
| US11725232B2 (en) | 2016-10-31 | 2023-08-15 | The Hong Kong University Of Science And Technology | Compositions, methods and kits for detection of genetic variants for alzheimer's disease |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10255990B2 (en) | 2016-11-11 | 2019-04-09 | uBiome, Inc. | Method and system for fragment assembly and sequence identification |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| WO2018111728A1 (en) * | 2016-12-12 | 2018-06-21 | Slipchip Corporation | Capsule containment of dried reagents |
| AU2017378492B2 (en) | 2016-12-16 | 2022-06-16 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| EP3555290B1 (en) | 2016-12-19 | 2022-11-02 | Bio-Rad Laboratories, Inc. | Droplet tagging contiguity preserved tagmented dna |
| CA3047328A1 (en) | 2016-12-21 | 2018-06-28 | The Regents Of The University Of California | Single cell genomic sequencing using hydrogel based droplets |
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11466318B2 (en) | 2016-12-27 | 2022-10-11 | Egi Tech (Shen Zhen) Co., Limited | Single fluorescent dye-based sequencing method |
| RS63419B2 (sr) * | 2017-01-04 | 2025-10-31 | Mgi Tech Co Ltd | Sekvenciranje nukleinske kiseline upotrebom afinitetnih reagenasa |
| GB201704754D0 (en) | 2017-01-05 | 2017-05-10 | Illumina Inc | Kinetic exclusion amplification of nucleic acid libraries |
| CA3050984A1 (en) | 2017-01-20 | 2018-07-26 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| US12264411B2 (en) | 2017-01-30 | 2025-04-01 | 10X Genomics, Inc. | Methods and systems for analysis |
| EP4029939B1 (en) | 2017-01-30 | 2023-06-28 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
| GB201701689D0 (en) | 2017-02-01 | 2017-03-15 | Illumia Inc | System and method with fiducials of non-closed shapes |
| SG11201906442TA (en) | 2017-02-01 | 2019-08-27 | Illumina Inc | System and method with fiducials responding to multiple excitation frequencies |
| GB201701688D0 (en) | 2017-02-01 | 2017-03-15 | Illumia Inc | System and method with fiducials in non-recliner layouts |
| GB201701686D0 (en) | 2017-02-01 | 2017-03-15 | Illunina Inc | System & method with fiducials having offset layouts |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| US10995333B2 (en) | 2017-02-06 | 2021-05-04 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation |
| US10894976B2 (en) | 2017-02-21 | 2021-01-19 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
| US11550939B2 (en) | 2017-02-22 | 2023-01-10 | Twist Bioscience Corporation | Nucleic acid based data storage using enzymatic bioencryption |
| GB201703049D0 (en) * | 2017-02-24 | 2017-04-12 | Univ I Tromsø - Norges Arktiske Univ | Single-strand binding protein |
| EP4218738B1 (en) * | 2017-02-24 | 2024-10-16 | The Regents of The University of California | Particle-drop structures and methods for making and using the same |
| JP6931540B2 (ja) * | 2017-02-27 | 2021-09-08 | シスメックス株式会社 | 検体処理チップを用いた送液方法、検体処理チップの送液装置 |
| WO2018165600A1 (en) | 2017-03-09 | 2018-09-13 | Genomedx Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| EP3595674A4 (en) | 2017-03-15 | 2020-12-16 | Twist Bioscience Corporation | BANKS OF VARIANTS OF IMMUNOLOGICAL SYNAPSE AND THEIR SYNTHESIS |
| CN110446787A (zh) | 2017-03-24 | 2019-11-12 | 生物辐射实验室股份有限公司 | 通用发夹引物 |
| EP3607087A4 (en) | 2017-04-04 | 2020-12-30 | Omniome, Inc. | FLUIDIC APPARATUS AND USEFUL METHODS FOR CHEMICAL AND BIOLOGICAL REACTIONS |
| US12492430B2 (en) | 2017-04-11 | 2025-12-09 | Tecan Genomics, Inc. | Library quantitation and qualification |
| WO2018191563A1 (en) | 2017-04-12 | 2018-10-18 | Karius, Inc. | Sample preparation methods, systems and compositions |
| CN109789167A (zh) | 2017-04-14 | 2019-05-21 | 哈佛学院董事及会员团体 | 用于产生细胞衍生的微丝网络的方法 |
| US20210371918A1 (en) | 2017-04-18 | 2021-12-02 | Dovetail Genomics, Llc | Nucleic acid characteristics as guides for sequence assembly |
| US10161003B2 (en) | 2017-04-25 | 2018-12-25 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
| JP2018183097A (ja) * | 2017-04-26 | 2018-11-22 | 株式会社エンプラス | 細胞由来の解析用液滴の単離方法、および細胞の解析方法 |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| CN106957842B (zh) * | 2017-05-15 | 2020-05-22 | 青岛安德贝生命科技有限公司 | Bac克隆dna的提取方法 |
| WO2018213774A1 (en) | 2017-05-19 | 2018-11-22 | 10X Genomics, Inc. | Systems and methods for analyzing datasets |
| EP3445876B1 (en) | 2017-05-26 | 2023-07-05 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| US10844372B2 (en) | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| CN110997934B (zh) * | 2017-05-31 | 2025-02-28 | 生捷科技控股公司 | 具有电子检测系统的寡核苷酸探针阵列 |
| CN110997711A (zh) | 2017-06-08 | 2020-04-10 | 布里格姆妇女医院 | 用于鉴定表位的方法和组合物 |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for assembling continuous nucleic acids |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| US11001885B2 (en) * | 2017-06-13 | 2021-05-11 | Personal Genomics Taiwan, Inc. | Apparatus for single molecular sequencing and method of sequencing nucleic acid molecules |
| EP3642363B1 (en) | 2017-06-20 | 2025-12-24 | Bio-Rad Laboratories, Inc. | Mda using bead oligonucleotide |
| US12040053B2 (en) | 2017-06-21 | 2024-07-16 | Bluedot, Llc | Methods for generating sequencer-specific nucleic acid barcodes that reduce demultiplexing errors |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| MX2019015877A (es) | 2017-06-29 | 2020-08-06 | Biolumic Ltd | Método para mejorar el rendimiento o la calidad de los cultivos. |
| CA3072061A1 (en) | 2017-08-04 | 2019-02-07 | The Regents Of The University Of Michigan | Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy |
| IL319255A (en) | 2017-08-07 | 2025-04-01 | Univ Johns Hopkins | Methods and materials for cancer assessment and treatment |
| CN111182972B (zh) | 2017-08-15 | 2022-03-08 | 欧姆尼奥姆股份有限公司 | 用于检测化学和生物分析物的扫描装置和方法 |
| WO2019038594A2 (en) | 2017-08-21 | 2019-02-28 | Biolumic Limited | TRANSGENIC PLANTS WITH HIGH GROWTH AND HIGH RUSTICITY |
| AU2018327337A1 (en) * | 2017-09-07 | 2020-04-30 | Coopersurgical, Inc. | Systems and methods for non-invasive preimplantation genetic diagnosis |
| GB2581620A (en) | 2017-09-11 | 2020-08-26 | Twist Bioscience Corp | GPCR binding proteins and synthesis thereof |
| RU2020113600A (ru) | 2017-09-20 | 2021-10-20 | Ридженерон Фармасьютикалз, Инк. | Способы иммунотерапии пациентов, опухоли которых характеризуются высокой нагрузкой пассажирскими генными мутациями |
| MX2020003113A (es) | 2017-09-21 | 2020-09-07 | Genapsys Inc | Sistemas y metodos para secuenciar acido nucleico. |
| WO2019060716A1 (en) | 2017-09-25 | 2019-03-28 | Freenome Holdings, Inc. | SAMPLE EXTRACTION METHODS AND SYSTEMS |
| ES2998086T3 (en) * | 2017-09-29 | 2025-02-19 | Univ California | Method of generating monodisperse emulsions |
| US10837047B2 (en) | 2017-10-04 | 2020-11-17 | 10X Genomics, Inc. | Compositions, methods, and systems for bead formation using improved polymers |
| US11598780B2 (en) | 2017-10-06 | 2023-03-07 | The University Of Chicago | Engineering lymphocytes with specific alpha and beta chains on their t-cell receptor |
| US10501739B2 (en) | 2017-10-18 | 2019-12-10 | Mission Bio, Inc. | Method, systems and apparatus for single cell analysis |
| CA3079411C (en) | 2017-10-19 | 2023-12-05 | Omniome, Inc. | Simultaneous background reduction and complex stabilization in binding assay workflows |
| CA3079613A1 (en) | 2017-10-20 | 2019-04-25 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
| US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
| WO2019084043A1 (en) | 2017-10-26 | 2019-05-02 | 10X Genomics, Inc. | METHODS AND SYSTEMS FOR NUCLEIC ACID PREPARATION AND CHROMATIN ANALYSIS |
| WO2019084165A1 (en) | 2017-10-27 | 2019-05-02 | 10X Genomics, Inc. | METHODS AND SYSTEMS FOR SAMPLE PREPARATION AND ANALYSIS |
| CN118186055A (zh) | 2017-11-02 | 2024-06-14 | 生物辐射实验室股份有限公司 | 基于转座酶的基因组分析 |
| SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
| US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
| AU2018372906B2 (en) | 2017-11-22 | 2025-04-03 | The Regents Of The University Of Michigan | Compositions and methods for treating cancer |
| SG11202004649SA (en) | 2017-11-29 | 2020-06-29 | Xgenomes Corp | Sequencing of nucleic acids by emergence |
| US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
| US11427867B2 (en) | 2017-11-29 | 2022-08-30 | Xgenomes Corp. | Sequencing by emergence |
| WO2019108851A1 (en) | 2017-11-30 | 2019-06-06 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation and analysis |
| WO2019118355A1 (en) | 2017-12-12 | 2019-06-20 | 10X Genomics, Inc. | Systems and methods for single cell processing |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| CN111712579B (zh) | 2017-12-22 | 2024-10-15 | 10X基因组学有限公司 | 用于处理来自一个或多个细胞的核酸分子的系统和方法 |
| JP2021509024A (ja) | 2018-01-02 | 2021-03-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 多数の液滴の捕捉 |
| GB2585506A (en) | 2018-01-04 | 2021-01-13 | Twist Bioscience Corp | DNA-based digital information storage |
| US20190237163A1 (en) | 2018-01-12 | 2019-08-01 | Life Technologies Corporation | Methods for flow space quality score prediction by neural networks |
| AU2019214956B2 (en) | 2018-01-31 | 2025-06-26 | Dovetail Genomics, Llc | Sample prep for DNA linkage recovery |
| CN111699253B (zh) | 2018-01-31 | 2025-01-14 | 生物辐射实验室股份有限公司 | 用于解卷积分区条码的方法和组合物 |
| EP3752832A1 (en) | 2018-02-12 | 2020-12-23 | 10X Genomics, Inc. | Methods characterizing multiple analytes from individual cells or cell populations |
| US12398389B2 (en) | 2018-02-15 | 2025-08-26 | Natera, Inc. | Methods for isolating nucleic acids with size selection |
| CN110184325A (zh) | 2018-02-22 | 2019-08-30 | 张家港万众一芯生物科技有限公司 | 基于微孔阵列芯片的单分子文库pcr扩增的基因测序方法 |
| US11639928B2 (en) | 2018-02-22 | 2023-05-02 | 10X Genomics, Inc. | Methods and systems for characterizing analytes from individual cells or cell populations |
| WO2019169028A1 (en) | 2018-02-28 | 2019-09-06 | 10X Genomics, Inc. | Transcriptome sequencing through random ligation |
| CA3133334A1 (en) * | 2018-03-13 | 2019-09-19 | Inanc ORTAC | Methods for single molecule sequencing |
| CN112166199B (zh) | 2018-04-02 | 2025-04-29 | 埃努梅拉分子股份有限公司 | 用于对核酸分子进行计数的方法、系统和组合物 |
| SG11202009889VA (en) | 2018-04-06 | 2020-11-27 | 10X Genomics Inc | Systems and methods for quality control in single cell processing |
| EP3553182A1 (en) | 2018-04-11 | 2019-10-16 | Université de Bourgogne | Detection method of somatic genetic anomalies, combination of capture probes and kit of detection |
| US11746151B2 (en) | 2018-04-13 | 2023-09-05 | The Regents Of The University Of Michigan | Compositions and methods for treating cancer |
| US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
| US20190338352A1 (en) | 2018-04-19 | 2019-11-07 | Omniome, Inc. | Accuracy of base calls in nucleic acid sequencing methods |
| EP4234718A3 (en) | 2018-04-26 | 2023-11-29 | Pacific Biosciences Of California, Inc. | Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes |
| US12235273B2 (en) | 2018-05-04 | 2025-02-25 | Abbott Laboratories | HBV diagnostic, prognostic, and therapeutic methods and products |
| WO2019217758A1 (en) | 2018-05-10 | 2019-11-14 | 10X Genomics, Inc. | Methods and systems for molecular library generation |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| US12234377B2 (en) | 2018-05-18 | 2025-02-25 | The University Of North Carolina At Chapel Hill | Compositions, devices, and methods for improving a surface property of a substrate |
| US11180794B2 (en) | 2018-05-31 | 2021-11-23 | Omniome, Inc. | Methods and compositions for capping nucleic acids |
| US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| AU2019276719B2 (en) | 2018-05-31 | 2025-11-13 | Pacific Biosciences Of California, Inc. | Increased signal to noise in nucleic acid sequencing |
| US11932899B2 (en) | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
| WO2019241250A1 (en) | 2018-06-11 | 2019-12-19 | Foundation Medicine, Inc. | Compositions and methods for evaluating genomic alterations |
| US11703427B2 (en) | 2018-06-25 | 2023-07-18 | 10X Genomics, Inc. | Methods and systems for cell and bead processing |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| CN112567048A (zh) | 2018-07-24 | 2021-03-26 | 欧姆尼欧美公司 | 三元复合物种类的连续形成 |
| US12188014B1 (en) | 2018-07-25 | 2025-01-07 | 10X Genomics, Inc. | Compositions and methods for nucleic acid processing using blocking agents |
| US20200032335A1 (en) | 2018-07-27 | 2020-01-30 | 10X Genomics, Inc. | Systems and methods for metabolome analysis |
| WO2020028194A1 (en) | 2018-07-30 | 2020-02-06 | Readcoor, Inc. | Methods and systems for sample processing or analysis |
| EP3830289A1 (en) | 2018-08-03 | 2021-06-09 | 10X Genomics, Inc. | Methods and systems to minimize barcode exchange |
| FI4417708T3 (fi) | 2018-08-08 | 2025-12-04 | Pml Screening Llc | Menetelmiä virustaudin kehittymisen riskin arvioimiseksi geneettisen testin avulla |
| CN118406747A (zh) | 2018-08-20 | 2024-07-30 | 生物辐射实验室股份有限公司 | 通过分区中条码珠共定位生成核苷酸序列 |
| US12065688B2 (en) | 2018-08-20 | 2024-08-20 | 10X Genomics, Inc. | Compositions and methods for cellular processing |
| WO2020041148A1 (en) | 2018-08-20 | 2020-02-27 | 10X Genomics, Inc. | Methods and systems for detection of protein-dna interactions using proximity ligation |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| WO2020069424A1 (en) | 2018-09-28 | 2020-04-02 | Centrillion Technologies, Inc. | Disulfide-linked reversible terminators |
| WO2020076976A1 (en) | 2018-10-10 | 2020-04-16 | Readcoor, Inc. | Three-dimensional spatial molecular indexing |
| CN117778535A (zh) | 2018-10-25 | 2024-03-29 | Illumina公司 | 使用索引和条形码识别阵列上的配体的方法和组合物 |
| WO2020102513A1 (en) | 2018-11-14 | 2020-05-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods for characterizing and treating cancer |
| WO2020101795A1 (en) | 2018-11-15 | 2020-05-22 | Omniome, Inc. | Electronic detection of nucleic acid structure |
| EP3887545A4 (en) * | 2018-11-29 | 2022-08-24 | XGenomes Corp. | COALESCENCE SEQUENCING |
| WO2020117653A1 (en) | 2018-12-04 | 2020-06-11 | Omniome, Inc. | Mixed-phase fluids for nucleic acid sequencing and other analytical assays |
| JP2022509850A (ja) | 2018-12-07 | 2022-01-24 | オクタント,インク. | タンパク質間相互作用スクリーニングのためのシステム |
| US11459607B1 (en) | 2018-12-10 | 2022-10-04 | 10X Genomics, Inc. | Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes |
| WO2020123320A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Imaging system hardware |
| AU2019398307A1 (en) | 2018-12-13 | 2021-06-10 | Dna Script | Direct oligonucleotide synthesis on cells and biomolecules |
| BR112020026667A2 (pt) * | 2018-12-19 | 2021-07-27 | Illumina, Inc. | métodos para melhorar a prioridade de clonalidade do agrupamento de polinucleotídeo |
| US11041199B2 (en) | 2018-12-20 | 2021-06-22 | Omniome, Inc. | Temperature control for analysis of nucleic acids and other analytes |
| US11358137B2 (en) | 2018-12-26 | 2022-06-14 | Industrial Technology Research Institute | Tubular structure for producing droplets and method for producing droplets |
| EP3902816A4 (en) | 2018-12-26 | 2022-09-14 | Twist Bioscience Corporation | HIGHLY ACCURATE POLYNUCLEOTIDE DE NOVO SYNTHESIS |
| CN109738469A (zh) * | 2018-12-29 | 2019-05-10 | 赛纳生物科技(北京)有限公司 | 一种fop表面微坑镀膜的致密性检测方法 |
| US20220081714A1 (en) | 2019-01-04 | 2022-03-17 | Northwestern University | Storing temporal data into dna |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US12169198B2 (en) | 2019-01-08 | 2024-12-17 | 10X Genomics, Inc. | Systems and methods for sample analysis |
| US11845983B1 (en) | 2019-01-09 | 2023-12-19 | 10X Genomics, Inc. | Methods and systems for multiplexing of droplet based assays |
| WO2020146740A1 (en) | 2019-01-10 | 2020-07-16 | Iovance Biotherapeutics, Inc. | System and methods for monitoring adoptive cell therapy clonality and persistence |
| WO2020167656A1 (en) * | 2019-02-11 | 2020-08-20 | Ultima Genomics, Inc. | Methods for nucleic acid analysis |
| US11851683B1 (en) | 2019-02-12 | 2023-12-26 | 10X Genomics, Inc. | Methods and systems for selective analysis of cellular samples |
| SG11202108788TA (en) | 2019-02-12 | 2021-09-29 | 10X Genomics Inc | Methods for processing nucleic acid molecules |
| US11467153B2 (en) | 2019-02-12 | 2022-10-11 | 10X Genomics, Inc. | Methods for processing nucleic acid molecules |
| US12275993B2 (en) | 2019-02-12 | 2025-04-15 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| WO2020167862A1 (en) | 2019-02-12 | 2020-08-20 | 10X Genomics, Inc. | Systems and methods for transfer of reagents between droplets |
| WO2020167866A1 (en) | 2019-02-12 | 2020-08-20 | 10X Genomics, Inc. | Systems and methods for transposon loading |
| US12305239B2 (en) | 2019-02-12 | 2025-05-20 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| EP3924513B1 (en) | 2019-02-14 | 2023-04-12 | Pacific Biosciences of California, Inc. | Mitigating adverse impacts of detection systems on nucleic acids and other biological analytes |
| CN113613787B (zh) | 2019-02-20 | 2023-06-13 | 加利福尼亚太平洋生物科学股份有限公司 | 用于检测化学和生物分析物的扫描装置和方法 |
| US11655499B1 (en) | 2019-02-25 | 2023-05-23 | 10X Genomics, Inc. | Detection of sequence elements in nucleic acid molecules |
| AU2020227802A1 (en) | 2019-02-26 | 2021-10-14 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
| JP2022521551A (ja) | 2019-02-26 | 2022-04-08 | ツイスト バイオサイエンス コーポレーション | Glp1受容体の変異体核酸ライブラリ |
| WO2020185791A1 (en) | 2019-03-11 | 2020-09-17 | 10X Genomics, Inc. | Systems and methods for processing optically tagged beads |
| EP3937780A4 (en) | 2019-03-14 | 2022-12-07 | InSilixa, Inc. | METHODS AND SYSTEMS FOR TIMED FLUORESCENCE-BASED DETECTION |
| WO2020191389A1 (en) | 2019-03-21 | 2020-09-24 | Illumina, Inc. | Training data generation for artificial intelligence-based sequencing |
| NL2023314B1 (en) | 2019-03-21 | 2020-09-28 | Illumina Inc | Artificial intelligence-based quality scoring |
| NL2023310B1 (en) | 2019-03-21 | 2020-09-28 | Illumina Inc | Training data generation for artificial intelligence-based sequencing |
| NL2023316B1 (en) | 2019-03-21 | 2020-09-28 | Illumina Inc | Artificial intelligence-based sequencing |
| NL2023311B9 (en) | 2019-03-21 | 2021-03-12 | Illumina Inc | Artificial intelligence-based generation of sequencing metadata |
| US11210554B2 (en) | 2019-03-21 | 2021-12-28 | Illumina, Inc. | Artificial intelligence-based generation of sequencing metadata |
| NL2023312B1 (en) | 2019-03-21 | 2020-09-28 | Illumina Inc | Artificial intelligence-based base calling |
| EP3947718A4 (en) | 2019-04-02 | 2022-12-21 | Enumera Molecular, Inc. | METHODS, SYSTEMS AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES |
| US11989216B2 (en) | 2019-04-09 | 2024-05-21 | University Of Washington | Systems and methods for providing similarity-based retrieval of information stored in DNA |
| BR112021006173A2 (pt) | 2019-04-29 | 2021-11-16 | Illumina Inc | Métodos para a identificação e análise de micro-organismos viáveis e/ou proliferativos e para determinação da eficácia de um agente antimicrobiano na modulação do crescimento e da proliferação de micro-organismos em uma amostra |
| US20210017596A1 (en) * | 2019-05-08 | 2021-01-21 | Qiagen Sciences, Llc | Sequential sequencing methods and compositions |
| US11593649B2 (en) | 2019-05-16 | 2023-02-28 | Illumina, Inc. | Base calling using convolutions |
| AU2020280104A1 (en) | 2019-05-22 | 2022-01-20 | Mission Bio, Inc. | Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein |
| EP3976795A1 (en) | 2019-05-28 | 2022-04-06 | Octant, Inc. | Transcriptional relay system |
| WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| WO2020247263A1 (en) | 2019-06-06 | 2020-12-10 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
| WO2020252186A1 (en) | 2019-06-11 | 2020-12-17 | Omniome, Inc. | Calibrated focus sensing |
| AU2020298294A1 (en) | 2019-06-21 | 2022-02-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| WO2020264185A1 (en) | 2019-06-27 | 2020-12-30 | Dovetail Genomics, Llc | Methods and compositions for proximity ligation |
| US11667954B2 (en) | 2019-07-01 | 2023-06-06 | Mission Bio, Inc. | Method and apparatus to normalize quantitative readouts in single-cell experiments |
| US11377655B2 (en) | 2019-07-16 | 2022-07-05 | Pacific Biosciences Of California, Inc. | Synthetic nucleic acids having non-natural structures |
| US10656368B1 (en) | 2019-07-24 | 2020-05-19 | Omniome, Inc. | Method and system for biological imaging using a wide field objective lens |
| US12496305B2 (en) | 2019-07-30 | 2025-12-16 | The Cleveland Clinic Foundation | Detection for determining corticosteroid responsiveness |
| CN110499361B (zh) * | 2019-07-31 | 2022-11-25 | 齐鲁工业大学 | 一种末端碱基流式荧光测序微球的制备方法及应用 |
| EP4020484A4 (en) | 2019-08-19 | 2023-08-30 | Green Cross Genome Corporation | METHOD FOR DETECTING A CHROMOSOME ABNORMALITY USING INFORMATION CONCERNING THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS |
| JP7675700B2 (ja) * | 2019-08-21 | 2025-05-13 | ライフ テクノロジーズ コーポレーション | シーケンシングのためのシステムおよび方法 |
| US12235262B1 (en) | 2019-09-09 | 2025-02-25 | 10X Genomics, Inc. | Methods and systems for single cell protein analysis |
| US11180520B2 (en) | 2019-09-10 | 2021-11-23 | Omniome, Inc. | Reversible modifications of nucleotides |
| WO2021055864A1 (en) | 2019-09-20 | 2021-03-25 | Illumina, Inc. | Methods and compositions for identifying ligands on arrays using indexes and barcodes |
| EP4034564A4 (en) | 2019-09-23 | 2023-12-13 | Twist Bioscience Corporation | VARIANT NUCLEIC ACID LIBRARIES FOR SINGLE-DOMAIN ANTIBODIES |
| US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
| CA3157359A1 (en) | 2019-10-10 | 2021-04-15 | 1859, Inc. | Methods and systems for microfluidic screening |
| CN118186063A (zh) | 2019-10-18 | 2024-06-14 | 加利福尼亚太平洋生物科学股份有限公司 | 用于对核酸加帽的方法和组合物 |
| CN114945987A (zh) | 2019-11-05 | 2022-08-26 | 佩索纳里斯公司 | 从单一样品预估肿瘤纯度 |
| CA3151629A1 (en) | 2019-11-07 | 2021-05-14 | Laura E. BENJAMIN | Classification of tumor microenvironments |
| WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| WO2021091611A1 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
| CN110951852B (zh) * | 2019-11-25 | 2022-11-25 | 齐鲁工业大学 | 单碱基连续延伸流式靶向测序法 |
| US20230028790A1 (en) | 2019-11-29 | 2023-01-26 | GC Genome Corporation | Artificial intelligence-based chromosomal abnormality detection method |
| EP3839509A1 (en) * | 2019-12-16 | 2021-06-23 | Blink AG | A library of prefabricated microparticles and precursors thereof |
| CN115038794A (zh) | 2019-12-23 | 2022-09-09 | 10X基因组学有限公司 | 在基于分区的测定中使用固定生物样品的组合物和方法 |
| EP4667585A2 (en) | 2019-12-23 | 2025-12-24 | 10X Genomics, Inc. | Methods for spatial analysis using rna-templated ligation |
| AU2021208466A1 (en) | 2020-01-13 | 2022-08-11 | Fluent Biosciences Inc. | Single cell sequencing |
| US11827936B2 (en) | 2020-01-13 | 2023-11-28 | Fluent Biosciences Inc. | Methods and systems for single cell gene profiling |
| US12365942B2 (en) | 2020-01-13 | 2025-07-22 | 10X Genomics, Inc. | Methods of decreasing background on a spatial array |
| CA3167729A1 (en) | 2020-01-13 | 2021-07-22 | Fluent Biosciences Inc. | Emulsion based drug screening |
| US12405264B2 (en) | 2020-01-17 | 2025-09-02 | 10X Genomics, Inc. | Electrophoretic system and method for analyte capture |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
| WO2021152586A1 (en) | 2020-01-30 | 2021-08-05 | Yeda Research And Development Co. Ltd. | Methods of analyzing microbiome, immunoglobulin profile and physiological state |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US12059674B2 (en) | 2020-02-03 | 2024-08-13 | Tecan Genomics, Inc. | Reagent storage system |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US20230054204A1 (en) | 2020-02-04 | 2023-02-23 | Pacific Biosciences Of California, Inc. | Flow cells and methods for their manufacture and use |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| WO2021158925A1 (en) | 2020-02-07 | 2021-08-12 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| US11835462B2 (en) | 2020-02-11 | 2023-12-05 | 10X Genomics, Inc. | Methods and compositions for partitioning a biological sample |
| US12449419B1 (en) | 2020-02-12 | 2025-10-21 | 10X Genomics, Inc. | Methods for detecting binding of peptide-MHC monomers to T cells |
| CN115349128A (zh) | 2020-02-13 | 2022-11-15 | 齐默尔根公司 | 宏基因组文库和天然产物发现平台 |
| EP4104179A1 (en) | 2020-02-13 | 2022-12-21 | 10X Genomics, Inc. | Systems and methods for joint interactive visualization of gene expression and dna chromatin accessibility |
| US12399123B1 (en) | 2020-02-14 | 2025-08-26 | 10X Genomics, Inc. | Spatial targeting of analytes |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| IL295297A (en) | 2020-02-14 | 2022-10-01 | Univ Johns Hopkins | Methods and materials for assessing nucleic acids |
| US12354008B2 (en) | 2020-02-20 | 2025-07-08 | Illumina, Inc. | Knowledge distillation and gradient pruning-based compression of artificial intelligence-based base caller |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| US11926863B1 (en) | 2020-02-27 | 2024-03-12 | 10X Genomics, Inc. | Solid state single cell method for analyzing fixed biological cells |
| US11768175B1 (en) | 2020-03-04 | 2023-09-26 | 10X Genomics, Inc. | Electrophoretic methods for spatial analysis |
| CA3175931A1 (en) | 2020-03-16 | 2021-09-23 | Fluent Biosciences Inc. | Multi-omic analysis in monodisperse droplets |
| EP4127058A4 (en) | 2020-03-24 | 2024-04-24 | Fluent Biosciences Inc. | VIRAL DETECTION USING MATRIX EMULSIFICATION |
| WO2021214766A1 (en) | 2020-04-21 | 2021-10-28 | Yeda Research And Development Co. Ltd. | Methods of diagnosing viral infections and vaccines thereto |
| EP4139485B1 (en) | 2020-04-22 | 2023-09-06 | 10X Genomics, Inc. | Methods for spatial analysis using targeted rna depletion |
| WO2021224677A1 (en) | 2020-05-05 | 2021-11-11 | Akershus Universitetssykehus Hf | Compositions and methods for characterizing bowel cancer |
| US11188778B1 (en) | 2020-05-05 | 2021-11-30 | Illumina, Inc. | Equalization-based image processing and spatial crosstalk attenuator |
| EP4146822A1 (en) | 2020-05-05 | 2023-03-15 | Pacific Biosciences of California, Inc. | Compositions and methods for modifying polymerase-nucleic acid complexes |
| US11851700B1 (en) | 2020-05-13 | 2023-12-26 | 10X Genomics, Inc. | Methods, kits, and compositions for processing extracellular molecules |
| WO2021236625A1 (en) | 2020-05-19 | 2021-11-25 | 10X Genomics, Inc. | Electrophoresis cassettes and instrumentation |
| WO2021237087A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
| WO2021236929A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
| CA3179313A1 (en) | 2020-05-27 | 2021-12-02 | Gillian Sue Dite | Methods of assessing risk of developing a severe response to coronavirus infection |
| US12265079B1 (en) | 2020-06-02 | 2025-04-01 | 10X Genomics, Inc. | Systems and methods for detecting analytes from captured single biological particles |
| AU2021283174A1 (en) | 2020-06-02 | 2023-01-05 | 10X Genomics, Inc. | Nucleic acid library methods |
| EP4600376A3 (en) | 2020-06-02 | 2025-10-22 | 10X Genomics, Inc. | Spatial transcriptomics for antigen-receptors |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| EP4162075A4 (en) | 2020-06-08 | 2024-06-26 | The Broad Institute, Inc. | Single cell combinatorial indexing from amplified nucleic acids |
| US12435363B1 (en) | 2020-06-10 | 2025-10-07 | 10X Genomics, Inc. | Materials and methods for spatial transcriptomics |
| EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
| AU2021294334A1 (en) | 2020-06-25 | 2023-02-02 | 10X Genomics, Inc. | Spatial analysis of DNA methylation |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| CN115956128A (zh) | 2020-07-08 | 2023-04-11 | 豪夫迈·罗氏有限公司 | 在下一代测序文库的靶捕获过程中使用毒性引物对非靶文库分子进行靶向消耗 |
| CA3189597A1 (en) | 2020-07-15 | 2022-01-20 | Fluent Biosciences Inc. | Tiered ligation oligos |
| EP4185301A4 (en) | 2020-07-24 | 2025-05-07 | The Regents Of The University Of Michigan | Compositions and methods for detecting and treating high grade subtypes of uterine cancer |
| EP4121557A4 (en) | 2020-08-06 | 2024-05-01 | Singular Genomics Systems, Inc. | Spatial sequencing |
| US11492662B2 (en) | 2020-08-06 | 2022-11-08 | Singular Genomics Systems, Inc. | Methods for in situ transcriptomics and proteomics |
| US20220049303A1 (en) | 2020-08-17 | 2022-02-17 | Readcoor, Llc | Methods and systems for spatial mapping of genetic variants |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| EP4491742A3 (en) | 2020-09-18 | 2025-05-21 | 10x Genomics, Inc. | Sample handling apparatus and image registration methods |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| IL301694A (en) | 2020-10-15 | 2023-05-01 | Univ Leland Stanford Junior | Detection and analysis of structural variations in genomes |
| EP4240868A4 (en) * | 2020-11-03 | 2024-11-13 | Illumina, Inc. | METHODS AND SYSTEMS FOR DETECTING PATHOGENIC MICROBES IN A PATIENT |
| US12084715B1 (en) | 2020-11-05 | 2024-09-10 | 10X Genomics, Inc. | Methods and systems for reducing artifactual antisense products |
| US12480158B1 (en) | 2020-11-05 | 2025-11-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11959074B2 (en) * | 2020-11-14 | 2024-04-16 | Life Technologies Corporation | System and method for automated repeat sequencing |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| KR102795708B1 (ko) | 2020-11-27 | 2025-04-16 | 주식회사 지씨지놈 | 인공지능 기반 암 진단 및 암 종 예측방법 |
| EP4257666A4 (en) * | 2020-12-04 | 2024-11-20 | Yamaguchi University | Nucleic acid amplification method and thermal cycler |
| AU2021409136A1 (en) | 2020-12-21 | 2023-06-29 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| CA3204784A1 (en) | 2021-01-13 | 2022-07-21 | Alex Nemiroski | Surface structuring with colloidal assembly |
| US12398262B1 (en) | 2021-01-22 | 2025-08-26 | 10X Genomics, Inc. | Triblock copolymer-based cell stabilization and fixation system and methods of use thereof |
| WO2022174054A1 (en) | 2021-02-13 | 2022-08-18 | The General Hospital Corporation | Methods and compositions for in situ macromolecule detection and uses thereof |
| EP4294571B8 (en) | 2021-02-19 | 2024-07-10 | 10X Genomics, Inc. | Method of using a modular assay support device |
| EP4298244A1 (en) | 2021-02-23 | 2024-01-03 | 10X Genomics, Inc. | Probe-based analysis of nucleic acids and proteins |
| EP4301870B1 (en) | 2021-03-18 | 2025-01-15 | 10X Genomics, Inc. | Multiplex capture of gene and protein expression from a biological sample |
| US20220333178A1 (en) | 2021-03-22 | 2022-10-20 | Illumina Cambridge Limited | Methods for improving nucleic acid cluster clonality |
| WO2022208171A1 (en) | 2021-03-31 | 2022-10-06 | UCL Business Ltd. | Methods for analyte detection |
| EP4305196B1 (en) | 2021-04-14 | 2025-04-02 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| US12176070B2 (en) * | 2021-04-19 | 2024-12-24 | University Of Utah Research Foundation | Systems and methods for facilitating rapid genome sequence analysis |
| WO2022236054A1 (en) | 2021-05-06 | 2022-11-10 | 10X Genomics, Inc. | Methods for increasing resolution of spatial analysis |
| WO2022240555A1 (en) | 2021-05-14 | 2022-11-17 | Pluton Biosciences, Inc. | Chryseobacterium insect inhibitory microbial compositions and methods of making and using |
| KR20220160806A (ko) | 2021-05-28 | 2022-12-06 | 주식회사 지씨지놈 | 세포유리 핵산단편 말단 서열 모티프 빈도 및 크기를 이용한 암 진단 및 암 종 예측방법 |
| WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| EP4355476A1 (en) | 2021-06-15 | 2024-04-24 | Illumina, Inc. | Hydrogel-free surface functionalization for sequencing |
| US11859241B2 (en) | 2021-06-17 | 2024-01-02 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
| US11535892B1 (en) | 2021-06-17 | 2022-12-27 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
| CN113174388B (zh) * | 2021-06-28 | 2021-09-10 | 中国农业大学 | 一种功能核酸纳米杆与功能核酸纳米花的制备及形貌转换方法 |
| WO2023003757A1 (en) | 2021-07-19 | 2023-01-26 | Illumina Software, Inc. | Intensity extraction with interpolation and adaptation for base calling |
| US11455487B1 (en) | 2021-10-26 | 2022-09-27 | Illumina Software, Inc. | Intensity extraction and crosstalk attenuation using interpolation and adaptation for base calling |
| CA3226451A1 (en) | 2021-07-21 | 2023-01-26 | Sam Reed | Method and system comprising a cartridge for sequencing target polynucleotides |
| GB202110479D0 (en) | 2021-07-21 | 2021-09-01 | Dnae Diagnostics Ltd | Compositions, kits and methods for sequencing target polynucleotides |
| GB202110485D0 (en) | 2021-07-21 | 2021-09-01 | Dnae Diagnostics Ltd | Compositions, kits and methods for sequencing target polynucleotides |
| EP4373958A1 (en) | 2021-07-23 | 2024-05-29 | Illumina, Inc. | Methods for preparing substrate surface for dna sequencing |
| CA3229536A1 (en) * | 2021-08-20 | 2023-02-23 | Florian OBERSTRASS | Systems and methods for sample preparation for sequencing |
| EP4344443A1 (en) | 2021-08-31 | 2024-04-03 | Illumina, Inc. | Flow cell with enhanced well imaging resolution |
| EP4196605B1 (en) | 2021-09-01 | 2024-12-04 | 10X Genomics, Inc. | Methods for blocking a capture probe on a spatial array |
| WO2023049215A1 (en) | 2021-09-22 | 2023-03-30 | Illumina, Inc. | Compressed state-based base calling |
| WO2023059654A1 (en) | 2021-10-05 | 2023-04-13 | Personalis, Inc. | Customized assays for personalized cancer monitoring |
| WO2023069927A1 (en) | 2021-10-20 | 2023-04-27 | Illumina, Inc. | Methods for capturing library dna for sequencing |
| WO2023070567A1 (zh) * | 2021-10-29 | 2023-05-04 | 京东方科技集团股份有限公司 | 检测芯片及其制备方法 |
| EP4426489A2 (en) * | 2021-11-03 | 2024-09-11 | Abbott Laboratories | Systems and methods for sample analysis |
| WO2023086880A1 (en) | 2021-11-10 | 2023-05-19 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| WO2023102118A2 (en) | 2021-12-01 | 2023-06-08 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
| WO2023108014A1 (en) | 2021-12-07 | 2023-06-15 | Luminex Corporation | Methods and compositions for nucleic acid analysis |
| WO2023114190A1 (en) * | 2021-12-13 | 2023-06-22 | Cz Biohub Sf, Inc. | Single-cell epigenomic profiling using fluidics and hydrogels |
| EP4441711A1 (en) | 2021-12-20 | 2024-10-09 | 10X Genomics, Inc. | Self-test for pathology/histology slide imaging device |
| WO2023122363A1 (en) | 2021-12-23 | 2023-06-29 | Illumina Software, Inc. | Dynamic graphical status summaries for nucelotide sequencing |
| US20230215515A1 (en) | 2021-12-23 | 2023-07-06 | Illumina Software, Inc. | Facilitating secure execution of external workflows for genomic sequencing diagnostics |
| AU2022425440A1 (en) | 2021-12-29 | 2024-07-11 | Illumina, Inc. | Automatically switching variant analysis model versions for genomic analysis applications |
| EP4463568A1 (en) | 2022-01-13 | 2024-11-20 | Oslo Universitetssykehus HF | Prostate cancer markers and uses thereof |
| WO2023141154A1 (en) | 2022-01-20 | 2023-07-27 | Illumina Cambridge Limited | Methods of detecting methylcytosine and hydroxymethylcytosine by sequencing |
| WO2023152568A2 (en) | 2022-02-10 | 2023-08-17 | Oslo Universitetssykehus Hf | Compositions and methods for characterizing lung cancer |
| US20230343414A1 (en) | 2022-03-25 | 2023-10-26 | Illumina, Inc. | Sequence-to-sequence base calling |
| CN114592023B (zh) * | 2022-03-31 | 2023-03-24 | 杭州优玛达生物科技有限公司 | 一种细胞裂解自组装多肽复合物、自组装方法、自组装多肽制剂及应用 |
| EP4253550A1 (en) | 2022-04-01 | 2023-10-04 | GenCC GmbH 6 Co. KG | Method for the manufacture of a viral system, a vector system or any transport system for cancer-specific crispr complexes |
| US20230392201A1 (en) | 2022-06-06 | 2023-12-07 | Element Biosciences, Inc. | Methods for assembling and reading nucleic acid sequences from mixed populations |
| CN119317964A (zh) | 2022-06-09 | 2025-01-14 | 因美纳有限公司 | 碱基检出对流通池倾斜的依赖 |
| WO2024050450A1 (en) | 2022-08-31 | 2024-03-07 | Gigamune, Inc. | Engineered enveloped vectors and methods of use thereof |
| US20240133892A1 (en) | 2022-09-27 | 2024-04-25 | Nautilus Subsidiary, Inc. | Polypeptide capture, in situ fragmentation and identification |
| US12373579B2 (en) | 2022-11-09 | 2025-07-29 | Bank Of America Corporation | Data processing and storage using quantum and DNA computing |
| CN121127582A (zh) | 2022-12-05 | 2025-12-12 | 特韦斯特生物科学公司 | 用于文库制备的酶 |
| WO2024129672A1 (en) | 2022-12-12 | 2024-06-20 | The Broad Institute, Inc. | Trafficked rnas for assessment of cell-cell connectivity and neuroanatomy |
| WO2024129969A1 (en) | 2022-12-14 | 2024-06-20 | Illumina, Inc. | Systems and methods for capture and enrichment of clustered beads on flow cell substrates |
| WO2024220475A1 (en) | 2023-04-21 | 2024-10-24 | Twist Bioscience Corporation | Polymerase variants |
| WO2024249961A1 (en) | 2023-06-01 | 2024-12-05 | Singular Genomics Systems, Inc. | Methods and probes for detecting polynucleotide sequences in cells and tissues |
| US20250140346A1 (en) | 2023-10-30 | 2025-05-01 | Myriad Women's Health, Inc. | Sensitivity of tumor-informed minimal residual disease panels |
| US20250140343A1 (en) | 2023-10-30 | 2025-05-01 | Myriad Women's Health, Inc. | Methods for improving minimal residual disease assays |
| US20250137038A1 (en) | 2023-10-30 | 2025-05-01 | Myriad Women's Health, Inc. | Sensitivity and estimation of tumor-informed minimal residual disease panels |
| US20250137061A1 (en) | 2023-10-30 | 2025-05-01 | Myriad Women's Health, Inc. | Methods for detection and quantitation of circulating tumor dna |
| US20250137064A1 (en) | 2023-10-30 | 2025-05-01 | Myriad Women's Health, Inc. | Use of multi-nucleotide and structural variants for improved sensitivity and specificity of circulating tumor dna assays |
| WO2025104619A1 (en) | 2023-11-13 | 2025-05-22 | Oslo Universitetssykehus Hf | Breast cancer markers and uses thereof |
| US20250320550A1 (en) | 2024-04-12 | 2025-10-16 | Robert Bosch Gmbh | Sequencing by synthesis using electroactively labeled 3-oh-modified nucleotides |
| WO2025240460A2 (en) | 2024-05-14 | 2025-11-20 | Roche Molecular Systems, Inc. | Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic agent |
| WO2025240905A1 (en) | 2024-05-17 | 2025-11-20 | The Broad Institute, Inc. | Imaging-free high-resolution spatial macromolecule abundance reconstruction |
Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506100A (en) * | 1990-10-11 | 1996-04-09 | Indiana University Foundation | Process and apparatus for fragmenting biomaterials |
| US5508169A (en) * | 1990-04-06 | 1996-04-16 | Queen's University At Kingston | Indexing linkers |
| US5610010A (en) * | 1990-10-11 | 1997-03-11 | Indiana University Foundation | Process and apparatus for fragmenting biomaterials |
| US5629158A (en) * | 1989-03-22 | 1997-05-13 | Cemu Bitecknik Ab | Solid phase diagnosis of medical conditions |
| US5728524A (en) * | 1992-07-13 | 1998-03-17 | Medical Research Counsil | Process for categorizing nucleotide sequence populations |
| US5814444A (en) * | 1995-06-07 | 1998-09-29 | University Of Washington | Methods for making and using single-chromosome amplfication libraries |
| US5863722A (en) * | 1994-10-13 | 1999-01-26 | Lynx Therapeutics, Inc. | Method of sorting polynucleotides |
| US5989892A (en) * | 1995-06-14 | 1999-11-23 | Tonen Corporation | Microorganisms, demulsifiers and processes for breaking an emulsion |
| US5994068A (en) * | 1997-03-11 | 1999-11-30 | Wisconsin Alumni Research Foundation | Nucleic acid indexing |
| US6004783A (en) * | 1994-03-18 | 1999-12-21 | The General Hospital Corporation | Cleaved amplified RFLP detection methods |
| US6023540A (en) * | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
| US6060245A (en) * | 1996-12-13 | 2000-05-09 | Stratagene | Methods and adaptors for generating specific nucleic acid populations |
| US6184012B1 (en) * | 1996-04-25 | 2001-02-06 | Medical Research Council | Isolation of enzymes |
| US6270966B1 (en) * | 1996-02-09 | 2001-08-07 | The United States Of America As Represented By The Department Of Health And Human Services | Restriction display (RD-PCR) of differentially expressed mRNAs |
| US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
| US6287825B1 (en) * | 1998-09-18 | 2001-09-11 | Molecular Staging Inc. | Methods for reducing the complexity of DNA sequences |
| US6468748B1 (en) * | 1996-03-04 | 2002-10-22 | Sequenom, Inc. | Methods of screening nucleic acids using volatile salts in mass spectrometry |
| US6475736B1 (en) * | 2000-05-23 | 2002-11-05 | Variagenics, Inc. | Methods for genetic analysis of DNA using biased amplification of polymorphic sites |
| US6489103B1 (en) * | 1997-07-07 | 2002-12-03 | Medical Research Council | In vitro sorting method |
Family Cites Families (255)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4175054A (en) | 1976-11-11 | 1979-11-20 | Petrolite Corporation | Use of hydrocarbon polymers in demulsification |
| US5821058A (en) | 1984-01-16 | 1998-10-13 | California Institute Of Technology | Automated DNA sequencing technique |
| US5171534A (en) | 1984-01-16 | 1992-12-15 | California Institute Of Technology | Automated DNA sequencing technique |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801529A (en) * | 1985-06-18 | 1989-01-31 | Brandeis University | Methods for isolating mutant microoganisms using microcapsules coated with indicator material |
| US4863849A (en) | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
| US4811218A (en) | 1986-06-02 | 1989-03-07 | Applied Biosystems, Inc. | Real time scanning electrophoresis apparatus for DNA sequencing |
| US5252494A (en) | 1986-06-25 | 1993-10-12 | Trustees Of Tufts College | Fiber optic sensors, apparatus, and detection methods using controlled release polymers and reagent formulations held within a polymeric reaction matrix |
| US5254477A (en) | 1986-06-25 | 1993-10-19 | Trustees Of Tufts College | Flourescence intramolecular energy transfer conjugate compositions and detection methods |
| US4822746A (en) | 1986-06-25 | 1989-04-18 | Trustees Of Tufts College | Radiative and non-radiative energy transfer and absorbance modulated fluorescence detection methods and sensors |
| US5143853A (en) | 1986-06-25 | 1992-09-01 | Trustees Of Tufts College | Absorbance modulated fluorescence detection methods and sensors |
| US4994372A (en) * | 1987-01-14 | 1991-02-19 | President And Fellows Of Harvard College | DNA sequencing |
| US5525464A (en) | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
| IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Methods and kits for amplification and testing of nucleic acid sequences |
| JP2846018B2 (ja) | 1988-01-21 | 1999-01-13 | ジェネンテク,インコーポレイテッド | 核酸配列の増幅および検出 |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| SE8801070D0 (sv) * | 1988-03-23 | 1988-03-23 | Pharmacia Ab | Method for immobilizing a dna sequence on a solid support |
| US4971903A (en) | 1988-03-25 | 1990-11-20 | Edward Hyman | Pyrophosphate-based method and apparatus for sequencing nucleic acids |
| AU3556789A (en) | 1988-04-22 | 1989-11-24 | Massachusetts Institute Of Technology | Process for forming and using microdroplets |
| US5225332A (en) | 1988-04-22 | 1993-07-06 | Massachusetts Institute Of Technology | Process for manipulation of non-aqueous surrounded microdroplets |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
| US5512439A (en) | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
| US4938876A (en) | 1989-03-02 | 1990-07-03 | Ohsol Ernest O | Method for separating oil and water emulsions |
| JPH02299598A (ja) * | 1989-04-14 | 1990-12-11 | Ro Inst For Molecular Genetics & Geneteic Res | 微視的サイズの別個の粒子と結合している核酸試料中のごく短い配列の全部または一部のオリゴヌクレチドプローブとのハイブリダイゼーションによる決定法 |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5302509A (en) * | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
| US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
| AU638762B2 (en) | 1989-10-05 | 1993-07-08 | Optein Inc | Cell-free synthesis and isolation of novel genes and polypeptides |
| WO1991012342A1 (en) * | 1990-02-16 | 1991-08-22 | F. Hoffmann-La Roche Ag | Improvements in the specificity and convenience of the polymerase chain reaction |
| JPH04223A (ja) * | 1990-04-16 | 1992-01-06 | Toshiba Corp | 無線電話装置、その充電方法および無線電話充電システム |
| US5244636A (en) | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample |
| US5320814A (en) | 1991-01-25 | 1994-06-14 | Trustees Of Tufts College | Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample |
| US5250264A (en) | 1991-01-25 | 1993-10-05 | Trustees Of Tufts College | Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample |
| US5114984A (en) | 1991-04-26 | 1992-05-19 | Olin Corporation | Process for producing an antimicrobially effective polyurethane |
| US5830663A (en) † | 1991-08-10 | 1998-11-03 | Medical Research Council | In situ recombinant PCR within single cells |
| US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| AU2674092A (en) * | 1991-09-09 | 1993-04-05 | Baylor College Of Medicine | Method and device for rapid dna or rna sequencing determination by a base addition sequencing scheme |
| EP0534858B2 (en) * | 1991-09-24 | 2005-04-27 | Keygene N.V. | Selective restriction fragment amplification : a general method for DNA fingerprinting |
| US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| WO1993009668A1 (en) | 1991-11-22 | 1993-05-27 | Affymax Technology N.V. | Combinatorial strategies for polymer synthesis |
| US5445971A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
| GB9208733D0 (en) | 1992-04-22 | 1992-06-10 | Medical Res Council | Dna sequencing method |
| GB9210176D0 (en) | 1992-05-12 | 1992-06-24 | Cemu Bioteknik Ab | Chemical method |
| DE4223169C1 (de) | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
| US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
| RU2048522C1 (ru) | 1992-10-14 | 1995-11-20 | Институт белка РАН | Способ размножения нуклеиновых кислот, способ их экспрессии и среда для их осуществления |
| US5436143A (en) | 1992-12-23 | 1995-07-25 | Hyman; Edward D. | Method for enzymatic synthesis of oligonucleotides |
| IL104384A (en) | 1993-01-13 | 1996-11-14 | Yeda Res & Dev | Method for screening catalytic non-enzyme polypeptides and proteins |
| US5298741A (en) | 1993-01-13 | 1994-03-29 | Trustees Of Tufts College | Thin film fiber optic sensor array and apparatus for concurrent viewing and chemical sensing of a sample |
| IL108497A0 (en) | 1993-02-01 | 1994-05-30 | Seq Ltd | Methods and apparatus for dna sequencing |
| US5436149A (en) | 1993-02-19 | 1995-07-25 | Barnes; Wayne M. | Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension |
| US5714320A (en) | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
| EP0695368A4 (en) | 1993-04-19 | 1996-05-08 | Stuart A Kauffman | RANDOM PROCESS FOR PRODUCING NEW CHEMICAL COMPOUNDS |
| NZ265818A (en) | 1993-04-19 | 1997-09-22 | Medisorb Technologies Internat | Compositions of nucleic acids encapsulated with molecules that facilitate uptake and integration into living cells |
| GB9315847D0 (en) | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
| US5482845A (en) | 1993-09-24 | 1996-01-09 | The Trustees Of Columbia University In The City Of New York | Method for construction of normalized cDNA libraries |
| US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
| PT725682E (pt) * | 1993-10-28 | 2002-09-30 | Houston Advanced Res Ct | Dispositivo poroso microfabricado de escoamento |
| AU8124694A (en) | 1993-10-29 | 1995-05-22 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| GB9401833D0 (en) | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
| US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| EP0804249A2 (en) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeric gene delivery system |
| JP2556293B2 (ja) | 1994-06-09 | 1996-11-20 | 日本電気株式会社 | Mos ota |
| US5512490A (en) | 1994-08-11 | 1996-04-30 | Trustees Of Tufts College | Optical sensor, optical sensing apparatus, and methods for detecting an analyte of interest using spectral recognition patterns |
| US5604097A (en) * | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
| WO1998053300A2 (en) | 1997-05-23 | 1998-11-26 | Lynx Therapeutics, Inc. | System and apparaus for sequential processing of analytes |
| US6013445A (en) | 1996-06-06 | 2000-01-11 | Lynx Therapeutics, Inc. | Massively parallel signature sequencing by ligation of encoded adaptors |
| US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
| FR2726286B1 (fr) | 1994-10-28 | 1997-01-17 | Genset Sa | Procede d'amplification d'acides nucleiques en phase solide et trousse de reactifs utile pour la mise en oeuvre de ce procede |
| US5919673A (en) | 1995-03-22 | 1999-07-06 | The Scripps Research Institute | One-pot enzymatic sulfation process using 3'-phosphoadenosine-5'-phosphosulfate and recycled phosphorylated adenosine intermediates |
| DE69621507T2 (de) * | 1995-03-28 | 2003-01-09 | Japan Science And Technology Corp., Kawaguchi | Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen |
| GB9507238D0 (en) | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
| US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
| CA2219136A1 (en) | 1995-04-24 | 1996-10-31 | Chromaxome Corp. | Methods for generating and screening novel metabolic pathways |
| US5648245A (en) | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
| DE19518505A1 (de) * | 1995-05-19 | 1996-11-21 | Max Planck Gesellschaft | Verfahren zur Genexpressionsanalyse |
| US5690894A (en) | 1995-05-23 | 1997-11-25 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
| US5910408A (en) | 1995-06-07 | 1999-06-08 | The General Hospital Corporation | Catalytic DNA having ligase activity |
| US5728529A (en) | 1995-06-23 | 1998-03-17 | Baylor College Of Medicine | Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis |
| US6200737B1 (en) | 1995-08-24 | 2001-03-13 | Trustees Of Tufts College | Photodeposition method for fabricating a three-dimensional, patterned polymer microstructure |
| US5843655A (en) | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
| US5871697A (en) | 1995-10-24 | 1999-02-16 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
| DE19646372C1 (de) | 1995-11-11 | 1997-06-19 | Evotec Biosystems Gmbh | Genotyp und Phänotyp koppelnde Verbindung |
| US5962228A (en) | 1995-11-17 | 1999-10-05 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
| US5780231A (en) | 1995-11-17 | 1998-07-14 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
| ATE199572T1 (de) | 1995-11-21 | 2001-03-15 | Univ Yale | Unimolekulare segmentamplifikation und bestimmung |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US5633972A (en) | 1995-11-29 | 1997-05-27 | Trustees Of Tufts College | Superresolution imaging fiber for subwavelength light energy generation and near-field optical microscopy |
| US5814524A (en) | 1995-12-14 | 1998-09-29 | Trustees Of Tufts College | Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations |
| US5837196A (en) | 1996-01-26 | 1998-11-17 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
| US5851772A (en) | 1996-01-29 | 1998-12-22 | University Of Chicago | Microchip method for the enrichment of specific DNA sequences |
| US5712127A (en) | 1996-04-29 | 1998-01-27 | Genescape Inc. | Subtractive amplification |
| US5770637A (en) * | 1996-05-01 | 1998-06-23 | Johnson & Johnson Vision Products, Inc. | Anti-bacterial, UV absorbable, tinted, metal-chelating polymers |
| US6022688A (en) * | 1996-05-13 | 2000-02-08 | Sequenom, Inc. | Method for dissociating biotin complexes |
| CA2256700A1 (en) * | 1996-06-06 | 1997-12-11 | Lynx Therapeutics, Inc. | Sequencing by ligation of encoded adaptors |
| US5846727A (en) | 1996-06-06 | 1998-12-08 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Microsystem for rapid DNA sequencing |
| US6083693A (en) | 1996-06-14 | 2000-07-04 | Curagen Corporation | Identification and comparison of protein-protein interactions that occur in populations |
| US5916524A (en) | 1997-07-23 | 1999-06-29 | Bio-Dot, Inc. | Dispensing apparatus having improved dynamic range |
| GB9618050D0 (en) | 1996-08-29 | 1996-10-09 | Cancer Res Campaign Tech | Global amplification of nucleic acids |
| US5846721A (en) | 1996-09-19 | 1998-12-08 | The Trustees Of Columbia University In The City Of New York | Efficient and simpler method to construct normalized cDNA libraries with improved representations of full-length cDNAs |
| GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
| CA2236867A1 (en) | 1996-09-27 | 1998-04-02 | Icos Corporation | Method to identify compounds for disrupting protein/protein interactions |
| US6124092A (en) | 1996-10-04 | 2000-09-26 | The Perkin-Elmer Corporation | Multiplex polynucleotide capture methods and compositions |
| US6133436A (en) | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
| EP0937097B1 (en) | 1996-11-06 | 2001-08-16 | Sequenom, Inc. | Compositions and methods for immobilizing nucleic acids to solid supports |
| US5900481A (en) | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
| US6887665B2 (en) | 1996-11-14 | 2005-05-03 | Affymetrix, Inc. | Methods of array synthesis |
| DE19648372A1 (de) | 1996-11-22 | 1998-05-28 | Serck Como Gmbh | Verfahren und Vorrichtung zum Eindampfen von Abwässern |
| WO1998023733A2 (en) | 1996-11-27 | 1998-06-04 | University Of Washington | Thermostable polymerases having altered fidelity |
| US6310354B1 (en) * | 1996-12-03 | 2001-10-30 | Erkki Soini | Method and a device for monitoring nucleic acid amplification reactions |
| US20020172965A1 (en) * | 1996-12-13 | 2002-11-21 | Arcaris, Inc. | Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom |
| GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
| KR100566859B1 (ko) | 1997-01-21 | 2006-04-03 | 제너럴 하스피톨 코포레이션 | Rna-단백질 융합물을 이용한 단백질의 선별 |
| CA2196496A1 (en) | 1997-01-31 | 1998-07-31 | Stephen William Watson Michnick | Protein fragment complementation assay for the detection of protein-protein interactions |
| US6136543A (en) | 1997-01-31 | 2000-10-24 | Hitachi, Ltd. | Method for determining nucleic acids base sequence and apparatus therefor |
| ATE273381T1 (de) | 1997-02-12 | 2004-08-15 | Eugene Y Chan | Verfahren zur analyse von polymeren |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| AU6571598A (en) | 1997-03-18 | 1998-10-12 | Chromaxome Corporation | Methods for screening compounds using encapsulated cells |
| US5891477A (en) * | 1997-03-28 | 1999-04-06 | Biohybrid Technologies, Inc. | Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| EP0975802B1 (en) * | 1997-04-01 | 2004-06-23 | Manteia S.A. | Method of nucleic acid sequencing |
| ATE364718T1 (de) * | 1997-04-01 | 2007-07-15 | Solexa Ltd | Verfahren zur vervielfältigung von nukleinsäure |
| US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
| US6406845B1 (en) | 1997-05-05 | 2002-06-18 | Trustees Of Tuft College | Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample |
| ES2163271T3 (es) * | 1997-05-13 | 2002-01-16 | Azign Bioscience As | Procedimiento para clonar arnm y visualizar transcriptores diferencialmente expresados (dodets). |
| IL133411A (en) | 1997-07-28 | 2003-09-17 | Medical Biosystems Ltd | Nucleic acid sequence analysis |
| JP3610231B2 (ja) * | 1997-08-01 | 2005-01-12 | キヤノン株式会社 | 反応場アレー、反応場アレーの製造方法、反応場アレーを用いた反応方法及び反応場アレーを用いた試料溶液中の物質の定量方法 |
| EP0895083B1 (en) | 1997-08-01 | 2009-09-23 | Canon Kabushiki Kaisha | Reaction site array, preparation of it, reaction process using it and quantitative determination method of substance in sample solution using it |
| EP0990049A1 (en) | 1997-08-07 | 2000-04-05 | Curagen Corporation | Detection and confirmation of nucleic acid sequences by use of oligonucleotides comprising a subsequence hybridizing exactly to a known terminal sequence and a subsequence hybridizing to an unidentified sequence |
| US5961228A (en) * | 1997-08-22 | 1999-10-05 | Paxar Corporation | Modular printer |
| US20010006630A1 (en) | 1997-09-02 | 2001-07-05 | Oron Yacoby-Zeevi | Introducing a biological material into a patient |
| US6087099A (en) * | 1997-09-08 | 2000-07-11 | Myriad Genetics, Inc. | Method for sequencing both strands of a double stranded DNA in a single sequencing reaction |
| US6399334B1 (en) | 1997-09-24 | 2002-06-04 | Invitrogen Corporation | Normalized nucleic acid libraries and methods of production thereof |
| US6475722B1 (en) | 1997-12-03 | 2002-11-05 | Curagen Corporation | Surface treatments for DNA processing devices |
| AU1623899A (en) | 1997-12-04 | 1999-06-16 | Packard Bioscience Company | Methods of using probes for analyzing polynucleotide sequence |
| NL1007781C2 (nl) | 1997-12-12 | 1999-06-15 | Packard Instr Bv | Microtiterplaat. |
| AU1926899A (en) | 1997-12-19 | 1999-07-12 | Affymetrix, Inc. | Exploiting genomics in the search for new drugs |
| EP1600512B1 (en) | 1997-12-22 | 2008-05-28 | Hitachi Chemical Co., Ltd. | mRNA purification on microplates |
| WO1999036576A1 (en) | 1998-01-20 | 1999-07-22 | Packard Bioscience Company | Gel pad arrays and methods and systems for making them |
| KR100280219B1 (ko) * | 1998-02-26 | 2001-04-02 | 이수빈 | 삼핵산 반복 서열을 이용한 신경정신 질환의 진단 방법 및 진단 시약 |
| US5882874A (en) | 1998-02-27 | 1999-03-16 | The Trustees Of Columbia University In The City Of New York | Reciprocal subtraction differential display |
| US6210910B1 (en) | 1998-03-02 | 2001-04-03 | Trustees Of Tufts College | Optical fiber biosensor array comprising cell populations confined to microcavities |
| US6378527B1 (en) | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
| WO1999053102A1 (en) | 1998-04-16 | 1999-10-21 | Packard Bioscience Company | Analysis of polynucleotide sequence |
| AU3572799A (en) * | 1998-04-24 | 1999-11-16 | Genova Pharmaceuticals Corporation | Function-based gene discovery |
| EP1428810A3 (en) | 1998-05-15 | 2004-07-14 | Oxford Gene Technology IP Limited | Libraries of oligomers labelled with different tags |
| GB9811403D0 (en) | 1998-05-27 | 1998-07-22 | Isis Innovation | Polynucleotide multimers and their use in hybridisation assays |
| GB9813216D0 (en) | 1998-06-18 | 1998-08-19 | Pyrosequencing Ab | Reaction monitoring systems |
| CA2335951C (en) | 1998-06-24 | 2013-07-30 | Mark S. Chee | Decoding of array sensors with microspheres |
| JP2981547B1 (ja) * | 1998-07-02 | 1999-11-22 | 農林水産省食品総合研究所長 | クロスフロー型マイクロチャネル装置及び同装置を用いたエマルションの生成または分離方法 |
| WO2000004139A1 (en) | 1998-07-17 | 2000-01-27 | Mirus Corporation | Micellar systems |
| DE69928265T3 (de) | 1998-07-30 | 2013-11-28 | Illumina Cambridge Ltd. | Matrizen von biomolekülen und ihre verwendung in sequenzierung |
| US6263286B1 (en) | 1998-08-13 | 2001-07-17 | U.S. Genomics, Inc. | Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer |
| US6210896B1 (en) | 1998-08-13 | 2001-04-03 | Us Genomics | Molecular motors |
| GB9820185D0 (en) | 1998-09-15 | 1998-11-11 | Dynal As | Method |
| US6203989B1 (en) | 1998-09-30 | 2001-03-20 | Affymetrix, Inc. | Methods and compositions for amplifying detectable signals in specific binding assays |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| CA2348696A1 (en) | 1998-11-06 | 2000-05-18 | Solexa Ltd. | A method for reproducing molecular arrays |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| WO2000039343A1 (en) * | 1998-12-31 | 2000-07-06 | City Of Hope | Method for detecting mutations in nucleic acids |
| GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
| GB9901475D0 (en) | 1999-01-22 | 1999-03-17 | Pyrosequencing Ab | A method of DNA sequencing |
| WO2000044491A2 (en) | 1999-01-29 | 2000-08-03 | Illumina, Inc. | Centrifuging apparatus and method for separation of liquid phases and organic synthesis |
| US20020150909A1 (en) * | 1999-02-09 | 2002-10-17 | Stuelpnagel John R. | Automated information processing in randomly ordered arrays |
| JP2002536665A (ja) | 1999-02-09 | 2002-10-29 | イルミナ インコーポレイテッド | ランダムに並んだアレイにおける自動情報処理 |
| WO2000048000A1 (en) | 1999-02-09 | 2000-08-17 | Illumina, Inc. | Intrabead screening methods and compositions |
| AU779231B2 (en) * | 1999-02-22 | 2005-01-13 | Lynx Therapeutics, Inc. | Polymorphic DNA fragments and uses thereof |
| US6255476B1 (en) | 1999-02-22 | 2001-07-03 | Pe Corporation (Ny) | Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports |
| US6225061B1 (en) | 1999-03-10 | 2001-05-01 | Sequenom, Inc. | Systems and methods for performing reactions in an unsealed environment |
| AU3174600A (en) * | 1999-03-10 | 2000-09-28 | Asm Scientific, Inc. | A method for direct nucleic acid sequencing |
| JP2004512807A (ja) * | 1999-03-18 | 2004-04-30 | コンプリート ゲノミックス エイエス | 可読情報を有するフラグメント鎖のクローニングおよび生成方法 |
| GB9906477D0 (en) | 1999-03-19 | 1999-05-12 | Pyrosequencing Ab | Liquid dispensing apparatus |
| US6506594B1 (en) | 1999-03-19 | 2003-01-14 | Cornell Res Foundation Inc | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| WO2000058507A1 (en) | 1999-03-30 | 2000-10-05 | Solexa Ltd. | Polynucleotide sequencing |
| GB9907813D0 (en) | 1999-04-06 | 1999-06-02 | Medical Biosystems Ltd | Synthesis |
| GB9907812D0 (en) | 1999-04-06 | 1999-06-02 | Medical Biosystems Ltd | Sequencing |
| US6284465B1 (en) * | 1999-04-15 | 2001-09-04 | Agilent Technologies, Inc. | Apparatus, systems and method for locating nucleic acids bound to surfaces |
| ATE413467T1 (de) | 1999-04-20 | 2008-11-15 | Illumina Inc | Detektion von nukleinsäurereaktionen auf kügelchen-arrays |
| US20030108867A1 (en) | 1999-04-20 | 2003-06-12 | Chee Mark S | Nucleic acid sequencing using microsphere arrays |
| US6355431B1 (en) * | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
| US6221653B1 (en) | 1999-04-27 | 2001-04-24 | Agilent Technologies, Inc. | Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids |
| WO2000071992A1 (en) | 1999-05-20 | 2000-11-30 | Illumina, Inc. | Method and apparatus for retaining and presenting at least one microsphere array to solutions and/or to optical imaging systems |
| US6544732B1 (en) | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
| EP2360270B1 (en) | 1999-05-20 | 2016-11-09 | Illumina, Inc. | Combinatorial decoding of random nucleic acid arrays |
| US20020051971A1 (en) | 1999-05-21 | 2002-05-02 | John R. Stuelpnagel | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
| US6300070B1 (en) * | 1999-06-04 | 2001-10-09 | Mosaic Technologies, Inc. | Solid phase methods for amplifying multiple nucleic acids |
| US6340589B1 (en) | 1999-07-23 | 2002-01-22 | Mj Research, Inc. | Thin-well microplate and methods of making same |
| US6942968B1 (en) | 1999-08-30 | 2005-09-13 | Illumina, Inc. | Array compositions for improved signal detection |
| GB9921155D0 (en) | 1999-09-08 | 1999-11-10 | Medical Res Council | Selection system |
| US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| GB9923324D0 (en) | 1999-10-01 | 1999-12-08 | Pyrosequencing Ab | Separation apparatus and method |
| GB9923644D0 (en) | 1999-10-06 | 1999-12-08 | Medical Biosystems Ltd | DNA sequencing |
| GB9929381D0 (en) | 1999-12-10 | 2000-02-09 | Pyrosequencing Ab | A method of assessing the amount of nucleic acid in a sample |
| AU2438501A (en) | 1999-12-21 | 2001-07-03 | Government Of The United States Of America, As Represented By The Secretary Of The Navy, The | Expression of proteins from amplified, immobilized nucleic acids |
| DE60041150D1 (de) | 1999-12-23 | 2009-01-29 | Illumina Inc | Dekodierung von matrixsensoren mit mikrokugeln |
| JP4860869B2 (ja) * | 1999-12-29 | 2012-01-25 | オックスフォード ジーン テクノロジー アイピー リミティド | 固相支持体上の複数のポリヌクレオチドを増幅し、検出する方法 |
| WO2001053532A2 (en) | 2000-01-20 | 2001-07-26 | Rosetta Inpharmatics, Inc. | Barcoded synthetic lethal screening to identify drug targets |
| CA2401962A1 (en) | 2000-02-07 | 2001-08-09 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
| US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
| EP1990428B1 (en) | 2000-02-07 | 2010-12-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
| WO2001059432A2 (en) | 2000-02-10 | 2001-08-16 | Illumina, Inc. | Array of individual arrays as substrate for bead-based simultaneous processing of samples and manufacturing method therefor |
| EP1967595A3 (en) | 2000-02-16 | 2008-12-03 | Illumina, Inc. | Parallel genotyping of multiple patient samples |
| US6714874B1 (en) * | 2000-03-15 | 2004-03-30 | Applera Corporation | Method and system for the assembly of a whole genome using a shot-gun data set |
| JP3442338B2 (ja) | 2000-03-17 | 2003-09-02 | 株式会社日立製作所 | Dna分析装置、dna塩基配列決定装置、dna塩基配列決定方法、および反応モジュール |
| CN1189159C (zh) * | 2000-05-05 | 2005-02-16 | 欧莱雅 | 含水溶性美容活性组分水性核的微胶囊及含其的组合物 |
| SE0001768D0 (sv) | 2000-05-12 | 2000-05-12 | Helen Andersson | Mikrofluidisk flödescell för manipulering av partiklar |
| US6808874B2 (en) | 2000-06-13 | 2004-10-26 | Cyclacel Ltd. | Methods of monitoring enzyme activity |
| AU2001271662B2 (en) | 2000-06-28 | 2006-07-27 | Illumina, Inc. | Composite arrays utilizing microspheres with a hybridization chamber |
| WO2002012897A2 (en) | 2000-08-09 | 2002-02-14 | Illumina, Inc. | Automated information processing in randomly ordered arrays |
| WO2002016649A2 (en) | 2000-08-25 | 2002-02-28 | Illumina, Inc. | Probes and decoder oligonucleotides |
| WO2002021128A2 (en) | 2000-09-05 | 2002-03-14 | Illumina, Inc. | Cellular arrays comprising encoded cells |
| GB0021977D0 (en) | 2000-09-07 | 2000-10-25 | Pyrosequencing Ab | Method of sequencing DNA |
| GB0022069D0 (en) * | 2000-09-08 | 2000-10-25 | Pyrosequencing Ab | Method |
| GB0022458D0 (en) * | 2000-09-13 | 2000-11-01 | Medical Res Council | Directed evolution method |
| WO2002027029A2 (en) * | 2000-09-27 | 2002-04-04 | Lynx Therapeutics, Inc. | Method for determining relative abundance of nucleic acid sequences |
| US6632610B2 (en) * | 2000-10-12 | 2003-10-14 | Gensat S.A. | Methods of identification and isolation of polynucleotides containing nucleic acid differences |
| US20020172980A1 (en) * | 2000-11-27 | 2002-11-21 | Phan Brigitte Chau | Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems |
| JP2002257070A (ja) | 2001-02-28 | 2002-09-11 | Toyota Industries Corp | 真空ポンプにおける軸封構造 |
| US6936264B2 (en) * | 2001-03-05 | 2005-08-30 | The Procter & Gamble Company | Delivery of reactive agents via multiple emulsions for use in shelf stable products |
| US6996287B1 (en) | 2001-04-20 | 2006-02-07 | Adobe Systems, Inc. | Method and apparatus for texture cloning |
| GB0114856D0 (en) | 2001-06-18 | 2001-08-08 | Medical Res Council | Selection by avidity capture |
| GB0114854D0 (en) * | 2001-06-18 | 2001-08-08 | Medical Res Council | Selective gene amplification |
| US20030096268A1 (en) * | 2001-07-06 | 2003-05-22 | Michael Weiner | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US20030064400A1 (en) * | 2001-08-24 | 2003-04-03 | Li-Cor, Inc. | Microfluidics system for single molecule DNA sequencing |
| US6956114B2 (en) | 2001-10-30 | 2005-10-18 | '454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| US6902921B2 (en) * | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| GB0127564D0 (en) * | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
| EP2196544A1 (en) | 2001-11-21 | 2010-06-16 | Applied Biosystems, LLC | Kit for ligation detection assays using codeable labels |
| US7198897B2 (en) * | 2001-12-19 | 2007-04-03 | Brandeis University | Late-PCR |
| JP4230364B2 (ja) * | 2002-04-04 | 2009-02-25 | バイオタージ アクチボラゲット | 新しい方法 |
| AU2003302770B2 (en) | 2002-12-20 | 2007-07-12 | Caliper Life Sciences, Inc. | Single molecule amplification and detection of DNA |
| EP1583831A2 (en) * | 2003-01-15 | 2005-10-12 | Wyeth | Novel high throughput method of generating and purifying labeled crna targets for gene expression analysis |
| US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
| EP1594950A4 (en) | 2003-01-29 | 2007-07-25 | 454 Corp | PRODUCT FOR THE PREPARATION OF SIMPLE STRANDED DNA BANKS |
| US8150627B2 (en) * | 2003-05-15 | 2012-04-03 | Illumina, Inc. | Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns |
| CA2531105C (en) * | 2003-07-05 | 2015-03-17 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| WO2005073410A2 (en) | 2004-01-28 | 2005-08-11 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| US7785862B2 (en) | 2005-04-07 | 2010-08-31 | 454 Life Sciences Corporation | Thin film coated microwell arrays |
| US7682816B2 (en) | 2005-04-07 | 2010-03-23 | 454 Life Sciences Corporation | Thin film coated microwell arrays and methods of using same |
| CA2615323A1 (en) | 2005-06-06 | 2007-12-21 | 454 Life Sciences Corporation | Paired end sequencing |
| EP2002367B1 (en) | 2006-02-16 | 2017-03-29 | 454 Life Sciences Corporation | System and method for correcting primer extension errors in nucleic acid sequence data |
| US8364417B2 (en) | 2007-02-15 | 2013-01-29 | 454 Life Sciences Corporation | System and method to correct out of phase errors in DNA sequencing data by use of a recursive algorithm |
| CN101506378A (zh) | 2006-06-19 | 2009-08-12 | 约翰·霍普金斯大学 | 在油包水乳液中的微粒上的单分子pcr |
| WO2008011621A2 (en) | 2006-07-21 | 2008-01-24 | The Penn State Research Foundation | Protein kinase c zeta inhibition to treat vascular permeability |
| US8617816B2 (en) | 2007-03-16 | 2013-12-31 | 454 Life Sciences, A Roche Company | System and method for detection of HIV drug resistant variants |
| EP3404009B1 (en) | 2017-05-16 | 2019-12-25 | Arkema France | Method for manufacturing 1,4-bis(4-phenoxybenzoyl)benzene in supersaturation conditions |
-
2004
- 2004-01-28 EP EP04706080A patent/EP1594950A4/en not_active Withdrawn
- 2004-01-28 JP JP2006532273A patent/JP4473878B2/ja not_active Expired - Lifetime
- 2004-01-28 WO PCT/US2004/002570 patent/WO2005003375A2/en not_active Ceased
- 2004-01-28 WO PCT/US2004/002484 patent/WO2004069849A2/en not_active Ceased
- 2004-01-28 EP EP09175588A patent/EP2145955B1/en not_active Expired - Lifetime
- 2004-01-28 CA CA002513541A patent/CA2513541A1/en not_active Abandoned
- 2004-01-28 AT AT04785758T patent/ATE437945T1/de not_active IP Right Cessation
- 2004-01-28 AU AU2004254552A patent/AU2004254552B2/en not_active Expired
- 2004-01-28 CA CA2727850A patent/CA2727850C/en not_active Expired - Lifetime
- 2004-01-28 AT AT04706053T patent/ATE461291T1/de not_active IP Right Cessation
- 2004-01-28 WO PCT/US2004/002485 patent/WO2004070005A2/en not_active Ceased
- 2004-01-28 EP EP08013208A patent/EP1997889A3/en not_active Withdrawn
- 2004-01-28 DE DE602004036672T patent/DE602004036672C5/de not_active Expired - Lifetime
- 2004-01-28 ES ES09166658T patent/ES2396245T3/es not_active Expired - Lifetime
- 2004-01-28 EP EP04706053A patent/EP1594981B1/en not_active Expired - Lifetime
- 2004-01-28 ES ES04706051.2T patent/ES2338654T5/es not_active Expired - Lifetime
- 2004-01-28 AU AU2004209001A patent/AU2004209001B2/en not_active Expired
- 2004-01-28 JP JP2006503133A patent/JP4768598B2/ja not_active Expired - Lifetime
- 2004-01-28 ES ES04785758T patent/ES2330339T3/es not_active Expired - Lifetime
- 2004-01-28 AT AT09175588T patent/ATE546525T1/de active
- 2004-01-28 CN CN2004800086365A patent/CN101128601B/zh not_active Expired - Lifetime
- 2004-01-28 US US10/768,729 patent/US7244567B2/en not_active Expired - Fee Related
- 2004-01-28 AU AU2004209426A patent/AU2004209426B2/en not_active Ceased
- 2004-01-28 CA CA002513889A patent/CA2513889A1/en not_active Abandoned
- 2004-01-28 CA CA2513899A patent/CA2513899C/en not_active Expired - Lifetime
- 2004-01-28 AU AU2004209416A patent/AU2004209416B2/en not_active Ceased
- 2004-01-28 EP EP09166658A patent/EP2159285B1/en not_active Expired - Lifetime
- 2004-01-28 EP EP04785758A patent/EP1590477B1/en not_active Expired - Lifetime
- 2004-01-28 EP EP04706051.2A patent/EP1594980B2/en not_active Expired - Lifetime
- 2004-01-28 JP JP2006503163A patent/JP2007525151A/ja active Pending
- 2004-01-28 ES ES09175588T patent/ES2380893T3/es not_active Expired - Lifetime
- 2004-01-28 DE DE602004026033T patent/DE602004026033D1/de not_active Expired - Lifetime
- 2004-01-28 CA CA2728746A patent/CA2728746C/en not_active Expired - Lifetime
- 2004-01-28 AT AT04706051T patent/ATE448302T1/de not_active IP Right Cessation
- 2004-01-28 EP EP10179652A patent/EP2261372B1/en not_active Expired - Lifetime
- 2004-01-28 ES ES04706053T patent/ES2342665T3/es not_active Expired - Lifetime
- 2004-01-28 DE DE602004022253T patent/DE602004022253D1/de not_active Expired - Lifetime
- 2004-01-28 CN CN2011100799896A patent/CN102212614B/zh not_active Expired - Lifetime
- 2004-01-28 US US10/767,894 patent/US20040185484A1/en not_active Abandoned
- 2004-01-28 JP JP2006503134A patent/JP4480715B2/ja not_active Expired - Fee Related
- 2004-01-28 CA CA2513535A patent/CA2513535C/en not_active Expired - Lifetime
- 2004-01-28 US US10/767,899 patent/US7842457B2/en not_active Expired - Lifetime
- 2004-01-28 DE DE602004024034T patent/DE602004024034D1/de not_active Expired - Lifetime
- 2004-01-28 US US10/767,779 patent/US7323305B2/en not_active Expired - Lifetime
- 2004-01-28 WO PCT/US2004/002571 patent/WO2004070007A2/en not_active Ceased
-
2007
- 2007-04-20 US US11/788,838 patent/US8790876B2/en not_active Expired - Lifetime
- 2007-10-31 US US11/982,095 patent/US8012690B2/en not_active Expired - Lifetime
-
2008
- 2008-05-27 US US12/154,901 patent/US20090011959A1/en not_active Abandoned
-
2009
- 2009-12-28 JP JP2009297745A patent/JP2010142233A/ja active Pending
-
2010
- 2010-03-10 JP JP2010053827A patent/JP5258822B2/ja not_active Expired - Lifetime
- 2010-06-24 US US12/803,362 patent/US8158359B2/en not_active Expired - Lifetime
-
2011
- 2011-02-23 US US13/033,240 patent/US8748102B2/en active Active
-
2012
- 2012-03-13 US US13/419,241 patent/US20120238475A1/en not_active Abandoned
- 2012-08-20 JP JP2012181295A patent/JP5495399B2/ja not_active Expired - Lifetime
- 2012-09-14 US US13/618,334 patent/US8765380B2/en not_active Expired - Lifetime
- 2012-11-27 JP JP2012258136A patent/JP5726155B2/ja not_active Expired - Lifetime
- 2012-12-26 JP JP2012282220A patent/JP2013090635A/ja active Pending
-
2013
- 2013-09-25 US US14/036,398 patent/US20140162885A1/en not_active Abandoned
-
2014
- 2014-10-20 US US14/518,700 patent/US20150099672A1/en not_active Abandoned
-
2016
- 2016-06-23 US US15/190,886 patent/US10240192B2/en not_active Expired - Lifetime
-
2019
- 2019-01-16 US US16/249,681 patent/US10982274B2/en not_active Expired - Fee Related
Patent Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629158A (en) * | 1989-03-22 | 1997-05-13 | Cemu Bitecknik Ab | Solid phase diagnosis of medical conditions |
| US5508169A (en) * | 1990-04-06 | 1996-04-16 | Queen's University At Kingston | Indexing linkers |
| US5506100A (en) * | 1990-10-11 | 1996-04-09 | Indiana University Foundation | Process and apparatus for fragmenting biomaterials |
| US5610010A (en) * | 1990-10-11 | 1997-03-11 | Indiana University Foundation | Process and apparatus for fragmenting biomaterials |
| US5728524A (en) * | 1992-07-13 | 1998-03-17 | Medical Research Counsil | Process for categorizing nucleotide sequence populations |
| US6004783A (en) * | 1994-03-18 | 1999-12-21 | The General Hospital Corporation | Cleaved amplified RFLP detection methods |
| US5863722A (en) * | 1994-10-13 | 1999-01-26 | Lynx Therapeutics, Inc. | Method of sorting polynucleotides |
| US5814444A (en) * | 1995-06-07 | 1998-09-29 | University Of Washington | Methods for making and using single-chromosome amplfication libraries |
| US5989892A (en) * | 1995-06-14 | 1999-11-23 | Tonen Corporation | Microorganisms, demulsifiers and processes for breaking an emulsion |
| US6270966B1 (en) * | 1996-02-09 | 2001-08-07 | The United States Of America As Represented By The Department Of Health And Human Services | Restriction display (RD-PCR) of differentially expressed mRNAs |
| US6468748B1 (en) * | 1996-03-04 | 2002-10-22 | Sequenom, Inc. | Methods of screening nucleic acids using volatile salts in mass spectrometry |
| US6184012B1 (en) * | 1996-04-25 | 2001-02-06 | Medical Research Council | Isolation of enzymes |
| US6060245A (en) * | 1996-12-13 | 2000-05-09 | Stratagene | Methods and adaptors for generating specific nucleic acid populations |
| US5994068A (en) * | 1997-03-11 | 1999-11-30 | Wisconsin Alumni Research Foundation | Nucleic acid indexing |
| US6023540A (en) * | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
| US6266459B1 (en) * | 1997-03-14 | 2001-07-24 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
| US6489103B1 (en) * | 1997-07-07 | 2002-12-03 | Medical Research Council | In vitro sorting method |
| US6287825B1 (en) * | 1998-09-18 | 2001-09-11 | Molecular Staging Inc. | Methods for reducing the complexity of DNA sequences |
| US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
| US6475736B1 (en) * | 2000-05-23 | 2002-11-05 | Variagenics, Inc. | Methods for genetic analysis of DNA using biased amplification of polymorphic sites |
Cited By (492)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100016177A1 (en) * | 2001-06-20 | 2010-01-21 | Henrik Pedersen | Templated molecules and methods for using such molecules |
| US8932992B2 (en) | 2001-06-20 | 2015-01-13 | Nuevolution A/S | Templated molecules and methods for using such molecules |
| US10669538B2 (en) | 2001-06-20 | 2020-06-02 | Nuevolution A/S | Templated molecules and methods for using such molecules |
| US20050009022A1 (en) * | 2001-07-06 | 2005-01-13 | Weiner Michael P. | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US20030096268A1 (en) * | 2001-07-06 | 2003-05-22 | Michael Weiner | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US20040056018A1 (en) * | 2001-09-25 | 2004-03-25 | Beru Ag | Method for operating a multi-stage electrical heater comprised of several heating elements |
| US10731151B2 (en) | 2002-03-15 | 2020-08-04 | Nuevolution A/S | Method for synthesising templated molecules |
| US8808984B2 (en) | 2002-03-15 | 2014-08-19 | Neuvolution A/S | Method for synthesising templated molecules |
| US10730906B2 (en) | 2002-08-01 | 2020-08-04 | Nuevolutions A/S | Multi-step synthesis of templated molecules |
| US20060121470A1 (en) * | 2002-08-01 | 2006-06-08 | Henrik Pedersen | Multi-step synthesis of templated molecules |
| US9109248B2 (en) | 2002-10-30 | 2015-08-18 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
| US20060292603A1 (en) * | 2002-10-30 | 2006-12-28 | Gouliaev Alex H | Method for selecting a chemical entity from a tagged library |
| US11001835B2 (en) | 2002-10-30 | 2021-05-11 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
| US8206901B2 (en) | 2002-10-30 | 2012-06-26 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
| US10077440B2 (en) | 2002-10-30 | 2018-09-18 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
| US8722583B2 (en) | 2002-10-30 | 2014-05-13 | Nuevolution A/S | Method for selecting a chemical entity from a tagged library |
| US9284600B2 (en) | 2002-10-30 | 2016-03-15 | Neuvolution A/S | Method for the synthesis of a bifunctional complex |
| US20080193983A1 (en) * | 2002-12-19 | 2008-08-14 | Nuevolution A/S | Quasirandom Structure and Function Guided Synthesis Methods |
| US9121110B2 (en) | 2002-12-19 | 2015-09-01 | Nuevolution A/S | Quasirandom structure and function guided synthesis methods |
| US20080132693A1 (en) * | 2003-01-29 | 2008-06-05 | Jan Berka | Bead emulsion nucleic acid amplification |
| US10240192B2 (en) | 2003-01-29 | 2019-03-26 | 454 Life Sciences Corporation | Bead emulsion nucleic acid amplification |
| US20090011959A1 (en) * | 2003-01-29 | 2009-01-08 | Costa Gina L | Method for preparing single-stranded DNA libraries |
| US8748102B2 (en) | 2003-01-29 | 2014-06-10 | 454 Life Sciences Corporation | Bead emulsion nucleic acid amplification |
| US10982274B2 (en) | 2003-01-29 | 2021-04-20 | Roche Molecular Systems, Inc. | Bead emulsion nucleic acid amplification |
| US8012690B2 (en) | 2003-01-29 | 2011-09-06 | 454 Life Sciences Corporation | Bead emulsion nucleic acid amplification |
| US8765380B2 (en) | 2003-01-29 | 2014-07-01 | 454 Life Sciences Corporation | Bead emulsion nucleic acid amplification |
| US9096951B2 (en) | 2003-02-21 | 2015-08-04 | Nuevolution A/S | Method for producing second-generation library |
| USRE43365E1 (en) | 2003-03-14 | 2012-05-08 | Lawrence Livermore National Security, Llc | Apparatus for chemical amplification based on fluid partitioning in an immiscible liquid |
| USRE41780E1 (en) | 2003-03-14 | 2010-09-28 | Lawrence Livermore National Security, Llc | Chemical amplification based on fluid partitioning in an immiscible liquid |
| USRE45539E1 (en) | 2003-03-14 | 2015-06-02 | Lawrence Livermore National Security, Llc | Method for chemical amplification based on fluid partitioning in an immiscible liquid |
| USRE47080E1 (en) | 2003-03-14 | 2018-10-09 | Lawrence Livermore National Security, Llc | Chemical amplification based on fluid partitioning |
| USRE46322E1 (en) | 2003-03-14 | 2017-02-28 | Lawrence Livermore National Security, Llc | Method for chemical amplification based on fluid partitioning in an immiscible liquid |
| US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| USRE48788E1 (en) | 2003-03-14 | 2021-10-26 | Lawrence Livermore National Security, Llc | Chemical amplification based on fluid partitioning |
| US10604797B2 (en) | 2003-07-05 | 2020-03-31 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| US20090286687A1 (en) * | 2003-07-05 | 2009-11-19 | The Johns Hopkins University | Method and Compositions for Detection and Enumeration of Genetic Variations |
| US8048627B2 (en) | 2003-07-05 | 2011-11-01 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| US20070065823A1 (en) * | 2003-07-05 | 2007-03-22 | Devin Dressman | Method and compositions for detection and enumeration of genetic variations |
| US9328343B2 (en) | 2003-07-05 | 2016-05-03 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| WO2005010145A3 (en) * | 2003-07-05 | 2005-08-11 | Univ Johns Hopkins | Method and compositions for detection and enumeration of genetic variations |
| US11965209B2 (en) | 2003-09-18 | 2024-04-23 | Nuevolution A/S | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| US20080305957A1 (en) * | 2003-09-18 | 2008-12-11 | Thomas Thisted | Method for Obtaining Structural Information Concerning an Encoded Molecule and Method for Selecting Compounds |
| US11118215B2 (en) | 2003-09-18 | 2021-09-14 | Nuevolution A/S | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| US10953379B2 (en) | 2004-01-07 | 2021-03-23 | Illumina Cambridge Limited | Methods and compositions of localizing nucleic acids to arrays |
| US10525437B2 (en) | 2004-01-07 | 2020-01-07 | Illumina Cambridge Limited | Methods and compositions of localizing nucleic acids to arrays |
| US11654411B2 (en) | 2004-01-07 | 2023-05-23 | Illumina Cambridge Limited | Methods and compositions of localizing nucleic acids to arrays |
| EP3175914A1 (en) * | 2004-01-07 | 2017-06-07 | Illumina Cambridge Limited | Improvements in or relating to molecular arrays |
| US9889422B2 (en) | 2004-01-07 | 2018-02-13 | Illumina Cambridge Limited | Methods of localizing nucleic acids to arrays |
| US20110177587A1 (en) * | 2004-01-28 | 2011-07-21 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| US20090239211A1 (en) * | 2004-02-17 | 2009-09-24 | Nuevolution A/S | Method For Enrichment Involving Elimination By Mismatch Hybridisation |
| US20130309668A1 (en) * | 2004-03-08 | 2013-11-21 | Rubicon Genomics, Inc. | Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| US9708652B2 (en) * | 2004-03-08 | 2017-07-18 | Rubicon Genomics, Inc. | Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
| US10563252B2 (en) | 2004-06-25 | 2020-02-18 | University Of Hawaii | Ultrasensitive biosensors |
| US9109251B2 (en) | 2004-06-25 | 2015-08-18 | University Of Hawaii | Ultrasensitive biosensors |
| US8476063B2 (en) | 2004-09-15 | 2013-07-02 | Integenx Inc. | Microfluidic devices |
| US8551714B2 (en) | 2004-09-15 | 2013-10-08 | Integenx Inc. | Microfluidic devices |
| US9752185B2 (en) | 2004-09-15 | 2017-09-05 | Integenx Inc. | Microfluidic devices |
| US8431340B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Methods for processing and analyzing nucleic acid samples |
| US8431390B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Systems of sample processing having a macro-micro interface |
| US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
| US20060110764A1 (en) * | 2004-10-25 | 2006-05-25 | Tom Tang | Large-scale parallelized DNA sequencing |
| US10822641B2 (en) | 2004-11-12 | 2020-11-03 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
| US8753812B2 (en) | 2004-11-12 | 2014-06-17 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection method for DNA and other molecules |
| US9228971B2 (en) | 2004-11-12 | 2016-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
| US12139749B2 (en) | 2004-11-12 | 2024-11-12 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
| US20090325184A1 (en) * | 2005-03-16 | 2009-12-31 | Life Technologies Corporation | Compositions and Methods for Clonal Amplification and Analysis of Polynucleotides |
| US20060269934A1 (en) * | 2005-03-16 | 2006-11-30 | Applera Corporation | Compositions and methods for clonal amplification and analysis of polynucleotides |
| US7604940B1 (en) | 2005-03-16 | 2009-10-20 | Applied Biosystems, Llc | Compositions and methods for analyzing isolated polynucleotides |
| US20090233291A1 (en) * | 2005-06-06 | 2009-09-17 | 454 Life Sciences Corporation | Paired end sequencing |
| US9896721B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9453256B2 (en) * | 2005-06-23 | 2016-09-27 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US10235494B2 (en) | 2005-06-23 | 2019-03-19 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US10095832B2 (en) | 2005-06-23 | 2018-10-09 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9898576B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US10978175B2 (en) | 2005-06-23 | 2021-04-13 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9376716B2 (en) | 2005-06-23 | 2016-06-28 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9493820B2 (en) * | 2005-06-23 | 2016-11-15 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9898577B2 (en) | 2005-06-23 | 2018-02-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US9447459B2 (en) | 2005-06-23 | 2016-09-20 | Keygene N.V. | Strategies for high throughput identification and detection of polymorphisms |
| US20070031865A1 (en) * | 2005-07-07 | 2007-02-08 | David Willoughby | Novel Process for Construction of a DNA Library |
| US8361807B2 (en) | 2005-08-22 | 2013-01-29 | Applied Biosystems, Llc | Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other |
| US10041113B2 (en) | 2005-08-22 | 2018-08-07 | Applied Biosystems, Llc | Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| US11162137B2 (en) | 2005-08-22 | 2021-11-02 | Applied Biosystems Llc | Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| US20110171748A1 (en) * | 2005-08-22 | 2011-07-14 | Life Technologies Corporation | Device And Method For Making Discrete Volumes Of A First Fluid In Contact With A Second Fluid, Which Are Immiscible With Each Other |
| US20070039866A1 (en) * | 2005-08-22 | 2007-02-22 | Schroeder Benjamin G | Device, system, and method for depositing processed immiscible-fluid-discrete-volumes |
| EP2660482A1 (en) | 2005-08-22 | 2013-11-06 | Life Technologies Corporation | Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| US7955864B2 (en) | 2005-08-22 | 2011-06-07 | Life Technologies Corporation | Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other |
| EP2660482B1 (en) * | 2005-08-22 | 2019-08-07 | Life Technologies Corporation | Vorrichtung, System und Verfahren unter Verwendung von nichtmischbaren Flüssigkeiten mit unterschiedlichen Volumen |
| US20070141593A1 (en) * | 2005-08-22 | 2007-06-21 | Lee Linda G | Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| US12435367B2 (en) | 2005-08-22 | 2025-10-07 | Applied Biosystems, Llc | Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| US9285297B2 (en) | 2005-08-22 | 2016-03-15 | Applied Biosystems, Llc | Device, system, and method for depositing processed immiscible-fluid-discrete-volumes |
| US20070068573A1 (en) * | 2005-08-22 | 2007-03-29 | Applera Corporation | Device and method for microfluidic control of a first fluid in contact with a second fluid, wherein the first and second fluids are immiscible |
| US11319585B2 (en) | 2005-08-22 | 2022-05-03 | Applied Biosystems, Llc | Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other |
| US20070062583A1 (en) * | 2005-08-22 | 2007-03-22 | Cox David M | Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other |
| US20070117121A1 (en) * | 2005-09-16 | 2007-05-24 | Hutchison Stephen K | cDNA library preparation |
| US10316364B2 (en) | 2005-09-29 | 2019-06-11 | Keygene N.V. | Method for identifying the source of an amplicon |
| US11649494B2 (en) | 2005-09-29 | 2023-05-16 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
| US10538806B2 (en) | 2005-09-29 | 2020-01-21 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
| US10233494B2 (en) | 2005-09-29 | 2019-03-19 | Keygene N.V. | High throughput screening of populations carrying naturally occurring mutations |
| US11702652B2 (en) | 2005-12-01 | 2023-07-18 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
| US9574189B2 (en) | 2005-12-01 | 2017-02-21 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
| US11008615B2 (en) | 2005-12-22 | 2021-05-18 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US9702004B2 (en) | 2005-12-22 | 2017-07-11 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US8815512B2 (en) | 2005-12-22 | 2014-08-26 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US10106850B2 (en) | 2005-12-22 | 2018-10-23 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US8911945B2 (en) | 2005-12-22 | 2014-12-16 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US9328383B2 (en) | 2005-12-22 | 2016-05-03 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US9062348B1 (en) | 2005-12-22 | 2015-06-23 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US9334536B2 (en) | 2005-12-22 | 2016-05-10 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US9777324B2 (en) | 2005-12-22 | 2017-10-03 | Keygene N.V. | Method for high-throughput AFLP-based polymorphism detection |
| US20180355350A1 (en) * | 2006-01-11 | 2018-12-13 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US12146134B2 (en) * | 2006-01-11 | 2024-11-19 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US20180080020A1 (en) * | 2006-01-11 | 2018-03-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US10633652B2 (en) * | 2006-01-11 | 2020-04-28 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US20070172839A1 (en) * | 2006-01-24 | 2007-07-26 | Smith Douglas R | Asymmetrical adapters and methods of use thereof |
| US20150197789A1 (en) * | 2006-02-08 | 2015-07-16 | Illumina Cambridge Limited | End modification to prevent over-representation of fragments |
| US10006081B2 (en) * | 2006-02-08 | 2018-06-26 | Illumina Cambridge Limited | End modification to prevent over-representation of fragments |
| US20070231823A1 (en) * | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
| US7993842B2 (en) | 2006-03-23 | 2011-08-09 | Life Technologies Corporation | Directed enrichment of genomic DNA for high-throughput sequencing |
| US10023907B2 (en) | 2006-04-04 | 2018-07-17 | Keygene N.V. | High throughput detection of molecular markers based on AFLP and high through-put sequencing |
| EP2963127A1 (en) * | 2006-04-04 | 2016-01-06 | Keygene N.V. | High throughput detection of molecular markers based on restriction fragments |
| US20120135871A1 (en) * | 2006-04-04 | 2012-05-31 | Keygene N.V. | High throughput detection of molecular markers based on aflp and high through-put sequencing |
| US20120202698A1 (en) * | 2006-04-04 | 2012-08-09 | Keygene N.V. | High throughput detection of molecular markers based on aflp and high through-put sequencing |
| EP3239304A1 (en) * | 2006-04-04 | 2017-11-01 | Keygene N.V. | High throughput detection of molecular markers based on aflp and high troughput sequencing |
| US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US12091710B2 (en) | 2006-05-11 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
| US12337287B2 (en) | 2006-05-11 | 2025-06-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US10202608B2 (en) | 2006-08-31 | 2019-02-12 | Gen9, Inc. | Iterative nucleic acid assembly using activation of vector-encoded traits |
| US20090318298A1 (en) * | 2006-09-28 | 2009-12-24 | President And Fellows Of Harvard College | Methods for Sequencing DNA |
| US20100143908A1 (en) * | 2006-11-15 | 2010-06-10 | Biospherex, Llc, A Limited Liability Company | Multitag sequencing ecogenomics analysis-us |
| US8603749B2 (en) * | 2006-11-15 | 2013-12-10 | Biospherex, LLC | Multitag sequencing ecogenomics analysis-US |
| US9404920B2 (en) | 2006-12-14 | 2016-08-02 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US12066399B2 (en) | 2006-12-14 | 2024-08-20 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8349167B2 (en) | 2006-12-14 | 2013-01-08 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8692298B2 (en) | 2006-12-14 | 2014-04-08 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| US8685230B2 (en) | 2006-12-14 | 2014-04-01 | Life Technologies Corporation | Methods and apparatus for high-speed operation of a chemically-sensitive sensor array |
| US20080145898A1 (en) * | 2006-12-14 | 2008-06-19 | Applera Corporation | Sequencing methods |
| US8415716B2 (en) | 2006-12-14 | 2013-04-09 | Life Technologies Corporation | Chemically sensitive sensors with feedback circuits |
| US8742472B2 (en) | 2006-12-14 | 2014-06-03 | Life Technologies Corporation | Chemically sensitive sensors with sample and hold capacitors |
| US8317999B2 (en) | 2006-12-14 | 2012-11-27 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US10816506B2 (en) | 2006-12-14 | 2020-10-27 | Life Technologies Corporation | Method for measuring analytes using large scale chemfet arrays |
| US8313639B2 (en) | 2006-12-14 | 2012-11-20 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8426898B2 (en) | 2006-12-14 | 2013-04-23 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US20090325183A1 (en) * | 2006-12-14 | 2009-12-31 | Life Technologies Corporation | Sequencing methods |
| US8313625B2 (en) | 2006-12-14 | 2012-11-20 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8426899B2 (en) | 2006-12-14 | 2013-04-23 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8658017B2 (en) | 2006-12-14 | 2014-02-25 | Life Technologies Corporation | Methods for operating an array of chemically-sensitive sensors |
| US8766328B2 (en) | 2006-12-14 | 2014-07-01 | Life Technologies Corporation | Chemically-sensitive sample and hold sensors |
| US10502708B2 (en) | 2006-12-14 | 2019-12-10 | Life Technologies Corporation | Chemically-sensitive sensor array calibration circuitry |
| US8764969B2 (en) | 2006-12-14 | 2014-07-01 | Life Technologies Corporation | Methods for operating chemically sensitive sensors with sample and hold capacitors |
| US8306757B2 (en) | 2006-12-14 | 2012-11-06 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8435395B2 (en) | 2006-12-14 | 2013-05-07 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US10415079B2 (en) | 2006-12-14 | 2019-09-17 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US20100282617A1 (en) * | 2006-12-14 | 2010-11-11 | Ion Torrent Systems Incorporated | Methods and apparatus for detecting molecular interactions using fet arrays |
| US8441044B2 (en) | 2006-12-14 | 2013-05-14 | Life Technologies Corporation | Methods for manufacturing low noise chemically-sensitive field effect transistors |
| US9989489B2 (en) | 2006-12-14 | 2018-06-05 | Life Technnologies Corporation | Methods for calibrating an array of chemically-sensitive sensors |
| US8445945B2 (en) | 2006-12-14 | 2013-05-21 | Life Technologies Corporation | Low noise chemically-sensitive field effect transistors |
| US11435314B2 (en) | 2006-12-14 | 2022-09-06 | Life Technologies Corporation | Chemically-sensitive sensor array device |
| US20220340965A1 (en) * | 2006-12-14 | 2022-10-27 | Life Technologies Corporation | Methods and Apparatus for Measuring Analytes Using Large Scale FET Arrays |
| US8450781B2 (en) | 2006-12-14 | 2013-05-28 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US10203300B2 (en) | 2006-12-14 | 2019-02-12 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8575664B2 (en) | 2006-12-14 | 2013-11-05 | Life Technologies Corporation | Chemically-sensitive sensor array calibration circuitry |
| US9951382B2 (en) | 2006-12-14 | 2018-04-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US9269708B2 (en) | 2006-12-14 | 2016-02-23 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8890216B2 (en) | 2006-12-14 | 2014-11-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8293082B2 (en) | 2006-12-14 | 2012-10-23 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8269261B2 (en) | 2006-12-14 | 2012-09-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8492800B2 (en) | 2006-12-14 | 2013-07-23 | Life Technologies Corporation | Chemically sensitive sensors with sample and hold capacitors |
| US8558288B2 (en) | 2006-12-14 | 2013-10-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US7948015B2 (en) | 2006-12-14 | 2011-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US11732297B2 (en) * | 2006-12-14 | 2023-08-22 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US12140560B2 (en) | 2006-12-14 | 2024-11-12 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8540867B2 (en) | 2006-12-14 | 2013-09-24 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8540865B2 (en) | 2006-12-14 | 2013-09-24 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8264014B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8492799B2 (en) | 2006-12-14 | 2013-07-23 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US9134269B2 (en) | 2006-12-14 | 2015-09-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US9023189B2 (en) | 2006-12-14 | 2015-05-05 | Life Technologies Corporation | High density sensor array without wells |
| US9039888B2 (en) | 2006-12-14 | 2015-05-26 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8540868B2 (en) | 2006-12-14 | 2013-09-24 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8540866B2 (en) | 2006-12-14 | 2013-09-24 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
| US8535513B2 (en) | 2006-12-14 | 2013-09-17 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8530941B2 (en) | 2006-12-14 | 2013-09-10 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8496802B2 (en) | 2006-12-14 | 2013-07-30 | Life Technologies Corporation | Methods for operating chemically-sensitive sample and hold sensors |
| US8519448B2 (en) | 2006-12-14 | 2013-08-27 | Life Technologies Corporation | Chemically-sensitive array with active and reference sensors |
| US10633699B2 (en) | 2006-12-14 | 2020-04-28 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8502278B2 (en) | 2006-12-14 | 2013-08-06 | Life Technologies Corporation | Chemically-sensitive sample and hold sensors |
| US8557518B2 (en) | 2007-02-05 | 2013-10-15 | Integenx Inc. | Microfluidic and nanofluidic devices, systems, and applications |
| US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
| US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11224876B2 (en) | 2007-04-19 | 2022-01-18 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11618024B2 (en) | 2007-04-19 | 2023-04-04 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US20090105959A1 (en) * | 2007-06-01 | 2009-04-23 | Braverman Michael S | System and method for identification of individual samples from a multiplex mixture |
| US20100267043A1 (en) * | 2007-06-01 | 2010-10-21 | Braverman Michael S | System and method for identification of individual samples from a multiplex mixture |
| US20090053724A1 (en) * | 2007-06-28 | 2009-02-26 | 454 Life Sciences Corporation | System and method for adaptive reagent control in nucleic acid sequencing |
| US8241850B2 (en) * | 2007-06-29 | 2012-08-14 | Population Genetics Technologies Ltd. | Methods and compositions for isolating nucleic acid sequence variants |
| US20100136557A1 (en) * | 2007-06-29 | 2010-06-03 | Sydney Brenner | Methods and Compositions for Isolating Nucleic Acid Sequence Variants |
| US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8748165B2 (en) | 2008-01-22 | 2014-06-10 | Integenx Inc. | Methods for generating short tandem repeat (STR) profiles |
| US20090203086A1 (en) * | 2008-02-06 | 2009-08-13 | 454 Life Sciences Corporation | System and method for improved signal detection in nucleic acid sequencing |
| US8524057B2 (en) | 2008-06-25 | 2013-09-03 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US9194000B2 (en) | 2008-06-25 | 2015-11-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US8470164B2 (en) | 2008-06-25 | 2013-06-25 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US7888034B2 (en) | 2008-07-01 | 2011-02-15 | 454 Life Sciences Corporation | System and method for detection of HIV tropism variants |
| US8344123B2 (en) | 2008-07-01 | 2013-01-01 | 454 Life Sciences Corporation | System and method for detection of HIV tropism variants |
| USRE46293E1 (en) | 2008-07-01 | 2017-01-31 | 454 Life Sciences Corporation | System and method for detection of HIV tropism variants |
| US11534727B2 (en) | 2008-07-18 | 2022-12-27 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US11596908B2 (en) | 2008-07-18 | 2023-03-07 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US9856471B2 (en) | 2008-08-27 | 2018-01-02 | Gen9, Inc. | Methods and devices for high fidelity polynucleotide synthesis |
| US11015191B2 (en) | 2008-08-27 | 2021-05-25 | Gen9, Inc. | Methods and devices for high fidelity polynucleotide synthesis |
| US8808986B2 (en) | 2008-08-27 | 2014-08-19 | Gen9, Inc. | Methods and devices for high fidelity polynucleotide synthesis |
| US20100261189A1 (en) * | 2008-10-03 | 2010-10-14 | Roche Molecular Systems, Inc. | System and method for detection of HLA Variants |
| US8936763B2 (en) | 2008-10-22 | 2015-01-20 | Life Technologies Corporation | Integrated sensor arrays for biological and chemical analysis |
| US11874250B2 (en) | 2008-10-22 | 2024-01-16 | Life Technologies Corporation | Integrated sensor arrays for biological and chemical analysis |
| US20100137143A1 (en) * | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
| US11448613B2 (en) | 2008-10-22 | 2022-09-20 | Life Technologies Corporation | ChemFET sensor array including overlying array of wells |
| US9964515B2 (en) | 2008-10-22 | 2018-05-08 | Life Technologies Corporation | Integrated sensor arrays for biological and chemical analysis |
| US11137369B2 (en) | 2008-10-22 | 2021-10-05 | Life Technologies Corporation | Integrated sensor arrays for biological and chemical analysis |
| US12146853B2 (en) | 2008-10-22 | 2024-11-19 | Life Technologies Corporation | Methods and apparatus including array of reaction chambers over array of chemFET sensors for measuring analytes |
| US9944981B2 (en) | 2008-10-22 | 2018-04-17 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8672532B2 (en) | 2008-12-31 | 2014-03-18 | Integenx Inc. | Microfluidic methods |
| US10518230B2 (en) | 2009-03-13 | 2019-12-31 | President And Fellows Of Harvard College | Scale-up of microfluidic devices |
| US9486757B2 (en) | 2009-03-13 | 2016-11-08 | President And Fellows Of Harvard College | Scale-up of microfluidic devices |
| US11517864B2 (en) | 2009-03-13 | 2022-12-06 | President And Fellows Of Harvard College | Scale-up of microfluidic devices |
| US12352673B2 (en) | 2009-03-23 | 2025-07-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
| US20100301398A1 (en) * | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
| US8748947B2 (en) | 2009-05-29 | 2014-06-10 | Life Technologies Corporation | Active chemically-sensitive sensors with reset switch |
| US12038405B2 (en) | 2009-05-29 | 2024-07-16 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8263336B2 (en) | 2009-05-29 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US12234452B2 (en) | 2009-05-29 | 2025-02-25 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
| US11692964B2 (en) | 2009-05-29 | 2023-07-04 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US10451585B2 (en) | 2009-05-29 | 2019-10-22 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8592153B1 (en) | 2009-05-29 | 2013-11-26 | Life Technologies Corporation | Methods for manufacturing high capacitance microwell structures of chemically-sensitive sensors |
| US10809226B2 (en) | 2009-05-29 | 2020-10-20 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8766327B2 (en) | 2009-05-29 | 2014-07-01 | Life Technologies Corporation | Active chemically-sensitive sensors with in-sensor current sources |
| US8994076B2 (en) | 2009-05-29 | 2015-03-31 | Life Technologies Corporation | Chemically-sensitive field effect transistor based pixel array with protection diodes |
| US8742469B2 (en) | 2009-05-29 | 2014-06-03 | Life Technologies Corporation | Active chemically-sensitive sensors with correlated double sampling |
| US11768171B2 (en) | 2009-05-29 | 2023-09-26 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8822205B2 (en) | 2009-05-29 | 2014-09-02 | Life Technologies Corporation | Active chemically-sensitive sensors with source follower amplifier |
| US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
| US8698212B2 (en) | 2009-05-29 | 2014-04-15 | Life Technologies Corporation | Active chemically-sensitive sensors |
| US8592154B2 (en) | 2009-05-29 | 2013-11-26 | Life Technologies Corporation | Methods and apparatus for high speed operation of a chemically-sensitive sensor array |
| US8912580B2 (en) | 2009-05-29 | 2014-12-16 | Life Technologies Corporation | Active chemically-sensitive sensors with in-sensor current sources |
| US10718733B2 (en) | 2009-05-29 | 2020-07-21 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US12461054B2 (en) | 2009-05-29 | 2025-11-04 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
| US9927393B2 (en) | 2009-05-29 | 2018-03-27 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US10612017B2 (en) | 2009-05-29 | 2020-04-07 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
| US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8388908B2 (en) | 2009-06-02 | 2013-03-05 | Integenx Inc. | Fluidic devices with diaphragm valves |
| US8562918B2 (en) | 2009-06-05 | 2013-10-22 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
| US8394642B2 (en) | 2009-06-05 | 2013-03-12 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
| US9012236B2 (en) | 2009-06-05 | 2015-04-21 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
| US20110087016A1 (en) * | 2009-10-09 | 2011-04-14 | 454 Life Sciences Corporation | System and Method for Emulsion Breaking and Recovery of Biological Elements |
| US8609339B2 (en) | 2009-10-09 | 2013-12-17 | 454 Life Sciences Corporation | System and method for emulsion breaking and recovery of biological elements |
| WO2011042189A1 (en) | 2009-10-09 | 2011-04-14 | Roche Diagnostics Gmbh | System and method for emulsion breaking and recovery of biological elements |
| US10207240B2 (en) * | 2009-11-03 | 2019-02-19 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| WO2011056872A3 (en) * | 2009-11-03 | 2011-11-03 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| US20120220497A1 (en) * | 2009-11-03 | 2012-08-30 | Gen 9, Inc. | Methods and Microfluidic Devices for the Manipulation of Droplets in High Fidelity Polynucleotide Assembly |
| US9422600B2 (en) | 2009-11-25 | 2016-08-23 | Gen9, Inc. | Methods and apparatuses for chip-based DNA error reduction |
| US9968902B2 (en) | 2009-11-25 | 2018-05-15 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| US9216414B2 (en) | 2009-11-25 | 2015-12-22 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| US10829759B2 (en) | 2009-11-25 | 2020-11-10 | Gen9, Inc. | Methods and apparatuses for chip-based DNA error reduction |
| US20110126911A1 (en) * | 2009-12-01 | 2011-06-02 | IntegenX Inc., a California Corporation | Composite Plastic Articles |
| US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
| US11071963B2 (en) | 2010-01-07 | 2021-07-27 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US9217144B2 (en) | 2010-01-07 | 2015-12-22 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US9925510B2 (en) | 2010-01-07 | 2018-03-27 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US12454718B2 (en) | 2010-02-12 | 2025-10-28 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| AU2011221243B2 (en) * | 2010-02-25 | 2016-06-02 | Advanced Liquid Logic, Inc. | Method of making nucleic acid libraries |
| WO2011106314A3 (en) * | 2010-02-25 | 2012-02-23 | Advanced Liquid Logic, Inc. | Method of making nucleic acid libraries |
| US9938553B2 (en) | 2010-03-03 | 2018-04-10 | Gen9, Inc. | Methods and devices for nucleic acid synthesis |
| US20110217738A1 (en) * | 2010-03-03 | 2011-09-08 | Gen9, Inc. | Methods and Devices for Nucleic Acid Synthesis |
| US9388407B2 (en) | 2010-03-03 | 2016-07-12 | Gen9, Inc. | Methods and devices for nucleic acid synthesis |
| US8716467B2 (en) | 2010-03-03 | 2014-05-06 | Gen9, Inc. | Methods and devices for nucleic acid synthesis |
| US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
| US8415176B2 (en) | 2010-06-30 | 2013-04-09 | Life Technologies Corporation | One-transistor pixel array |
| US8487790B2 (en) | 2010-06-30 | 2013-07-16 | Life Technologies Corporation | Chemical detection circuit including a serializer circuit |
| US8772698B2 (en) | 2010-06-30 | 2014-07-08 | Life Technologies Corporation | CCD-based multi-transistor active pixel sensor array |
| US8217433B1 (en) | 2010-06-30 | 2012-07-10 | Life Technologies Corporation | One-transistor pixel array |
| US9957564B2 (en) | 2010-06-30 | 2018-05-01 | Bgi Genomics Co., Ltd. | Application of a PCR sequencing method, based on DNA barcoding technique and DNA incomplete shearing strategy, in HLA genotyping |
| US8247849B2 (en) | 2010-06-30 | 2012-08-21 | Life Technologies Corporation | Two-transistor pixel array |
| US8415177B2 (en) | 2010-06-30 | 2013-04-09 | Life Technologies Corporation | Two-transistor pixel array |
| US10641729B2 (en) | 2010-06-30 | 2020-05-05 | Life Technologies Corporation | Column ADC |
| US8421437B2 (en) | 2010-06-30 | 2013-04-16 | Life Technologies Corporation | Array column integrator |
| US8432150B2 (en) | 2010-06-30 | 2013-04-30 | Life Technologies Corporation | Methods for operating an array column integrator |
| EP2599877B1 (en) * | 2010-06-30 | 2017-09-27 | BGI Genomics Co., Limited | New pcr sequencing method and use thereof in hla genotyping |
| US8432149B2 (en) | 2010-06-30 | 2013-04-30 | Life Technologies Corporation | Array column integrator |
| US8455927B2 (en) | 2010-06-30 | 2013-06-04 | Life Technologies Corporation | One-transistor pixel array with cascoded column circuit |
| US8742471B2 (en) | 2010-06-30 | 2014-06-03 | Life Technologies Corporation | Chemical sensor array with leakage compensation circuit |
| US12038406B2 (en) | 2010-06-30 | 2024-07-16 | Life Technologies Corporation | Semiconductor-based chemical detection device |
| US9239313B2 (en) | 2010-06-30 | 2016-01-19 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
| US9164070B2 (en) | 2010-06-30 | 2015-10-20 | Life Technologies Corporation | Column adc |
| US8524487B2 (en) | 2010-06-30 | 2013-09-03 | Life Technologies Corporation | One-transistor pixel array with cascoded column circuit |
| US11231451B2 (en) | 2010-06-30 | 2022-01-25 | Life Technologies Corporation | Methods and apparatus for testing ISFET arrays |
| US10481123B2 (en) | 2010-06-30 | 2019-11-19 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
| US8983783B2 (en) | 2010-06-30 | 2015-03-17 | Life Technologies Corporation | Chemical detection device having multiple flow channels |
| US8731847B2 (en) | 2010-06-30 | 2014-05-20 | Life Technologies Corporation | Array configuration and readout scheme |
| US8858782B2 (en) | 2010-06-30 | 2014-10-14 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
| US8823380B2 (en) | 2010-06-30 | 2014-09-02 | Life Technologies Corporation | Capacitive charge pump |
| US8741680B2 (en) | 2010-06-30 | 2014-06-03 | Life Technologies Corporation | Two-transistor pixel array |
| US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
| US8653567B2 (en) | 2010-07-03 | 2014-02-18 | Life Technologies Corporation | Chemically sensitive sensor with lightly doped drains |
| US9960253B2 (en) | 2010-07-03 | 2018-05-01 | Life Technologies Corporation | Chemically sensitive sensor with lightly doped drains |
| US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
| US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
| US9731266B2 (en) | 2010-08-20 | 2017-08-15 | Integenx Inc. | Linear valve arrays |
| US9958415B2 (en) | 2010-09-15 | 2018-05-01 | Life Technologies Corporation | ChemFET sensor including floating gate |
| US9958414B2 (en) | 2010-09-15 | 2018-05-01 | Life Technologies Corporation | Apparatus for measuring analytes including chemical sensor array |
| US12050195B2 (en) | 2010-09-15 | 2024-07-30 | Life Technologies Corporation | Methods and apparatus for measuring analytes using chemfet arrays |
| US9618475B2 (en) | 2010-09-15 | 2017-04-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
| US8912005B1 (en) | 2010-09-24 | 2014-12-16 | Life Technologies Corporation | Method and system for delta double sampling |
| US9110015B2 (en) | 2010-09-24 | 2015-08-18 | Life Technologies Corporation | Method and system for delta double sampling |
| US8685324B2 (en) | 2010-09-24 | 2014-04-01 | Life Technologies Corporation | Matched pair transistor circuits |
| US8796036B2 (en) | 2010-09-24 | 2014-08-05 | Life Technologies Corporation | Method and system for delta double sampling |
| US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| US10246703B2 (en) | 2010-10-08 | 2019-04-02 | President And Fellows Of Harvard College | High-throughput single cell barcoding |
| US9902950B2 (en) | 2010-10-08 | 2018-02-27 | President And Fellows Of Harvard College | High-throughput single cell barcoding |
| GB2497912B (en) * | 2010-10-08 | 2014-06-04 | Harvard College | High-throughput single cell barcoding |
| US10752895B2 (en) | 2010-10-08 | 2020-08-25 | President And Fellows Of Harvard College | High-throughput single cell barcoding |
| US11396651B2 (en) | 2010-10-08 | 2022-07-26 | President And Fellows Of Harvard College | High-throughput single cell barcoding |
| US11084014B2 (en) | 2010-11-12 | 2021-08-10 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
| US10982208B2 (en) | 2010-11-12 | 2021-04-20 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| US11845054B2 (en) | 2010-11-12 | 2023-12-19 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
| US10457935B2 (en) | 2010-11-12 | 2019-10-29 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| US11965877B2 (en) | 2011-02-18 | 2024-04-23 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11747327B2 (en) | 2011-02-18 | 2023-09-05 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140590B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11768198B2 (en) | 2011-02-18 | 2023-09-26 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12461094B2 (en) | 2011-02-18 | 2025-11-04 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140591B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| WO2012130681A1 (en) | 2011-03-25 | 2012-10-04 | Roche Diagnostics Gmbh | System and method for detection of hiv integrase variants |
| US11754499B2 (en) | 2011-06-02 | 2023-09-12 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US9752176B2 (en) | 2011-06-15 | 2017-09-05 | Ginkgo Bioworks, Inc. | Methods for preparative in vitro cloning |
| US9513253B2 (en) | 2011-07-11 | 2016-12-06 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based enzymatic assays |
| US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
| US11702662B2 (en) | 2011-08-26 | 2023-07-18 | Gen9, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
| US12168798B2 (en) | 2011-10-21 | 2024-12-17 | Integenx. Inc. | Sample preparation, processing and analysis systems |
| US10525467B2 (en) | 2011-10-21 | 2020-01-07 | Integenx Inc. | Sample preparation, processing and analysis systems |
| US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
| US11684918B2 (en) | 2011-10-21 | 2023-06-27 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
| US10365321B2 (en) | 2011-12-01 | 2019-07-30 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
| US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
| US10598723B2 (en) | 2011-12-01 | 2020-03-24 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
| US10704091B2 (en) | 2012-01-13 | 2020-07-07 | Data2Bio | Genotyping by next-generation sequencing |
| US20180201996A1 (en) * | 2012-01-13 | 2018-07-19 | Data2Bio | Genotyping by next-generation sequencing |
| US9951384B2 (en) | 2012-01-13 | 2018-04-24 | Data2Bio | Genotyping by next-generation sequencing |
| US8821798B2 (en) | 2012-01-19 | 2014-09-02 | Life Technologies Corporation | Titanium nitride as sensing layer for microwell structure |
| US8747748B2 (en) | 2012-01-19 | 2014-06-10 | Life Technologies Corporation | Chemical sensor with conductive cup-shaped sensor surface |
| US10308931B2 (en) | 2012-03-21 | 2019-06-04 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| US10081807B2 (en) | 2012-04-24 | 2018-09-25 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| US10927369B2 (en) | 2012-04-24 | 2021-02-23 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| US10192024B2 (en) | 2012-05-18 | 2019-01-29 | 454 Life Sciences Corporation | System and method for generation and use of optimal nucleotide flow orders |
| US8786331B2 (en) | 2012-05-29 | 2014-07-22 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US10404249B2 (en) | 2012-05-29 | 2019-09-03 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US9985624B2 (en) | 2012-05-29 | 2018-05-29 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US9270264B2 (en) | 2012-05-29 | 2016-02-23 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US8552771B1 (en) | 2012-05-29 | 2013-10-08 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
| US12241057B2 (en) | 2012-06-25 | 2025-03-04 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| US11072789B2 (en) | 2012-06-25 | 2021-07-27 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| US11441179B2 (en) | 2012-08-14 | 2022-09-13 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US12037634B2 (en) | 2012-08-14 | 2024-07-16 | 10X Genomics, Inc. | Capsule array devices and methods of use |
| US12098423B2 (en) | 2012-08-14 | 2024-09-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11359239B2 (en) | 2012-08-14 | 2022-06-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| EP3901273A1 (en) * | 2012-08-14 | 2021-10-27 | 10X Genomics, Inc. | Microcapsule compositions and methods |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US12281354B2 (en) | 2012-09-04 | 2025-04-22 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US11434523B2 (en) | 2012-09-04 | 2022-09-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US12116624B2 (en) | 2012-09-04 | 2024-10-15 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| WO2014043140A1 (en) * | 2012-09-12 | 2014-03-20 | The Regents Of The University Of California | Accurate genome sequencing of single cells by single-stranded amplification and sequencing |
| US10752945B2 (en) | 2012-09-12 | 2020-08-25 | The Regents Of The University Of California | Accurate genome sequencing of single cells by single-stranded amplification and sequencing |
| US9803226B2 (en) | 2012-10-26 | 2017-10-31 | Sysmex Corporation | Emulsion systems and emulsion-based amplification of nucleic acid |
| WO2014068407A3 (en) * | 2012-10-26 | 2014-06-26 | Sysmex Corporation | Emulsion systems and emulsion-based amplification of nucleic acid |
| US11473138B2 (en) | 2012-12-14 | 2022-10-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11421274B2 (en) | 2012-12-14 | 2022-08-23 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9852919B2 (en) | 2013-01-04 | 2017-12-26 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
| US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
| US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
| US10436742B2 (en) | 2013-01-08 | 2019-10-08 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
| US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
| US11193121B2 (en) | 2013-02-08 | 2021-12-07 | 10X Genomics, Inc. | Partitioning and processing of analytes and other species |
| US9995708B2 (en) | 2013-03-13 | 2018-06-12 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
| US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
| US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
| US10422767B2 (en) | 2013-03-15 | 2019-09-24 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
| US9816088B2 (en) | 2013-03-15 | 2017-11-14 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US9671363B2 (en) | 2013-03-15 | 2017-06-06 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
| US11118176B2 (en) | 2013-03-15 | 2021-09-14 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US9128044B2 (en) | 2013-03-15 | 2015-09-08 | Life Technologies Corporation | Chemical sensors with consistent sensor surface areas |
| US10119134B2 (en) | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US10481124B2 (en) | 2013-03-15 | 2019-11-19 | Life Technologies Corporation | Chemical device with thin conductive element |
| US9116117B2 (en) | 2013-03-15 | 2015-08-25 | Life Technologies Corporation | Chemical sensor with sidewall sensor surface |
| US10392614B2 (en) | 2013-03-15 | 2019-08-27 | Abvitro Llc | Methods of single-cell barcoding and sequencing |
| US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
| US9823217B2 (en) | 2013-03-15 | 2017-11-21 | Life Technologies Corporation | Chemical device with thin conductive element |
| EP2971168B1 (en) | 2013-03-15 | 2021-05-05 | Guardant Health, Inc. | Method of detecting cancer |
| US12129462B2 (en) | 2013-03-15 | 2024-10-29 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US10876107B2 (en) | 2013-03-15 | 2020-12-29 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| US10100357B2 (en) | 2013-05-09 | 2018-10-16 | Life Technologies Corporation | Windowed sequencing |
| US10655175B2 (en) | 2013-05-09 | 2020-05-19 | Life Technologies Corporation | Windowed sequencing |
| US11028438B2 (en) | 2013-05-09 | 2021-06-08 | Life Technologies Corporation | Windowed sequencing |
| US10816504B2 (en) | 2013-06-10 | 2020-10-27 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| US11499938B2 (en) | 2013-06-10 | 2022-11-15 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| US11774401B2 (en) | 2013-06-10 | 2023-10-03 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
| EP2840148A1 (en) | 2013-08-23 | 2015-02-25 | F. Hoffmann-La Roche AG | System and method for nucleic acid amplification |
| US9624519B2 (en) | 2013-08-23 | 2017-04-18 | 454 Life Sciences Corporation | System and method for nucleic acid amplification |
| EP2848698A1 (en) | 2013-08-26 | 2015-03-18 | F. Hoffmann-La Roche AG | System and method for automated nucleic acid amplification |
| US9808806B2 (en) | 2013-08-26 | 2017-11-07 | 454 Life Sciences Corporation | System and method for automated nucleic acid amplification |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US10989723B2 (en) | 2013-11-18 | 2021-04-27 | IntegenX, Inc. | Cartridges and instruments for sample analysis |
| US10191071B2 (en) | 2013-11-18 | 2019-01-29 | IntegenX, Inc. | Cartridges and instruments for sample analysis |
| US12385933B2 (en) | 2013-11-18 | 2025-08-12 | Integenx Inc. | Cartridges and instruments for sample analysis |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11639526B2 (en) | 2013-12-28 | 2023-05-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11959139B2 (en) | 2013-12-28 | 2024-04-16 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12024745B2 (en) | 2013-12-28 | 2024-07-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12024746B2 (en) | 2013-12-28 | 2024-07-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12435368B2 (en) | 2013-12-28 | 2025-10-07 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12098421B2 (en) | 2013-12-28 | 2024-09-24 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12319961B1 (en) | 2013-12-28 | 2025-06-03 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12098422B2 (en) | 2013-12-28 | 2024-09-24 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12286672B2 (en) | 2013-12-28 | 2025-04-29 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11767556B2 (en) | 2013-12-28 | 2023-09-26 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11767555B2 (en) | 2013-12-28 | 2023-09-26 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12258626B2 (en) | 2013-12-28 | 2025-03-25 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US12054774B2 (en) | 2013-12-28 | 2024-08-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11639525B2 (en) | 2013-12-28 | 2023-05-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11434531B2 (en) | 2013-12-28 | 2022-09-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11649491B2 (en) | 2013-12-28 | 2023-05-16 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
| US11667959B2 (en) | 2014-03-05 | 2023-06-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US11447813B2 (en) | 2014-03-05 | 2022-09-20 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US12152272B2 (en) | 2014-05-21 | 2024-11-26 | Integenx Inc. | Fluidic cartridge with valve mechanism |
| US11891650B2 (en) | 2014-05-21 | 2024-02-06 | IntegenX, Inc. | Fluid cartridge with valve mechanism |
| US10961561B2 (en) | 2014-05-21 | 2021-03-30 | IntegenX, Inc. | Fluidic cartridge with valve mechanism |
| US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
| US12312640B2 (en) | 2014-06-26 | 2025-05-27 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| US11713457B2 (en) | 2014-06-26 | 2023-08-01 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US11629344B2 (en) | 2014-06-26 | 2023-04-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10590483B2 (en) | 2014-09-15 | 2020-03-17 | Abvitro Llc | High-throughput nucleotide library sequencing |
| US10344317B2 (en) | 2014-10-13 | 2019-07-09 | Mgi Tech Co., Ltd | Method and a sequence combination for producing nucleic acid fragments |
| EP3208343A4 (en) * | 2014-10-13 | 2018-03-21 | BGI Shenzhen Co., Limited | Nucleic acid fragmentation method and sequence combination |
| US12099032B2 (en) | 2014-10-22 | 2024-09-24 | IntegenX, Inc. | Systems and methods for sample preparation, processing and analysis |
| US10690627B2 (en) | 2014-10-22 | 2020-06-23 | IntegenX, Inc. | Systems and methods for sample preparation, processing and analysis |
| US11536688B2 (en) | 2014-12-18 | 2022-12-27 | Life Technologies Corporation | High data rate integrated circuit with transmitter configuration |
| US10767224B2 (en) | 2014-12-18 | 2020-09-08 | Life Technologies Corporation | High data rate integrated circuit with power management |
| US10605767B2 (en) | 2014-12-18 | 2020-03-31 | Life Technologies Corporation | High data rate integrated circuit with transmitter configuration |
| US10379079B2 (en) | 2014-12-18 | 2019-08-13 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
| US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
| US12196704B2 (en) | 2014-12-18 | 2025-01-14 | Life Technologies Corporation | High data rate integrated circuit with transmitter configuration |
| US10421993B2 (en) | 2015-02-11 | 2019-09-24 | Paragon Genomics, Inc. | Methods and compositions for reducing non-specific amplification products |
| US9464318B2 (en) * | 2015-02-11 | 2016-10-11 | Paragon Genomics, Inc. | Methods and compositions for reducing non-specific amplification products |
| US10227647B2 (en) | 2015-02-17 | 2019-03-12 | Complete Genomics, Inc. | DNA sequencing using controlled strand displacement |
| US11319588B2 (en) | 2015-02-17 | 2022-05-03 | Mgi Tech Co., Ltd. | DNA sequencing using controlled strand displacement |
| EP3259372A4 (en) * | 2015-02-17 | 2018-11-07 | Complete Genomics, Inc. | Dna sequencing using controlled strand displacement |
| AU2016220404B2 (en) * | 2015-02-17 | 2021-05-27 | Mgi Tech Co., Ltd. | DNA sequencing using controlled strand displacement |
| WO2016160965A1 (en) * | 2015-03-30 | 2016-10-06 | Rubicon Genomics, Inc. | Methods and compositions for repair of dna ends by multiple enzymatic activities |
| US10301660B2 (en) | 2015-03-30 | 2019-05-28 | Takara Bio Usa, Inc. | Methods and compositions for repair of DNA ends by multiple enzymatic activities |
| US11339422B2 (en) | 2015-05-29 | 2022-05-24 | Illumina, Inc. | Methods of analyzing nucleic acids |
| US20180148767A1 (en) * | 2015-05-29 | 2018-05-31 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| US11795578B2 (en) | 2015-05-29 | 2023-10-24 | Illumina, Inc. | Methods of analyzing nucleic acids |
| US10640809B2 (en) * | 2015-05-29 | 2020-05-05 | Epicentre Technologies Corporation | Methods of analyzing nucleic acids |
| US11124842B2 (en) | 2015-06-09 | 2021-09-21 | Life Technologies Corporation | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging |
| US12338496B2 (en) | 2015-06-09 | 2025-06-24 | Life Technologies Corporation | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging |
| US10344336B2 (en) | 2015-06-09 | 2019-07-09 | Life Technologies Corporation | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging |
| WO2018049260A1 (en) * | 2016-09-09 | 2018-03-15 | Tl Biolabs Corp . | Reusable microarray compositions and methods |
| CN110062809A (zh) * | 2016-12-20 | 2019-07-26 | 豪夫迈·罗氏有限公司 | 用于环状共有序列测序的单链环状dna文库 |
| US12270070B2 (en) | 2016-12-20 | 2025-04-08 | Roche Sequencing Solutions, Inc. | Single stranded circular DNA libraries for circular consensus sequencing |
| US10100358B2 (en) | 2017-01-10 | 2018-10-16 | Paragon Genomics, Inc. | Methods and compositions for reducing redundant molecular barcodes created in primer extension reactions |
| CN110719958B (zh) * | 2017-04-06 | 2023-07-18 | 康博国际有限公司 | 构建核酸文库的方法和试剂盒 |
| WO2018186930A1 (en) * | 2017-04-06 | 2018-10-11 | MyOmicsDx, Inc | Method and kit for constructing nucleic acid library |
| CN110719958A (zh) * | 2017-04-06 | 2020-01-21 | 王磬 | 构建核酸文库的方法和试剂盒 |
| CN111133135A (zh) * | 2017-07-17 | 2020-05-08 | 希昆斯生物科学公司 | 用于高通量测序的快速文库构建 |
| US12203128B2 (en) | 2017-08-24 | 2025-01-21 | Takara Bio Usa, Inc. | Methods of producing nucleic acids using oligonucleotides modified by a stimulus |
| US11667952B2 (en) | 2017-08-24 | 2023-06-06 | Takara Bio Usa, Inc. | Methods of producing nucleic acids using oligonucleotides modified by a stimulus |
| CN108588200A (zh) * | 2018-05-06 | 2018-09-28 | 湖南大地同年生物科技有限公司 | 一种R-Loop高通量测序文库构建方法 |
| CN109853047A (zh) * | 2019-04-10 | 2019-06-07 | 翌圣生物科技(上海)有限公司 | 一种基因组dna测序文库快速构建方法及配套试剂盒 |
| EP3973070A1 (en) * | 2019-05-22 | 2022-03-30 | Oxford Nanopore Technologies PLC | Protocol for detecting interactions within one or more dna molecules within a cell |
| CN111455469A (zh) * | 2020-04-07 | 2020-07-28 | 深圳易倍科华生物科技有限公司 | 一种单链快速建库方法及建库仪器 |
| US10941453B1 (en) | 2020-05-20 | 2021-03-09 | Paragon Genomics, Inc. | High throughput detection of pathogen RNA in clinical specimens |
| WO2023175040A3 (en) * | 2022-03-15 | 2023-11-02 | Illumina, Inc. | Concurrent sequencing of forward and reverse complement strands on concatenated polynucleotides for methylation detection |
| US12091715B2 (en) | 2022-04-21 | 2024-09-17 | Paragon Genomics, Inc. | Methods and compositions for reducing base errors of massive parallel sequencing using triseq sequencing |
| US11680293B1 (en) | 2022-04-21 | 2023-06-20 | Paragon Genomics, Inc. | Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules |
| CN118086457A (zh) * | 2024-02-22 | 2024-05-28 | 纳昂达(南京)生物科技有限公司 | Dna文库的构建方法及应用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004209426B2 (en) | Method for preparing single-stranded DNA libraries | |
| KR102592367B1 (ko) | 게놈 및 치료학적 적용을 위한 핵산 분자의 클론 복제 및 증폭을 위한 시스템 및 방법 | |
| US20050221341A1 (en) | Sequence-based karyotyping | |
| CN110997932A (zh) | 用于甲基化测序的单细胞全基因组文库 | |
| KR20220034716A (ko) | 고체 지지물 상에 고정된 crispr/cas9를 사용하여 핵산 서열분석 라이브러리를 제조하기 위한 조성물 및 방법 | |
| AU2008200151B2 (en) | Bead Emulsion Nucleic Acid Amplification | |
| HK40063948A (en) | Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications | |
| CA2773059C (en) | Bead emulsion nucleic acid amplification | |
| HK40027672A (en) | Single cell whole genome libraries for methylation sequencing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: 454 CORPORATION, CONNECTICUT Free format text: CHANGE OF ADDRESS OF THE ASSIGNEE;ASSIGNORS:COSTA, GINA L.;LEAMON, JOHN H.;ROTHBERG, JONATHAN M.;AND OTHERS;REEL/FRAME:015388/0227;SIGNING DATES FROM 20040430 TO 20040514 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |